TW201837025A - Novel dithiolane compound or a salt or an n-oxide and use thereof - Google Patents

Novel dithiolane compound or a salt or an n-oxide and use thereof Download PDF

Info

Publication number
TW201837025A
TW201837025A TW107108616A TW107108616A TW201837025A TW 201837025 A TW201837025 A TW 201837025A TW 107108616 A TW107108616 A TW 107108616A TW 107108616 A TW107108616 A TW 107108616A TW 201837025 A TW201837025 A TW 201837025A
Authority
TW
Taiwan
Prior art keywords
optionally substituted
compound
group
salt
oxide
Prior art date
Application number
TW107108616A
Other languages
Chinese (zh)
Inventor
今井哲弥
蘇倫德拉 庫馬爾 庫瑪瓦
馬尼什 庫馬爾 辛格
帕拉莫德 庫馬爾 肖漢
阿米特 蕭漢
穆迪 賈德 阿什拉夫
博本德 庫馬爾 薩多利亞
阿納尼亞 提瓦利
Original Assignee
日商日本歐愛特農業科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日本歐愛特農業科技股份有限公司 filed Critical 日商日本歐愛特農業科技股份有限公司
Publication of TW201837025A publication Critical patent/TW201837025A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates

Abstract

An object of the present invention is to provide a dithiolane compound or a salt or an N-oxide thereof that controls diseases. The present invention provides a dithiolane compound represented by Formula (1):, or a salt or an N-oxide thereof, wherein R1 represents hydrogen, halogen, C1-6 alkyl or a substituent as defined herein; R2 represents hydrogen, halogen, C1-6 alkyl or a substituent as defined herein; R3 represents hydrogen, halogen, C1-6 alkyl or a substituent as defined herein; Y1 represents optionally substituted aryl, optionally substituted pyridyl or a substituent as defined herein; Y2 represents optionally substituted aryl, optionally substituted pyridyl or a substituent as defined herein; Q represents cyano or a substituent as defined herein.

Description

新穎二噻𠷬化合物或其鹽或其N-氧化物及其用途Novel dithiazide compound or salt thereof or N-oxide thereof and use thereof

本發明係關於新穎二噻𠷬化合物或其鹽或其N-氧化物及其製備方法。本發明進一步提供包含該等化合物之農業及園藝殺真菌劑組合物。The present invention relates to a novel dithiazide compound or a salt thereof or an N-oxide thereof and a process for the preparation thereof. The invention further provides agricultural and horticultural fungicide compositions comprising the compounds.

近年來,為保護植物免受由真菌引起之病害,正在使用各種已知之殺真菌劑。然而,由於該等殺真菌劑之長期及大量使用,已觀察到在各種真菌中產生抗性。因此,藉由使用已知殺真菌劑不能完成抗藥性真菌之防治。因此,業內需要開發具有針對抗藥性真菌之殺真菌活性之新型化合物。 WO 2015/003991 (專利文獻(PTL) 1)揭示由式(A)表示之化合物:, 其中,X係O、S或NR4 ;Y及Z獨立地係O、S、NR5 或C(R6 R7 );A係氫、烷基、鹵代烷基、環烷基、鹵代環烷基、芳基、雜芳基、諸如硝基、氰基、乙醯基、羧基或諸如此類之各種拉電子基團;Q係烷基、鹵代烷基、環烷基、芳基、雜芳基、雜環基或諸如此類;R1 、R2 及R3 獨立地係氫、鹵素、C1-6 烷基、C1-6 鹵代烷基、C3-7 環烷基、C1-6 烷氧基、C1-6 鹵代烷氧基或視情況經取代之苯基。該公開案亦提及由式(A)表示之化合物可用作防治植物病害之殺真菌劑。 專利文獻WO 2015/162271 (專利文獻(PTL) 2)及WO 2015/162269 (專利文獻(PTL) 3)亦揭示由式(B)表示之經咪唑取代之化合物:, 其中,X及Y獨立地係O、S或NR5 ;R1 、R2 及R4 獨立地係氫、鹵素、C1-6 烷基、C1-6 鹵代烷基、C1-6 環烷基、C1-6 烷氧基、C1-6 鹵代烷氧基;R3 係苯基,其經至少一個取代基R6 或芳香族5員雜環取代;且R5 係氫、C1-6 烷基、C1-6 烷氧基或C1-6 環烷基。 該等公開案亦提及由式(B)表示之化合物可用作防治植物病害之殺真菌劑。然而,該等公開案未揭示本發明之化合物。 另一專利文獻WO 2015/162268 (專利文獻(PTL) 4)亦揭示由式(C)表示之經咪唑取代之化合物:, 其中,X及Y獨立地係O、S或NR4 ;R1 、R2 及R3 獨立地係氫、鹵素、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基;Z1 、Z2 、Z3 、Z4 及Z5 獨立地係CR5 或N。 該公開案亦提及由式(C)表示之化合物可用作防治植物病害之殺真菌劑。然而,該公開案未揭示本發明之化合物。 引文清單 專利文獻 PTL 1:WO 2015/003991 PTL 2:WO 2015/162271 PTL 3:WO 2015/162269 PTL 4:WO 2015/162268In recent years, in order to protect plants from diseases caused by fungi, various known fungicides are being used. However, resistance to various fungi has been observed due to the long-term and extensive use of such fungicides. Therefore, the control of resistant fungi cannot be accomplished by using known fungicides. Therefore, there is a need in the industry to develop novel compounds having fungicidal activity against drug resistant fungi. WO 2015/003991 (Patent Document (PTL) 1) discloses a compound represented by the formula (A): Wherein X is O, S or NR 4 ; Y and Z are independently O, S, NR 5 or C(R 6 R 7 ); A is hydrogen, alkyl, haloalkyl, cycloalkyl, halogen ring An alkyl group, an aryl group, a heteroaryl group, various electron withdrawing groups such as a nitro group, a cyano group, an ethyl fluorenyl group, a carboxyl group or the like; a Q-based alkyl group, a halogenated alkyl group, a cycloalkyl group, an aryl group, a heteroaryl group, Heterocyclic group or the like; R 1 , R 2 and R 3 are independently hydrogen, halogen, C 1-6 alkyl, C 1-6 haloalkyl, C 3-7 cycloalkyl, C 1-6 alkoxy , C 1-6 haloalkoxy or optionally substituted phenyl. The publication also mentions that the compound represented by the formula (A) can be used as a fungicide for controlling plant diseases. Patent documents WO 2015/162271 (PTL 2) and WO 2015/162269 (PTL 3) also disclose imidazole-substituted compounds represented by formula (B): Wherein X and Y are independently O, S or NR 5 ; R 1 , R 2 and R 4 are independently hydrogen, halogen, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 ring An alkyl group, a C 1-6 alkoxy group, a C 1-6 haloalkoxy group; an R 3 -based phenyl group substituted with at least one substituent R 6 or an aromatic 5-membered heterocyclic ring; and R 5 is hydrogen, C 1 -6 alkyl, C 1-6 alkoxy or C 1-6 cycloalkyl. The publications also mention that the compound represented by the formula (B) can be used as a fungicide for controlling plant diseases. However, the publications do not disclose the compounds of the invention. Another patent document WO 2015/162268 (Patent Document (PTL) 4) also discloses an imidazole-substituted compound represented by formula (C): Wherein X and Y are independently O, S or NR 4 ; R 1 , R 2 and R 3 are independently hydrogen, halogen, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkane Oxyl, C 1-6 haloalkoxy; Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are independently CR 5 or N. The publication also mentions that the compound represented by the formula (C) can be used as a fungicide for controlling plant diseases. However, this publication does not disclose the compounds of the present invention. Citation List Patent Literature PTL 1: WO 2015/003991 PTL 2: WO 2015/162271 PTL 3: WO 2015/162269 PTL 4: WO 2015/162268

問題之解決 本發明提供新穎二噻𠷬化合物或其鹽或其N-氧化物,其展現針對抗藥性真菌以及藥物敏感性真菌之優良殺真菌活性。 本發明亦提供用於製備該二噻𠷬化合物或其鹽或其N-氧化物之方法。 本發明進一步提供用於農業及園藝之新型殺真菌劑,其展現針對抗化學品性真菌以及化學品敏感性真菌之顯著殺真菌效應。 具體而言,本發明者進行廣泛研究,且成功合成具有殺真菌活性之由式(1)表示之化合物或其鹽或其N-氧化物。本發明者已基於以上發現進行進一步研究。由此完成本發明。 更具體而言,本發明包括以下實施例: 項目1: 一種由式(1)表示之二噻𠷬化合物:, 或其鹽或其N-氧化物, 其中R1 、R2 及R3 相同或不同,且各自表示氫、鹵素、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基、C1-6 烷氧基C1-6 烷基、C1-6 鹵代烷氧基C1-6 烷基、C2-6 烯基、C2-6 鹵代烯基、C2-6 炔基、C2-6 鹵代炔基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、視情況經取代之芳基、視情況經取代之雜芳基或視情況經取代之雜環基,R1 、R2 及R3 基團中之兩者一起可經由或不經由至少一個雜原子形成環,表示為R1 、R2 及R3 之基團可視情況經進一步取代; Y1 表示視情況經取代之芳基、視情況經取代之吡啶基、視情況經取代之吡嗪基、視情況經取代之嘧啶基或視情況經取代之嗒嗪基; Y2 表示視情況經取代之芳基或視情況經取代之雜芳基;且 Q表示氫、硝基、氰基、C1-6 烷基、C1-6 鹵代烷基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、C1-6 烷基羰基、C1-6 鹵代烷基羰基、C3-8 環烷基羰基、C1-6 烷氧基羰基、C1-6 鹵代烷氧基羰基、C3-8 環烷氧基羰基、C1-6 烷硫基、C1-6 鹵代烷基硫基、C3-8 環烷基硫基、C3-8 環烷基C1-6 烷硫基、C1-6 烷氧基C1-6 烷硫基、C1-6 烷基磺醯基、C1-6 烷基亞磺醯基、C1-6 鹵代烷基磺醯基、C1-6 鹵代烷基亞磺醯基、C3-8 環烷基磺醯基、C3-8 環烷基亞磺醯基、C3-8 環烷基C1-6 烷基磺醯基、C3-8 環烷基C1-6 烷基亞磺醯基、視情況經取代之芳硫基、視情況經取代之芳基C1-6 烷硫基、視情況經取代之芳基磺醯基、視情況經取代之芳基亞磺醯基、視情況經取代之芳基、視情況經取代之雜芳基或視情況經取代之雜環基。 項目2: 如項目1之二噻𠷬化合物或其鹽或其N-氧化物,其中R1 、R2 及R3 相同或不同,且各自表示氫、鹵素或C1-6 烷基。 項目3: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中R1 、R2 及R3 相同或不同,且各自表示氫或C1-6 烷基。 項目4: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 係視情況經取代之芳基或視情況經取代之吡啶基。 項目5: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 係由Y1a 表示之苯環:, 其中R4 、R5 、R6 、R7 及R8 相同或不同,且各自表示氫、鹵素、硝基、氰基、羥基、甲醯基、視情況經取代之胺基、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基、C1-6 烷氧基C1-6 烷基、C1-6 鹵代烷氧基C1-6 烷基、C1-6 烷氧基羰基、C1-6 鹵代烷氧基羰基、氰基C1-6 烷基、氰基C1-6 烷氧基、C2-6 烯基、C2-6 鹵代烯基、氰基C2-6 烯基、C2-6 炔基、C2-6 鹵代炔基、氰基C2-6 炔基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、C1-6 烷硫基、C1-6 鹵代烷基硫基、C3-8 環烷基硫基、C3-8 環烷基C1-6 烷硫基、C1-6 烷氧基C1-6 烷硫基、C1-6 烷基磺醯基、C1-6 烷基亞磺醯基、C1-6 鹵代烷基磺醯基、C1-6 鹵代烷基亞磺醯基、C3-8 環烷基磺醯基、C3-8 環烷基亞磺醯基、C3-8 環烷基、C1-6 烷基磺醯基、C3-8 環烷基C1-6 烷基亞磺醯基、C2-6 烯氧基、C2-6 炔基氧基、C2-6 鹵代烯氧基、C2-6 鹵代炔基氧基、C1-6 烷基磺醯基氧基、C1-6 烷基亞磺醯基氧基、C1-6 烷基羰基、C1-6 鹵代烷基羰基、羧基、OCN、SCN、SF5 、視情況經取代之芳基氧基、視情況經取代之芳基C1-6 烷氧基、視情況經取代之芳硫基、視情況經取代之芳基C1-6 烷硫基、視情況經取代之芳基磺醯基、視情況經取代之芳基亞磺醯基、視情況經取代之雜芳基氧基、視情況經取代之芳基磺醯基氧基、視情況經取代之芳基亞磺醯基氧基、視情況經取代之芳基、視情況經取代之雜芳基或視情況經取代之雜環基;且 *係與母體化合物之連接點。 項目6: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,R4 、R5 、R6 、R7 及R8 相同或不同,且各自表示氫、鹵素、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基或C1-6 鹵代烷氧基。 項目7: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 係視情況經取代之4-吡啶基、視情況經取代之3-吡啶基或視情況經取代之2-吡啶基。 項目8: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 係由Y1b 、Y1c 及Y1d 中之任一者表示之吡啶環:, 其中R9 、R10 、R11 、R12 、R13 、R14 、R15 、R16 、R17 、R18 、R19 及R20 相同或不同,且各自表示氫、鹵素、硝基、氰基、羥基、甲醯基、視情況經取代之胺基、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基、C1-6 烷氧基C1-6 烷基、C1-6 鹵代烷氧基C1-6 烷基、C1-6 烷氧基羰基、C1-6 鹵代烷氧基羰基、氰基C1-6 烷基、氰基C1-6 烷氧基、C2-6 烯基、C2-6 鹵代烯基、氰基C2-6 烯基、C2-6 炔基、C2-6 鹵代炔基、氰基C2-6 炔基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、C1-6 烷硫基、C1-6 鹵代烷基硫基、C3-8 環烷基硫基、C3-8 環烷基C1-6 烷硫基、C1-6 烷氧基C1-6 烷硫基、C1-6 烷基磺醯基、C1-6 烷基亞磺醯基、C1-6 鹵代烷基磺醯基、C1-6 鹵代烷基亞磺醯基、C3-8 環烷基磺醯基、C3-8 環烷基亞磺醯基、C3-8 環烷基、C1-6 烷基磺醯基、C3-8 環烷基C1-6 烷基亞磺醯基、C2-6 烯氧基、C2-6 炔基氧基、C2-6 鹵代烯氧基、C2-6 鹵代炔基氧基、C1-6 烷基磺醯基氧基、C1-6 烷基亞磺醯基氧基、C1-6 烷基羰基、C1-6 鹵代烷基羰基、羧基、OCN、SCN、SF5 、視情況經取代之芳基氧基、視情況經取代之芳基C1-6 烷氧基、視情況經取代之芳硫基、視情況經取代之芳基C1-6 烷硫基、視情況經取代之芳基磺醯基、視情況經取代之芳基亞磺醯基、視情況經取代之雜芳基氧基、視情況經取代之芳基磺醯基氧基、視情況經取代之芳基亞磺醯基氧基、視情況經取代之芳基、視情況經取代之雜芳基或視情況經取代之雜環基;且 *係與母體化合物之連接點。 項目9: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中R9 、R10 、R11 、R12 、R13 、R14 、R15 、R16 、R17 、R18 、R19 及R20 相同或不同,且各自表示氫或鹵素。 項目10: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 表示:, 其中*係與母體化合物之連接點。 項目11: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 表示:, 其中*係與母體化合物之連接點。 項目12: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 表示:, 其中*係與母體化合物之連接點。 項目13: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係視情況經取代之芳基。 項目14: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係由Y2a 表示之苯環:, 其中R21 、R22 、R23 、R24 及R25 相同或不同,且各自表示氫、鹵素、硝基、氰基、羥基、甲醯基、視情況經取代之胺基、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基、C1-6 烷氧基C1-6 烷基、C1-6 鹵代烷氧基C1-6 烷基、C1-6 烷氧基羰基、C1-6 鹵代烷氧基羰基、氰基C1-6 烷基、氰基C1-6 烷氧基、C2-6 烯基、C2-6 鹵代烯基、氰基C2-6 烯基、C2-6 炔基、C2-6 鹵代炔基、氰基C2-6 炔基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、C1-6 烷硫基、C1-6 鹵代烷基硫基、C3-8 環烷基硫基、C3-8 環烷基C1-6 烷硫基、C1-6 烷氧基C1-6 烷硫基、C1-6 烷基磺醯基、C1-6 烷基亞磺醯基、C1-6 鹵代烷基磺醯基、C1-6 鹵代烷基亞磺醯基、C3-8 環烷基磺醯基、C3-8 環烷基亞磺醯基、C3-8 環烷基、C1-6 烷基磺醯基、C3-8 環烷基C1-6 烷基亞磺醯基、C2-6 烯氧基、C2-6 炔基氧基、C2-6 鹵代烯氧基、C2-6 鹵代炔基氧基、C1-6 烷基磺醯基氧基、C1-6 烷基亞磺醯基氧基、C1-6 烷基羰基、C1-6 鹵代烷基羰基、羧基、OCN、SCN、SF5 、視情況經取代之芳基氧基、視情況經取代之芳基C1-6 烷氧基、視情況經取代之芳硫基、視情況經取代之芳基C1-6 烷硫基、視情況經取代之芳基磺醯基、視情況經取代之芳基亞磺醯基、視情況經取代之雜芳基氧基、視情況經取代之芳基磺醯基氧基、視情況經取代之芳基亞磺醯基氧基、視情況經取代之芳基、視情況經取代之雜芳基或視情況經取代之雜環基;且 *係與母體化合物之連接點。 項目15: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中R21 、R22 、R23 、R24 及R25 相同或不同,且各自表示氫、鹵素、硝基、氰基、視情況經取代之胺基、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基或視情況經取代之芳基。 項目16: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係視情況經取代之雜芳基。 項目17: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係視情況經取代之吡啶基、視情況經取代之吡嗪基、視情況經取代之嘧啶基、視情況經取代之嗒嗪基或視情況經取代之噻唑基。 項目18: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係視情況經取代之吡啶基、視情況經取代之吡嗪基或視情況經取代之噻唑基。 項目19: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係視情況經取代之吡啶基。 項目20: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係視情況經取代之4-吡啶基、視情況經取代之3-吡啶基或視情況經取代之2-吡啶基。 項目21: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係由Y2b 、Y2c 及Y2d 中之任一者表示之吡啶環:, 其中R26 、R27 、R28 、R29 、R30 、R31 、R32 、R33 、R34 、R35 、R36 及R37 相同或不同,且各自表示氫、鹵素、硝基、氰基、羥基、甲醯基、視情況經取代之胺基、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基、C1-6 烷氧基C1-6 烷基、C1-6 鹵代烷氧基C1-6 烷基、C1-6 烷氧基羰基、C1-6 鹵代烷氧基羰基、氰基C1-6 烷基、氰基C1-6 烷氧基、C2-6 烯基、C2-6 鹵代烯基、氰基C2-6 烯基、C2-6 炔基、C2-6 鹵代炔基、氰基C2-6 炔基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、C1-6 烷硫基、C1-6 鹵代烷基硫基、C3-8 環烷基硫基、C3-8 環烷基C1-6 烷硫基、C1-6 烷氧基C1-6 烷硫基、C1-6 烷基磺醯基、C1-6 烷基亞磺醯基、C1-6 鹵代烷基磺醯基、C1-6 鹵代烷基亞磺醯基、C3-8 環烷基磺醯基、C3-8 環烷基亞磺醯基、C3-8 環烷基、C1-6 烷基磺醯基、C3-8 環烷基C1-6 烷基亞磺醯基、C2-6 烯氧基、C2-6 炔基氧基、C2-6 鹵代烯氧基、C2-6 鹵代炔基氧基、C1-6 烷基磺醯基氧基、C1-6 烷基亞磺醯基氧基、C1-6 烷基羰基、C1-6 鹵代烷基羰基、羧基、OCN、SCN、SF5 、視情況經取代之芳基氧基、視情況經取代之芳基C1-6 烷氧基、視情況經取代之芳硫基、視情況經取代之芳基C1-6 烷硫基、視情況經取代之芳基磺醯基、視情況經取代之芳基亞磺醯基、視情況經取代之雜芳基氧基、視情況經取代之芳基磺醯基氧基、視情況經取代之芳基亞磺醯基氧基、視情況經取代之芳基、視情況經取代之雜芳基或視情況經取代之雜環基;且 *係與母體化合物之連接點。 項目22: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中R26 、R27 、R28 、R29 、R30 、R31 、R32 、R33 、R34 、R35 、R36 及R37 相同或不同,且各自表示氫或鹵素。 項目23: 如前述項目中任一項目之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係選自由以下組成之群:;且 *係與母體化合物之連接點。 項目24: 一種選自由以下化合物組成之群之二噻𠷬化合物:1c-1、1c-2H、1c-2L、1c-3、1c-3H、1c-3L、1c-4H、1c-4L、1c-5L、1c-6L、1c-8、1c-8H、1c-8L、1c-9、1c-9H、1c-9L、1c-10H、1c-10L、1c-11H、1c-11L、1c-13H、1c-13L、1c-14H、1c-15H、1c-16、1c-16H、1c-19、1c-20、1c-23、1c-23H、1c-23L、1c-24、1c-24H、1c-25H、1c-25L、1c-26、1c-26H、1c-26L、1c-27H、1c-28L、1c-29H、1c-29L、1c-30H、1c-32H、1c-32L、1c-33、1c-34H、1c-34L、1c-35、1c-35H、1c-35L、1d-1H、1d-6H、1d-6L、1d-13、1d-17、1d-17H、1d-17L、1e-3及1e-7或其鹽或其N-氧化物。 項目25: 一種選自由以下化合物組成之群之二噻𠷬化合物:1c-2H、1c-2L、1c-3、1c-3H、1c-3L、1c-4H、1c-4L、1c-5L、1c-6L、1c-8、1c-8H、1c-8L、1c-9、1c-9H、1c-9L、1c-10H、1c-10L、1c-11H、1c-13H、1c-13L、1c-14H、1c-15H、1c-16、1c-16H、1c-19、1c-20、1c-23、1c-23H、1c-23L、1c-24H、1c-25H、1c-25L、1c-26、1c-26H、1c-26L、1c-27H、1c-29H、1c-29L、1c-32H、1c-32L、1c-33、1c-34H、1c-34L、1c-35及1c-35H或其鹽或其N-氧化物。 項目26: 一種選自由以下化合物組成之群之二噻𠷬化合物:1c-1、1c-1H、1c-1L、1c-2H、1c-2L、1c-3、1c-3H、1c-3L、1c-4H、1c-4L、1c-5H、1c-5L、1c-6、1c-6H、1c-6L、1c-7H、1c-7L、1c-8、1c-8H、1c-8L、1c-9、1c-9H、1c-9L、1c-10H、1c-10L、1c-11H、1c-11L、1c-13H、1c-13L、1c-14H、1c-15H、1c-15L、1c-16、1c-16H、1c-16L、1c-17H、1c-18L、1c-19H、1c-19L、1c-20、1c-21H、1c-21L、1c-22H、1c-23、1c-23H、1c-23L、1c-25H、1c-25L、1c-26、1c-26H、1c-26L、1c-27H、1c-27L、1c-28H、1c-28L、1c-29H、1c-29L、1c-30H、1c-30L、1c-31H、1c-31L、1c-32H、1c-32L、1c-33、1c-34H、1c-34L、1c-35、1c-35H、1c-35L、1c-36、1c-37、1c-37、1c-40H、1c-40L、1c-41H、1c-41L、1d-1、1d-1H、1d-1L、1d-12、1d-13及1d-13L或其鹽或其N-氧化物。 項目27: 一種選自由以下化合物組成之群之二噻𠷬化合物:1c-1、1C-16、1c-16H、1c-16L及1c-19H或其鹽或其N-氧化物。 項目28: 一種選自由以下化合物組成之群之二噻𠷬化合物:1c-1、1c-1L、1c-2H、1c-2L、1c-3、1c-3H、1c-3L、1c-4H、1c-4L、1c-5H、1c-5L、1c-6、1c-6H、1c-6L、1c-8、1c-8H、1c-8L、1c-9、1c-9H、1c-9L、1c-10H、1c-10L、1c-11H、1c-11L、1c-12、1c-12H、1c-13、1c-13H、1c-13L、1c-14H、1c-15H、1c-15L、1c-16、1c-16H、1c-16L、1c-17H、1c-18L、1c-19、1c-19L、1c-20、1c-21H、1c-21L、1c-23、1c-23H、1c-23L、1c-24、1c-24H、1c-25H、1c-25L、1c-26、1c-26H、1c-26L、1c-27H、1c-30L、1c-32H、1c-32L、1c-34H、1c-34L、1c-35、1c-35H、1c-35L、1c-37、1c-37L、1c-38H、1c-38L、1c-44、1b-5L、1d-1H、1d-1L、1d-6L、1d-7、1d-7H、1d-7L、1d-8、1d-11、1d-11H、1d-11L、1d-12L、1d-15、1d-16、1d-16H、1d-16L、1d-17、1d-17H及1e-6或其鹽或其N-氧化物。 項目29: 一種含有如項目1至28中任一項目之二噻𠷬化合物或其鹽或其N-氧化物之植物病害防治劑。 項目30: 一種含有如項目1至28中任一項目之二噻𠷬化合物或其鹽或其N-氧化物之殺真菌劑。 本發明之有利效應 本發明之二噻𠷬化合物或其鹽或其N-氧化物達成對真菌性植物病原體之優良殺真菌效應。另外,本發明之二噻𠷬化合物或其鹽或其N-氧化物可用作新型殺真菌劑,其展現不僅針對化學品敏感性真菌且亦針對抗化學品性真菌之優良殺真菌活性。Solution to Problem The present invention provides a novel dithiazinium compound or a salt thereof or an N-oxide thereof which exhibits excellent fungicidal activity against drug-resistant fungi and drug-sensitive fungi. The invention also provides a process for the preparation of the dithiazide compound or a salt thereof or an N-oxide thereof. The present invention further provides novel fungicides for use in agriculture and horticulture that exhibit significant fungicidal effects against chemical resistant fungi as well as chemically sensitive fungi. Specifically, the inventors conducted extensive research and successfully synthesized a compound represented by the formula (1) or a salt thereof or an N-oxide thereof having fungicidal activity. The inventors have conducted further research based on the above findings. The present invention has thus been completed. More specifically, the present invention includes the following examples: Item 1: A dithiazide compound represented by the formula (1): Or a salt thereof or an N-oxide thereof, wherein R 1 , R 2 and R 3 are the same or different and each represents hydrogen, halogen, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkane Oxy, C 1-6 haloalkoxy, C 1-6 alkoxy C 1-6 alkyl, C 1-6 haloalkoxy C 1-6 alkyl, C 2-6 alkenyl, C 2-6 Haloalkenyl, C 2-6 alkynyl, C 2-6 haloalkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-6 alkyl, optionally substituted aryl And optionally substituted heteroaryl or optionally substituted heterocyclic group, the two of the R 1 , R 2 and R 3 groups together may form a ring via or without at least one hetero atom, denoted as R 1 The groups of R 2 and R 3 may be further substituted as appropriate; Y 1 represents an optionally substituted aryl group, optionally substituted pyridyl group, optionally substituted pyrazinyl group, optionally substituted pyrimidinyl group Or optionally substituted pyridazinyl; Y 2 represents an optionally substituted aryl or optionally substituted heteroaryl; and Q represents hydrogen, nitro, cyano, C 1-6 alkyl, C 1 -6 haloalkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 haloalkyl Carbonyl group, C 3-8 cycloalkylcarbonyl, C 1-6 alkoxycarbonyl, C 1-6 haloalkoxycarbonyl group, C 3-8 cycloalkoxy-carbonyl, C 1-6 alkoxy -alkylthio, C 1 -6 haloalkylthio, C 3-8 cycloalkylthio, C 3-8 cycloalkyl C 1-6 alkylthio, C 1-6 alkoxy C 1-6 alkylthio, C 1- 6 alkylsulfonyl, C 1-6 alkylsulfinylene, C 1-6 haloalkylsulfonyl, C 1-6 haloalkylsulfinyl, C 3-8 cycloalkylsulfonyl, C 3-8 cycloalkylsulfinyl, C 3-8 cycloalkyl C 1-6 alkylsulfonyl, C 3-8 cycloalkyl C 1-6 alkylsulfinylene, optionally Substituted arylthio, optionally substituted aryl C 1-6 alkylthio, optionally substituted arylsulfonyl, optionally substituted arylsulfinyl, optionally substituted a heteroaryl group or a optionally substituted heterocyclic group which is optionally substituted. Item 2: The thiazide compound according to item 1 or a salt thereof or an N-oxide thereof, wherein R 1 , R 2 and R 3 are the same or different and each represents hydrogen, halogen or C 1-6 alkyl. Item 3: The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein R 1 , R 2 and R 3 are the same or different and each represents hydrogen or a C 1-6 alkyl group. Item 4: The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 1 is optionally substituted aryl or optionally substituted pyridyl. Item 5: A dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 1 is a benzene ring represented by Y 1a : Wherein R 4 , R 5 , R 6 , R 7 and R 8 are the same or different and each represents hydrogen, halogen, nitro, cyano, hydroxy, formamyl, optionally substituted amine, C 1- 6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, C 1-6 alkoxy C 1-6 alkyl, C 1-6 haloalkoxy C 1 -6 alkyl, C 1-6 alkoxycarbonyl, C 1-6 haloalkoxycarbonyl, cyano C 1-6 alkyl, cyano C 1-6 alkoxy, C 2-6 alkenyl, C 2-6 haloalkenyl, cyano C 2-6 alkenyl, C 2-6 alkynyl, C 2-6 haloalkynyl, cyano C 2-6 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-6 alkyl, C 1-6 alkylthio, C 1-6 haloalkylthio, C 3-8 cycloalkylthio, C 3-8 cycloalkyl C 1 -6 alkylthio, C 1-6 alkoxy C 1-6 alkylthio, C 1-6 alkylsulfonyl, C 1-6 alkylsulfinyl, C 1-6 haloalkylsulfonate , C 1-6 haloalkylsulfinyl, C 3-8 cycloalkylsulfonyl, C 3-8 cycloalkylsulfinyl, C 3-8 cycloalkyl, C 1-6 alkyl sulfo acyl, C 3-8 cycloalkyl C 1-6 alkylsulfinyl acyl, C C2-6 alkenyloxy, C C2-6 alkynyl group, C C2-6 haloalkenyl group, C 2-6 haloalkynyloxy, C 1-6 alkylsulfonyloxy, C 1-6 alkylsulfinyloxy, C 1-6 alkylcarbonyl, C 1-6 haloalkylcarbonyl, carboxyl, OCN, SCN, SF 5 , An optionally substituted aryloxy group, optionally substituted aryl C 1-6 alkoxy group, optionally substituted arylthio group, optionally substituted aryl C 1-6 alkylthio group, optionally Substituted arylsulfonyl, optionally substituted arylsulfinyl, optionally substituted heteroaryloxy, optionally substituted arylsulfonyloxy, optionally substituted An arylsulfinyloxy group, an optionally substituted aryl group, an optionally substituted heteroaryl group or an optionally substituted heterocyclic group; and a linkage point of the * to the parent compound. Item 6: The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein R 4 , R 5 , R 6 , R 7 and R 8 are the same or different and each represents hydrogen, halogen, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy or C 1-6 haloalkoxy. Item 7: A dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 1 is optionally substituted 4-pyridyl, optionally substituted 3-pyridyl or 2-pyridyl group substituted. Item 8: The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 1 is a pyridine ring represented by any one of Y 1b , Y 1c and Y 1d : Wherein R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 and R 20 are the same or different and each represents hydrogen, halogen, nitro , cyano, hydroxy, formamidine, optionally substituted amino, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, C 1 -6 alkoxy C 1-6 alkyl, C 1-6 haloalkoxy C 1-6 alkyl, C 1-6 alkoxycarbonyl, C 1-6 haloalkoxycarbonyl, cyano C 1-6 Alkyl, cyano C 1-6 alkoxy, C 2-6 alkenyl, C 2-6 haloalkenyl, cyano C 2-6 alkenyl, C 2-6 alkynyl, C 2-6 halo Alkynyl, cyano C 2-6 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-6 alkyl, C 1-6 alkylthio, C 1-6 haloalkyl sulphide , C 3-8 cycloalkylthio, C 3-8 cycloalkyl C 1-6 alkylthio, C 1-6 alkoxy C 1-6 alkylthio, C 1-6 alkylsulfonyl , C 1-6 alkylsulfinyl, C 1-6 haloalkylsulfonyl, C 1-6 haloalkylsulfinyl, C 3-8 cycloalkylsulfonyl, C 3-8 ring Alkylsulfinyl, C 3-8 cycloalkyl, C 1-6 alkylsulfonyl, C 3-8 cycloalkyl C 1-6 alkyl sulfinylene, C 2-6 alkenyloxy , C 2-6 alkynyl Alkoxy, C haloalkoxy C2-6 alkenyloxy, C C2-6 haloalkynyl group, C 1-6 alkyl sulfonic acyl group, C 1-6 alkylsulfinyl acyl group, C 1-6 alkylcarbonyl, C 1-6 haloalkylcarbonyl, carboxyl, OCN, SCN, SF 5 , optionally substituted aryloxy, optionally substituted aryl C 1-6 alkoxy, optionally Substituted arylthio, optionally substituted aryl C 1-6 alkylthio, optionally substituted arylsulfonyl, optionally substituted arylsulfinyl, optionally substituted Heteroaryloxy, optionally substituted arylsulfonyloxy, optionally substituted arylsulfinyloxy, optionally substituted aryl, optionally substituted heteroaryl Or a heterocyclic group which is optionally substituted; and * is the point of attachment to the parent compound. Item 9. The dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 and R 20 are the same or different and each represents hydrogen or halogen. Item 10: A dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 1 represents: , where * is the point of attachment to the parent compound. Item 11: A dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 1 represents: , where * is the point of attachment to the parent compound. Item 12: A dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 1 represents: , where * is the point of attachment to the parent compound. Item 13. The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 2 is an optionally substituted aryl group. Item 14: The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 2 is a benzene ring represented by Y 2a : Wherein R 21 , R 22 , R 23 , R 24 and R 25 are the same or different and each represents hydrogen, halogen, nitro, cyano, hydroxy, formamyl, optionally substituted amine, C 1- 6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, C 1-6 alkoxy C 1-6 alkyl, C 1-6 haloalkoxy C 1 -6 alkyl, C 1-6 alkoxycarbonyl, C 1-6 haloalkoxycarbonyl, cyano C 1-6 alkyl, cyano C 1-6 alkoxy, C 2-6 alkenyl, C 2-6 haloalkenyl, cyano C 2-6 alkenyl, C 2-6 alkynyl, C 2-6 haloalkynyl, cyano C 2-6 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-6 alkyl, C 1-6 alkylthio, C 1-6 haloalkylthio, C 3-8 cycloalkylthio, C 3-8 cycloalkyl C 1 -6 alkylthio, C 1-6 alkoxy C 1-6 alkylthio, C 1-6 alkylsulfonyl, C 1-6 alkylsulfinyl, C 1-6 haloalkylsulfonate , C 1-6 haloalkylsulfinyl, C 3-8 cycloalkylsulfonyl, C 3-8 cycloalkylsulfinyl, C 3-8 cycloalkyl, C 1-6 alkyl sulfo acyl, C 3-8 cycloalkyl C 1-6 alkylsulfinyl acyl, C C2-6 alkenyloxy, C C2-6 alkynyl group, C C2-6 haloalkenyl group, C 2-6 haloalkynyl oxygen , C 1-6 alkyl sulfonic acyl group, C 1-6 alkylsulfinyl acyl group, C 1-6 alkylcarbonyl, C 1-6 haloalkylcarbonyl group, a carboxyl group, OCN, SCN, SF 5 An optionally substituted aryloxy group, optionally substituted aryl C 1-6 alkoxy group, optionally substituted arylthio group, optionally substituted aryl C 1-6 alkylthio group, Optionally substituted arylsulfonyl, optionally substituted arylsulfinyl, optionally substituted heteroaryloxy, optionally substituted arylsulfonyloxy, optionally Substituted arylsulfinyloxy, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heterocyclyl; and * is the point of attachment to the parent compound. Item 15. The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein R 21 , R 22 , R 23 , R 24 and R 25 are the same or different and each represents hydrogen or halogen , nitro, cyano, optionally substituted amino, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy or, as appropriate, substituted Aryl. Item 16. The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 2 is optionally substituted heteroaryl. Item 17. A dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 2 is optionally substituted pyridyl, optionally substituted pyrazinyl, optionally substituted Pyrimidyl, optionally substituted pyridazinyl or optionally substituted thiazolyl. Item 18. A dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 2 is optionally substituted pyridyl, optionally substituted pyrazinyl or optionally substituted Thiazolyl. Item 19. The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 2 is optionally substituted pyridyl. Item 20: A dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 2 is optionally substituted 4-pyridyl, optionally substituted 3-pyridyl or 2-pyridyl group substituted. Item: The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein Y 2 is a pyridine ring represented by any one of Y 2b , Y 2c and Y 2d : Wherein R 26 , R 27 , R 28 , R 29 , R 30 , R 31 , R 32 , R 33 , R 34 , R 35 , R 36 and R 37 are the same or different and each represents hydrogen, halogen, nitro , cyano, hydroxy, formamidine, optionally substituted amino, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, C 1 -6 alkoxy C 1-6 alkyl, C 1-6 haloalkoxy C 1-6 alkyl, C 1-6 alkoxycarbonyl, C 1-6 haloalkoxycarbonyl, cyano C 1-6 Alkyl, cyano C 1-6 alkoxy, C 2-6 alkenyl, C 2-6 haloalkenyl, cyano C 2-6 alkenyl, C 2-6 alkynyl, C 2-6 halo Alkynyl, cyano C 2-6 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-6 alkyl, C 1-6 alkylthio, C 1-6 haloalkyl sulphide , C 3-8 cycloalkylthio, C 3-8 cycloalkyl C 1-6 alkylthio, C 1-6 alkoxy C 1-6 alkylthio, C 1-6 alkylsulfonyl , C 1-6 alkylsulfinyl, C 1-6 haloalkylsulfonyl, C 1-6 haloalkylsulfinyl, C 3-8 cycloalkylsulfonyl, C 3-8 ring Alkylsulfinyl, C 3-8 cycloalkyl, C 1-6 alkylsulfonyl, C 3-8 cycloalkyl C 1-6 alkyl sulfinylene, C 2-6 alkenyloxy C 2-6 alkyne Alkoxy group, C 2-6 haloalkenyloxy group, C 2-6 haloalkynyloxy group, C 1-6 alkylsulfonyloxy group, C 1-6 alkylsulfinyloxy group, C 1-6 alkylcarbonyl, C 1-6 haloalkylcarbonyl, carboxyl, OCN, SCN, SF 5 , optionally substituted aryloxy, optionally substituted aryl C 1-6 alkoxy, Optionally substituted arylthio, optionally substituted aryl C 1-6 alkylthio, optionally substituted arylsulfonyl, optionally substituted arylsulfinyl, optionally Substituted heteroaryloxy, optionally substituted arylsulfonyloxy, optionally substituted arylsulfinyloxy, optionally substituted aryl, optionally substituted heteroaryl a heterocyclic group substituted or optionally substituted; and * is the point of attachment to the parent compound. Item 22. The dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein R 26 , R 27 , R 28 , R 29 , R 30 , R 31 , R 32 , R 33 , R 34 , R 35 , R 36 and R 37 are the same or different and each represents hydrogen or halogen. Item 23. The dithiazide compound or a salt thereof or an N-oxide thereof according to any one of the preceding items, wherein the Y 2 is selected from the group consisting of: , and And * is the point of attachment to the parent compound. Item 24: A dithiazide compound selected from the group consisting of 1c-1, 1c-2H, 1c-2L, 1c-3, 1c-3H, 1c-3L, 1c-4H, 1c-4L, 1c -5L, 1c-6L, 1c-8, 1c-8H, 1c-8L, 1c-9, 1c-9H, 1c-9L, 1c-10H, 1c-10L, 1c-11H, 1c-11L, 1c-13H , 1c-13L, 1c-14H, 1c-15H, 1c-16, 1c-16H, 1c-19, 1c-20, 1c-23, 1c-23H, 1c-23L, 1c-24, 1c-24H, 1c -25H, 1c-25L, 1c-26, 1c-26H, 1c-26L, 1c-27H, 1c-28L, 1c-29H, 1c-29L, 1c-30H, 1c-32H, 1c-32L, 1c-33 , 1c-34H, 1c-34L, 1c-35, 1c-35H, 1c-35L, 1d-1H, 1d-6H, 1d-6L, 1d-13, 1d-17, 1d-17H, 1d-17L, 1e -3 and 1e-7 or a salt thereof or an N-oxide thereof. Item 25: A dithiazide compound selected from the group consisting of 1c-2H, 1c-2L, 1c-3, 1c-3H, 1c-3L, 1c-4H, 1c-4L, 1c-5L, 1c -6L, 1c-8, 1c-8H, 1c-8L, 1c-9, 1c-9H, 1c-9L, 1c-10H, 1c-10L, 1c-11H, 1c-13H, 1c-13L, 1c-14H , 1c-15H, 1c-16, 1c-16H, 1c-19, 1c-20, 1c-23, 1c-23H, 1c-23L, 1c-24H, 1c-25H, 1c-25L, 1c-26, 1c -26H, 1c-26L, 1c-27H, 1c-29H, 1c-29L, 1c-32H, 1c-32L, 1c-33, 1c-34H, 1c-34L, 1c-35 and 1c-35H or salts thereof or Its N-oxide. Item 26: A dithiazide compound selected from the group consisting of 1c-1, 1c-1H, 1c-1L, 1c-2H, 1c-2L, 1c-3, 1c-3H, 1c-3L, 1c -4H, 1c-4L, 1c-5H, 1c-5L, 1c-6, 1c-6H, 1c-6L, 1c-7H, 1c-7L, 1c-8, 1c-8H, 1c-8L, 1c-9 , 1c-9H, 1c-9L, 1c-10H, 1c-10L, 1c-11H, 1c-11L, 1c-13H, 1c-13L, 1c-14H, 1c-15H, 1c-15L, 1c-16, 1c -16H, 1c-16L, 1c-17H, 1c-18L, 1c-19H, 1c-19L, 1c-20, 1c-21H, 1c-21L, 1c-22H, 1c-23, 1c-23H, 1c-23L , 1c-25H, 1c-25L, 1c-26, 1c-26H, 1c-26L, 1c-27H, 1c-27L, 1c-28H, 1c-28L, 1c-29H, 1c-29L, 1c-30H, 1c -30L, 1c-31H, 1c-31L, 1c-32H, 1c-32L, 1c-33, 1c-34H, 1c-34L, 1c-35, 1c-35H, 1c-35L, 1c-36, 1c-37 , 1c-37, 1c-40H, 1c-40L, 1c-41H, 1c-41L, 1d-1, 1d-1H, 1d-1L, 1d-12, 1d-13 and 1d-13L or a salt thereof or N thereof - Oxide. Item 27: A dithiazide compound selected from the group consisting of 1c-1, 1C-16, 1c-16H, 1c-16L and 1c-19H or a salt thereof or an N-oxide thereof. Item 28: A dithiazide compound selected from the group consisting of 1c-1, 1c-1L, 1c-2H, 1c-2L, 1c-3, 1c-3H, 1c-3L, 1c-4H, 1c -4L, 1c-5H, 1c-5L, 1c-6, 1c-6H, 1c-6L, 1c-8, 1c-8H, 1c-8L, 1c-9, 1c-9H, 1c-9L, 1c-10H , 1c-10L, 1c-11H, 1c-11L, 1c-12, 1c-12H, 1c-13, 1c-13H, 1c-13L, 1c-14H, 1c-15H, 1c-15L, 1c-16, 1c -16H, 1c-16L, 1c-17H, 1c-18L, 1c-19, 1c-19L, 1c-20, 1c-21H, 1c-21L, 1c-23, 1c-23H, 1c-23L, 1c-24 , 1c-24H, 1c-25H, 1c-25L, 1c-26, 1c-26H, 1c-26L, 1c-27H, 1c-30L, 1c-32H, 1c-32L, 1c-34H, 1c-34L, 1c -35, 1c-35H, 1c-35L, 1c-37, 1c-37L, 1c-38H, 1c-38L, 1c-44, 1b-5L, 1d-1H, 1d-1L, 1d-6L, 1d-7 , 1d-7H, 1d-7L, 1d-8, 1d-11, 1d-11H, 1d-11L, 1d-12L, 1d-15, 1d-16, 1d-16H, 1d-16L, 1d-17, 1d -17H and 1e-6 or a salt thereof or an N-oxide thereof. Item 29: A plant disease controlling agent comprising the dithiazide compound according to any one of items 1 to 28, or a salt thereof or an N-oxide thereof. Item 30: A fungicide comprising a dithiazide compound according to any one of items 1 to 28, or a salt thereof or an N-oxide thereof. Advantageous Effects of the Invention The dithiazide compound of the present invention or a salt thereof or an N-oxide thereof achieves an excellent fungicidal effect on a fungal plant pathogen. Further, the dithiazide compound of the present invention or a salt thereof or an N-oxide thereof can be used as a novel fungicide which exhibits excellent fungicidal activity not only against chemically sensitive fungi but also against chemical fungi.

在下文中,將參考實例更詳細地闡述本發明,但本發明之技術範圍不限於該等實例。除非另外明確註明,否則遍及整個說明書中,單數表述應理解為涵蓋其呈複數形式之概念。因此,除非另外明確註明,否則單數冠詞(例如在英文情形下之「一(a、an)」、「該(the)」及諸如此類)亦應理解為涵蓋其呈複數形式之概念。此外,除非另外明確註明,否則本文中所使用之術語應理解為以業內常用之含義使用。因此,除非另有定義,否則本文中所使用之所有術語及科學技術術語均具有與熟習本發明所屬領域者所通常理解之術語相同之含義。倘若出現矛盾,則以本說明書(包括定義)為準。二噻 𠷬 化合物或其鹽或其 N- 氧化物 本發明提供用於農業及園藝之由式(1)表示之二噻𠷬化合物或其鹽或其N-氧化物。其中R1 、R2 、R3 、Y1 、Y2 及Q係如上文所定義。 式(1)化合物中一或多個可能之不對稱碳原子之存在意味著化合物可視情況以異構形式存在,亦即鏡像異構或非鏡像異構形式。式(1)化合物中一或多個可能之雙鍵之存在意味著化合物可以各種非鏡像異構形式存在。 因此,結構:意指兩種形式,亦即Z形式及E形式:。 亦可由於繞單鍵之受限旋轉而存在阻轉異構物。式(1)意欲包括所有彼等可能之異構形式及其混合物。本發明包括式(1)化合物之所有彼等可能之異構形式及其混合物。同樣,式(1)意欲包括所有可能之互變異構物。本發明包括式(1)化合物之所有可能之互變異構形式。 接下來,下文闡述本說明書中之術語。 在本說明書中,若其可經取代,則由「視情況經取代之」或「經取代之」界定之基團之取代基數目並無具體限制,且係一個或複數個。另外,除非另外指示,否則針對每一基團之描述在該基團係其他基團之一部分或其他基團上之取代基時亦適用。 「C1-6 烷基」意指具有1個至6個碳原子之直鏈或具支鏈飽和烴基。 「C2-6 烯基」意指具有2個至6個碳原子且含有1個至3個雙鍵之直鏈或具支鏈不飽和烴基。 「C2-6 炔基」意指具有2個至6個碳原子且含有1個三鍵之直鏈或具支鏈不飽和烴基。 「C3-8 環烷基」意指具有3個至8個碳原子之環狀烷基,且包括具有部分橋接結構之彼等環狀烷基。 「C1-6 烷氧基(C1-6 alkoxy)」係指「C1-6 烷氧基(C1-6 alkoxy group)」,且「C1-6 烷基」部分之定義與上文所闡述之「C1-6 烷基」相同。 「芳基」意指單環或多環芳香族烴。 「雜環」意指在環中具有氮、氧、磷及/或硫原子中之至少一者且可在任一可取代之位置鍵結之飽和、不飽和或芳香族雜環基。 「雜芳基」意指在環中具有氮、氧及/或硫原子中之至少一者且可在任一可取代之位置鍵結之芳香族雜環基,其中該雜芳基之環成員原子除碳原子以外亦包括1、2、3或4個選自N、O及S之雜原子。 以下顯示如本說明書中所使用之每一基團之具體實例。 鹵素之實例包括(但不特定地限於)氟、氯、溴、碘及諸如此類。 C1-6 烷基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷基,例如甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基、正戊基、正己基及諸如此類。 C1-6 鹵代烷基之實例包括(但不特定地限於)經1個至9個、較佳1個至5個鹵素原子取代之C1-6 直鏈或具支鏈烷基,例如氟甲基、氯甲基、溴甲基、碘甲基、二氟甲基、2,2-二氟乙基、三氟甲基、2,2,2-三氟乙基、五氟乙基、3,3,3-三氟丙基、4,4,4-三氟丁基、七氟異丁基及諸如此類。 C1-6 烷氧基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷氧基,例如甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第二丁氧基、第三丁氧基及諸如此類。 C1-6 鹵代烷氧基之實例包括(但不特定地限於)經1個至9個、較佳1個至5個鹵素原子取代之C1-6 直鏈或具支鏈烷氧基,例如氟甲氧基、氯甲氧基、溴甲氧基、碘甲氧基、二氟甲氧基、三氟甲氧基、2,2,2-三氟乙氧基、五氟乙氧基、3,3,3-三氟丙氧基、4,4,4-三氟丁氧基、七氟異丁氧基及諸如此類。 C1-6 烷氧基C1-6 烷基之實例包括(但不特定地限於)其中C1-6 直鏈或具支鏈烷基經C1-6 直鏈或具支鏈烷氧基取代之烷氧基烷基,例如甲氧基甲基、乙氧基甲基、正丙氧基甲基、異丙氧基甲基、正丁氧基甲基、異丁氧基甲基、第二丁氧基甲基、第三丁氧基甲基、甲氧基乙基、乙氧基乙基、甲氧基-正丙基、甲氧基-正丁基及諸如此類。 C1-6 鹵代烷氧基C1-6 烷基之實例包括(但不特定地限於)經1個至9個、較佳1個至5個鹵素原子取代之直鏈或具支鏈烷氧基烷基,例如氟甲氧基甲基、氯甲氧基甲基、溴甲氧基甲基、碘甲氧基甲基、二氟甲氧基甲基、三氟甲氧基甲基、2,2,2-三氟乙氧基甲基及諸如此類。 C3-8 環烷基之實例包括(但不特定地限於)環丙基、環丁基、環戊基、環己基、環庚基、環辛基及諸如此類。 C3-8 環烷基C1-6 烷基之實例包括(但不特定地限於)環丙基甲基、環丁基乙基、環戊基甲基、環己基甲基及諸如此類。 C1-6 烷基羰基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷基羰基,例如甲基羰基(乙醯基)、乙基羰基(丙醯基)、正丙基羰基(丁醯基)、異丙基羰基(異丁醯基)、正丁基羰基(戊醯基)、異丁基羰基(異戊醯基)、第二丁基羰基、第三丁基羰基及諸如此類。 C1-6 鹵代烷基羰基之實例包括(但不特定地限於)經1個至9個且較佳地1個至5個鹵素原子取代之C1-6 直鏈或具支鏈烷基羰基,例如氟甲基羰基、氯甲基羰基、溴甲基羰基、碘甲基羰基、二氯甲基羰基、三氯甲基羰基、二氟甲基羰基、三氟甲基羰基、氯二氟甲基羰基、溴二氟甲基羰基、二氯氟甲基羰基、2,2,2-三氯乙基羰基、2,2,2-三氟乙基羰基、五氟乙基羰基及諸如此類。 C1-6 烷氧基羰基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷氧基羰基,例如甲氧基羰基、乙氧基羰基、正丙氧基羰基、異丙氧基羰基、正丁氧基羰基、異丁氧基羰基、第二丁氧基羰基、第三丁氧基羰基及諸如此類。 C1-6 鹵代烷氧基羰基之實例包括(但不特定地限於)經1個至9個、較佳1個至5個鹵素原子取代之C1-6 直鏈或具支鏈烷氧基羰基,例如氟甲氧基羰基、氯甲氧基羰基、溴甲氧基羰基、碘甲氧基羰基、二氯甲氧基羰基、三氯甲氧基羰基、二氟甲氧基羰基、三氟甲氧基羰基、2,2,2-三氟乙氧基甲基、五氟乙氧基羰基、3,3,3-三氟丙氧基羰基、4,4,4-三氟丁氧基羰基、七氟異丙氧基羰基及諸如此類。 C3-8 環烷基羰基之實例包括(但不特定地限於)環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基及諸如此類。 C3-8 環烷氧基羰基之實例包括(但不特定地限於)環丙基氧基羰基、環丁基氧基羰基、環戊基氧基羰基、環己基氧基羰基及諸如此類。 氰基C1-6 烷基之實例包括(但不特定地限於)經氰基取代之C1-6 直鏈或具支鏈烷基,例如氰基甲基、氰基乙基、氰基-正丙基、氰基-異丙基、氰基-正丁基、氰基-異丁基、氰基-第二丁基、氰基-第三丁基、氰基-正己基及諸如此類。 氰基C1-6 烷氧基之實例包括經氰基取代之C1-6 直鏈或具支鏈烷氧基,例如氰基甲氧基、氰基乙氧基、氰基-正丙氧基、氰基-異丙氧基、氰基-正丁氧基、氰基-異丁氧基、氰基-第二丁氧基、氰基-第三丁氧基、氰基-己氧基及諸如此類。 C2-6 烯基之實例包括(但不特定地限於)乙烯基、烯丙基、2-丁烯基、3-丁烯基、1-甲基烯丙基及諸如此類。 C2-6 鹵代烯基之實例包括(但不特定地限於) 2,2-二氯乙烯基、2,2-二溴乙烯基、2,2-二氟乙烯基、3,3-二氟-2-烯丙基、4,4-二氟-3-丁烯基、4,4,4-三氟-2-丁烯基及諸如此類。 C2-6 炔基之實例包括(但不特定地限於)乙炔基、2-丙炔基(炔丙基)、1-甲基-2-丙炔基、1-丁炔基、2-丁炔基、3-丁炔基及諸如此類。 C2-6 鹵代炔基之實例包括(但不特定地限於)氟乙炔基、溴乙炔基、氯乙炔基、碘乙炔基、3,3,3-三氟-1-丙炔基及諸如此類。 氰基C2-6 烯基之實例包括(但不特定地限於) 2-氰基乙烯基、2,2-二氰基乙烯基、3-氰基-2-烯丙基、3,3-二氰基-2-烯丙基、4-氰基-3-丁烯基、4,4-二氰基-3-丁烯基、4,4,4-三氰基-2-丁烯基及諸如此類。 氰基C2-6 炔基之實例包括(但不特定地限於)氰基乙炔基、3-氰基-1-丙炔基及諸如此類。 C1-6 烷基磺醯基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷基磺醯基,例如甲基磺醯基、乙基磺醯基、正丙基磺醯基、異丙基磺醯基、正丁基磺醯基、異丁基磺醯基、第二丁基磺醯基、第三丁基磺醯基及諸如此類。 C1-6 鹵代烷基磺醯基之實例包括(但不特定地限於)經1個至9個、較佳1個至5個鹵素原子取代之C1-6 直鏈或具支鏈烷基亞磺醯基,例如氟甲基磺醯基、氯甲基磺醯基、溴甲基磺醯基、碘甲基磺醯基、二氯甲基磺醯基、三氯甲基磺醯基、二氟甲基磺醯基、三氟甲基磺醯基、氯二氟甲基磺醯基、溴二氟甲基磺醯基、二氯氟甲基磺醯基、2,2,2-三氯乙基磺醯基、2,2,2-三氟乙基磺醯基、五氟乙基磺醯基及諸如此類。 C1-6 烷基亞磺醯基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷基亞磺醯基,例如甲基亞磺醯基、乙基亞磺醯基、正丙基亞磺醯基、異丙基亞磺醯基、正丁基亞磺醯基、異丁基亞磺醯基、第二丁基亞磺醯基、第三丁基亞磺醯基及諸如此類。 C1-6 鹵代烷基亞磺醯基之實例包括(但不特定地限於)經1個至9個且較佳地1個至5個鹵素原子取代之C1-6 直鏈或具支鏈烷基亞磺醯基,例如氟甲基亞磺醯基、氯甲基亞磺醯基、溴甲基亞磺醯基、碘甲基亞磺醯基、二氯甲基亞磺醯基、三氯甲基亞磺醯基、二氟甲基亞磺醯基、三氟甲基亞磺醯基、氯二氟甲基亞磺醯基、溴二氟甲基亞磺醯基、二氯氟甲基亞磺醯基、2,2,2-三氯乙基亞磺醯基、2,2,2-三氟乙基亞磺醯基、五氟乙基亞磺醯基及諸如此類。 C1-6 烷硫基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷硫基,例如甲硫基、乙基硫基、正丙基硫基、異丙基硫基、正丁基硫基、異丁基硫基、第二丁基硫基、第三丁基硫基及諸如此類。 C1-6 鹵代烷基硫基之實例包括(但不特定地限於)經1個至9個且較佳地1個至5個鹵素原子取代之C1-6 直鏈或具支鏈烷硫基,例如氟甲硫基、氯甲硫基、溴甲硫基、碘甲硫基、二氯甲硫基、三氯甲硫基、二氟甲硫基、三氟甲硫基、氯二氟甲硫基、溴二氟甲硫基、二氯氟甲硫基、2,2,2-三氯乙基硫基、2,2,2-三氟乙基硫基、五氟乙基硫基及諸如此類。 C3-8 環烷基磺醯基之實例包括(但不特定地限於)環丙基磺醯基、環丁基磺醯基、環戊基磺醯基、環己基磺醯基及諸如此類。 C3-8 環烷基亞磺醯基之實例包括(但不特定地限於)環丙基亞磺醯基、環丁基亞磺醯基、環戊基亞磺醯基、環己基亞磺醯基及諸如此類。 C3-8 環烷基硫基之實例包括(但不特定地限於)環丙基硫基、環丁基硫基、環戊基硫基、環己基硫基及諸如此類。 C3-8 環烷基C1-6 烷基磺醯基之實例包括(但不特定地限於)環丙基甲基磺醯基、2-環丙基乙基磺醯基、3-環丙基丙基磺醯基、環己基甲基磺醯基及諸如此類。 C3-8 環烷基C1-6 烷基亞磺醯基之實例包括(但不特定地限於)環丙基甲基亞磺醯基、2-環丙基乙基亞磺醯基、3-環丙基丙基亞磺醯基、環己基甲基亞磺醯基及諸如此類。 C3-8 環烷基C1-6 烷硫基之實例包括(但不特定地限於)環丙基甲硫基、2-環丙基乙基硫基、3-環丙基丙基硫基、環己基甲硫基及諸如此類。 C1-6 烷氧基C1-6 烷硫基之實例包括(但不特定地限於)其中C1-6 直鏈或具支鏈烷硫基經C1-6 直鏈或具支鏈烷氧基取代之烷氧基烷基硫基,例如甲氧基甲硫基、乙氧基甲硫基、正丙氧基甲硫基、異丙氧基甲硫基、正丁氧基甲硫基、第二丁氧基甲硫基、第三丁氧基甲硫基、2-甲氧基乙基硫基及諸如此類。 C2-6 烯氧基之實例包括(但不特定地限於)乙烯基氧基、1-丙烯基氧基、異丙烯基氧基、烯丙基氧基、2-丁烯基氧基、3-丁烯基氧基、1-甲基烯丙基氧基及諸如此類。 C2-6 鹵代烯氧基之實例包括(但不特定地限於) 2,2-二氯乙烯基氧基、2,2-二溴乙烯基氧基、2,2-二氟乙烯基氧基、3,3-二氟-2-烯丙基氧基、4,4-二氟-3-丁烯基氧基、4,4,4-三氟-2-丁烯基氧基及諸如此類。 C2-6 炔基氧基之實例包括(但不特定地限於)乙炔基氧基、2-丙炔基氧基、1-甲基-2-丙炔基氧基、1,1-二甲基-2-丙炔基氧基、1-丁炔基氧基、2-丁炔基氧基、3-丁炔基氧基及諸如此類。 C2-6 鹵代炔基氧基之實例包括(但不特定地限於)氟乙炔基氧基、溴乙炔基氧基、氯乙炔基氧基、碘乙炔基氧基、3,3,3-三氟-1-丙炔基氧基及諸如此類。 C1-6 烷基磺醯基氧基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷基磺醯基,例如甲基磺醯基氧基、乙基磺醯基氧基、正丙基磺醯基氧基、異丙基磺醯基氧基、正丁基磺醯基氧基、異丁基磺醯基氧基、第二丁基磺醯基氧基、第三丁基磺醯基氧基及諸如此類。 C1-6 烷基亞磺醯基氧基之實例包括(但不特定地限於) C1-6 直鏈或具支鏈烷基亞磺醯基氧基,例如甲基亞磺醯基氧基、乙基亞磺醯基氧基、正丙基亞磺醯基氧基、異丙基亞磺醯基氧基、正丁基亞磺醯基氧基、異丁基亞磺醯基氧基、第二丁基亞磺醯基氧基、第三丁基亞磺醯基氧基及諸如此類。 經取代或未經取代之胺基之實例包括(但不特定地限於)胺基、單烷基胺基、二烷基胺基、單醯基胺基及諸如此類。烷基之實例包括上文所提及之C1-6 烷基及諸如此類。醯基之實例包括上文所提及之C1-6 烷基羰基、C1-6 鹵代烷基羰基、C1-6 烷氧基羰基、C1-6 鹵代烷氧基羰基、芳基羰基、芳基氧基羰基及諸如此類。 芳基之實例包括(但不特定地限於)苯基、1-萘基、2-萘基及諸如此類。 芳基C1-6 烷基之實例包括(但不特定地限於)苄基、苯基乙基、苯基-正丙基及諸如此類。該等芳基C1-6 烷基可在烷基以及芳基二者部分處經進一步取代。 芳基氧基之實例包括(但不特定地限於)苯氧基、1-萘基氧基、2-萘基氧基及諸如此類。 芳基C1-6 烷氧基之實例包括(但不特定地限於)苄基氧基、苯基乙氧基、苯基-正丙氧基、苯基-正丁氧基、1-萘基甲氧基、2-萘基甲氧基及諸如此類。 雜芳基氧基之實例包括(但不特定地限於)吡啶基氧基、嘧啶基氧基、吡唑基氧基及諸如此類。 芳基磺醯基之實例包括(但不特定地限於)苯基磺醯基、1-萘基磺醯基、2-萘基磺醯基及諸如此類。 芳基亞磺醯基之實例包括(但不特定地限於)苯基亞磺醯基、1-萘基亞磺醯基、2-萘基亞磺醯基及諸如此類。 芳硫基之實例包括(但不特定地限於)苯基硫基、1-萘基硫基、2-萘基硫基及諸如此類。 芳基磺醯基氧基之實例包括(但不特定地限於)苯基磺醯基氧基、1-萘基磺醯基氧基、2-萘基磺醯基氧基及諸如此類。 芳基亞磺醯基氧基之實例包括(但不特定地限於)苯基亞磺醯基氧基、1-萘基亞磺醯基氧基、2-萘基亞磺醯基氧基及諸如此類。 芳基C1-6 烷硫基之實例包括(但不特定地限於)苄基硫基、苯基乙基硫基、苯基-正丙基硫基、苯基-正丁基硫基、1-萘基甲硫基、2-萘基甲硫基及諸如此類。 芳基羰基之實例包括(但不特定地限於)苯基羰基、1-萘基羰基、2-萘基羰基及諸如此類。 芳基氧基羰基之實例包括(但不特定地限於)苯基氧基羰基、1-萘基氧基羰基、2-萘基氧基羰基及諸如此類。 雜芳基之實例包括(但不特定地限於)噻吩基、呋喃基、吡咯基、噁唑基、異噁唑基、噻唑基、異噻唑基、吡唑基、咪唑基、噁二唑基、噻二唑基、三唑基、四唑基、吡啶基、嗒嗪基、嘧啶基、吡嗪基、三嗪基、四嗪基、吲哚基、異吲哚基、吲唑基、喹唑啉基、咔唑基、苯并噁唑基、苯并異噁唑基、苯并噻唑基、苯并異噻唑基、苯并咪唑基、喹啉基、異喹啉基、吡啶并吲哚基、㖕啉基、呔嗪基、喹喏啉基、嘌呤基、吩噻嗪基呋喃基、苯并呋喃基、𠳭烷基、苯并噻吩基及諸如此類。 上文所提及之所有芳基及雜芳基可視情況經進一步取代。取代基數目之實例包括(但不特定地限於) 1個至20個(較佳地1個至10個,且更佳地1個至5個)。 雜環基之實例包括(但不特定地限於)噻吩基、呋喃基、四氫呋喃基、二氧戊環基、二噁烷基、吡咯基、吡咯啉基、吡咯啶基、噁唑基、異噁唑基、噁唑啉基、噁唑啶基、異噁唑啉基、噻唑基、異噻唑基、噻唑啉基、噻唑啶基、異噻唑啉基、吡唑基、吡唑啶基、咪唑基、咪唑啉基、咪唑啶基、噁二唑基、噁二唑啉基、噻二唑啉基、三唑基、三唑啉基、三唑啶基、四唑基、四唑啉基、吡啶基、二氫吡啶基、四氫吡啶基、六氫吡啶基、噁嗪基、二氫噁嗪基、嗎啉基、噻嗪基、二氫噻嗪基、硫雜嗎啉基、嗒嗪基、二氫嗒嗪基、四氫嗒嗪基、六氫嗒嗪基、噁二嗪基、二氫噁二嗪基、四氫噁二嗪基、噻二唑基、噻二嗪基、二氫噻二嗪基、四氫噻二嗪基、嘧啶基、二氫嘧啶基、四氫嘧啶基、六氫嘧啶基、吡嗪基、二氫吡嗪基、四氫吡嗪基、六氫吡嗪基、三嗪基、二氫三嗪基、四氫三嗪基、六氫三嗪基、四嗪基、二氫四嗪基、吲哚基、吲哚啉基、異吲哚基、吲唑基、喹唑啉基、二氫喹唑啉基、四氫喹唑啉基、咔唑基、苯并噁唑基、苯并噁唑啉基、苯并異噁唑基、苯并異噁唑啉基、苯并噻唑基、苯并異噻唑基、苯并異噻唑啉基、苯并咪唑基、吲唑啉基、喹啉基、二氫喹啉基、四氫喹啉基、異喹啉基、二氫異喹啉基、四氫異喹啉基、吡啶并吲哚基、二氫苯并噁嗪基、㖕啉基、二氫㖕啉基、四氫㖕啉基、呔嗪基、二氫呔嗪基、四氫呔嗪基、喹喏啉基、二氫喹喏啉基、四氫喹喏啉基、嘌呤基、二氫苯并三嗪基、二氫苯并四嗪基、吩噻嗪基呋喃基、苯并呋喃基、𠳭烷基、苯并噻吩基及諸如此類。 該等雜環基包括在任一可取代之位置經側氧基或硫基酮基取代之彼等基團。 上文所提及之所有雜環可視情況經進一步取代。取代基數目之實例包括(但不特定地限於) 1個至20個(較佳地1個至10個且更佳地1個至5個)。 「經取代」或「取代基」之實例包括(但不特定地限於)鹵素、硝基、氰基、羥基、甲醯基、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基、C1-6 烷氧基C1-6 烷基、C1-6 鹵代烷氧基C1-6 烷基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、C1-6 烷基羰基、C1-6 鹵代烷基羰基、C1-6 烷氧基羰基、C1-6 鹵代烷氧基羰基、芳基羰基、芳基氧基羰基、C1-6 氰基烷基、C1-6 氰基烷氧基、C2-6 烯基、C2-6 鹵代烯基、C2-6 炔基、C2-6 鹵代炔基、C1-6 烷基磺醯基、C1-6 鹵代烷基磺醯基、C1-6 烷基亞磺醯基、C1-6 鹵代烷基亞磺醯基、C1-6 烷硫基、C1-6 鹵代烷基硫基、C3-8 環烷基磺醯基、C3-8 環烷基亞磺醯基、C3-8 環烷基硫基、C3-8 環烷基C1-6 烷基磺醯基、C3-8 環烷基C1-6 烷基亞磺醯基、C3-8 環烷基C1-6 烷硫基、C1-6 烷氧基C1-6 烷基磺醯基、C1-6 烷氧基C1-6 烷基亞磺醯基、C1-6 烷氧基C1-6 烷硫基、C2-6 烯氧基、C2-6 鹵代烯氧基、C2-6 炔基氧基、C2-6 鹵代炔基氧基、C1-6 烷基磺醯基氧基、C1-6 鹵代烷基磺醯基氧基、C1-6 烷基亞磺醯基氧基、C1-6 鹵代烷基亞磺醯基氧基、OCN、SCN、SF5 、經取代或未經取代之胺基、芳基、芳基C1-6 烷基、芳基氧基、芳基C1-6 烷氧基、芳基磺醯基、芳基亞磺醯基、芳硫基、芳基C1-6 烷基磺醯基、芳基C1-6 烷基亞磺醯基、芳基C1-6 烷硫基、雜環、雜環C1-6 烷基、雜環氧基及諸如此類。 由式(1)表示之化合物之鹽可係任何類型之鹽,只要其為農業上可接受之鹽即可。該等鹽之實例包括無機酸鹽,例如鹽酸鹽、硫酸鹽、硝酸鹽及諸如此類;有機酸鹽,例如乙酸鹽、甲磺酸鹽及諸如此類;鹼金屬鹽,例如鈉鹽、鉀鹽及諸如此類;鹼土金屬鹽,例如鎂鹽、鈣鹽及諸如此類;四級銨鹽,例如二甲基銨、三乙基銨及諸如此類;及諸如此類。 在本發明中,N-氧化物係構成雜環基中之環之原子經氧化之化合物。可構成N-氧化物之雜環基可係(例如)含有吡啶環之稠環、含有吡嗪環之稠環、含有嗒嗪環之稠環或含有嘧啶環之稠環。 在本發明之化合物(1)中,較佳化合物係其中R1 係氫、鹵素或C1-6 烷基之化合物,且更佳化合物(1)係其中R1 係氫或甲基之化合物。 在本發明之化合物(1)中,較佳化合物係其中R2 係氫、鹵素或C1-6 烷基之化合物,且更佳化合物(1)係其中R2 係氫之化合物。 在本發明之化合物(1)中,較佳化合物係其中R3 係氫、鹵素或C1-6 烷基之化合物,且更佳化合物(1)係其中R3 係氫之化合物。 在本發明之化合物(1)中,較佳化合物係其中Y1 係視情況經取代之芳基或視情況經取代之吡啶基之化合物,且更佳化合物(1)係其中Y1 係視情況經取代之苯基、視情況經取代之3-吡啶基或視情況經取代之4-吡啶基之化合物,且尤佳化合物(1)係其中Y1 係視情況經取代之3-吡啶基之化合物。 在本發明之化合物(1)中,較佳化合物係其中Y2 係視情況經取代之芳基或視情況經取代之吡啶基之化合物,且更佳化合物(1)係其中Y2 係視情況經取代之苯基之化合物。 在本發明之化合物(1)中,較佳化合物係其中Q係氰基之化合物。 在本發明之化合物(1)中,較佳化合物係其中R4 、R5 、R6 、R7 及R8 相同或不同且各自係氫、鹵素、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基或C1-6 鹵代烷氧基之化合物,且更佳化合物(1)係其中R4 、R5 、R6 、R7 及R8 相同或不同且各自係氫、氟、氯、溴、第三丁基、三氟甲基、甲氧基或三氟甲氧基之化合物。 在本發明之化合物(1)中,較佳化合物係其中R9 、R10 、R11 、R12 、R13 、R14 、R15 、R16 、R17 、R18 、R19 及R20 相同或不同且各自係氫或鹵素之化合物,且更佳化合物(1)係其中R9 、R10 、R11 、R12 、R13 、R14 、R15 、R16 、R17 、R18 、R19 及R20 係氫或氯之化合物。 在本發明之化合物(1)中,較佳化合物係其中R21 、R22 、R23 、R24 及R25 相同或不同且各自係氫、鹵素、硝基、氰基、視情況經取代之胺基、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基或視情況經取代之芳基之化合物,且更佳化合物(1)係其中R21 、R22 、R23 、R24 及R25 相同或不同且各自係氫、氟、氯、溴、硝基、氰基、胺基、甲基、三氟甲基、甲氧基、三氟甲氧基或苯基之化合物。 在本發明之化合物(1)中,較佳化合物係其中R26 、R27 、R28 、R29 、R30 、R31 、R32 、R33 、R34 、R35 、R36 及R37 相同或不同且各自係氫或鹵素之化合物,且更佳化合物(1)係其中R26 、R27 、R28 、R29 、R30 、R31 、R32 、R33 、R34 、R35 、R36 及R37 係氫之化合物。 在該等化合物中,本發明之更佳化合物係其中具有以下情況之化合物或其鹽或其N-氧化物: R1 係氫、鹵素或C1-6 烷基; R2 係氫、鹵素或C1-6 烷基; R3 係氫、鹵素或C1-6 烷基; Y1 係視情況經取代之芳基或視情況經取代之吡啶基; Y2 係視情況經取代之芳基或視情況經取代之吡啶基; Q係氰基。 本發明之更尤佳化合物係其中具有以下情況之化合物或其鹽或其N-氧化物: R1 係氫或甲基; R2 係氫; R3 係氫; Y1 係視情況經取代之苯基、視情況經取代之3-吡啶基或視情況經取代之4-吡啶基; Y2 係視情況經取代之苯基; Q係氰基。 本發明之特別尤佳化合物係其中具有以下情況之化合物或其鹽或其N-氧化物: R1 係氫或甲基; R2 係氫; R3 係氫; Y1 係視情況經取代之3-吡啶基; Y2 係視情況經取代之苯基; Q係氰基。 本發明亦提供用於製備由式(1)表示之二噻𠷬或其鹽或其N-氧化物之方法:, 其中R1 、R2 、R3 、Y1 、Y2 及Q係如上文所定義。 本發明之由式(1)表示之二噻𠷬化合物可根據以下反應方案1容易地製備,但不限於該等方法。 由式(1)表示之二噻𠷬化合物可藉由使化合物(2)與化合物(3)及二硫化碳在如反應方案1中所提及之鹼及溶劑存在下反應來製備。 反應方案1其中,R1 、R2 、R3 、Y1 、Y2 及Q係如上文所定義。同時,A及B相同或不同且各自表示適宜脫離基,例如氯、溴及碘;經取代或未經取代之C1-6 烷基磺酸酯基;及經取代或未經取代之芳基磺酸酯基。 每1 mol化合物(2),所用化合物(3)之量通常係0.5 mol至5 mol、較佳地1 mol至2 mol。 每1 mol化合物(2),所用二硫化碳之量通常係2 mol至10 mol、較佳地1 mol至2 mol。 該反應係在適宜鹼存在下進行。作為鹼,可廣泛使用習知之鹼,且該等鹼之實例包括:鹼金屬碳酸鹽,例如碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉及諸如此類;鹼金屬氫氧化物,例如氫氧化鈉、氫氧化鉀及諸如此類;鹼金屬氫化物,例如氫化鈉及氫化鉀及諸如此類;鹼金屬氫化物,例如氫化鈉及氫化鉀及諸如此類;鹼金屬醇鹽,例如甲醇鈉、乙醇鈉、第三丁醇鉀及諸如此類;有機鹼,例如吡啶、三乙胺、二乙胺、二甲胺、甲胺、咪唑、苯并咪唑、二異丙基乙胺、4-二甲基胺基吡啶、六氫吡啶及諸如此類,較佳氫氧化鈉、氫氧化鉀、氫化鈉、氫化鉀、甲醇鈉、乙醇鈉及第三丁醇鉀。使用該等鹼中之任何單獨一者或其兩種或更多種類型之組合。 在使用有機鹼時之情形下,其可大量過量使用以用作溶劑。 每1 mol化合物(2),所用鹼之量通常係2 mol至5 mol、較佳地2 mol至3 mol。 上文所提及之反應係在適當溶劑中或在無任何溶劑之情形下實施。當上文所提及之反應係在溶劑中進行時,對溶劑並無限制,只要該溶劑關於上文所提及之反應無活性即可。 此一溶劑之實例包括:基於脂肪酸或脂環族烴之溶劑,例如正己烷、環己烷、正庚烷及諸如此類;基於芳香族烴之溶劑,例如苯、氯苯、甲苯、二甲苯及諸如此類;基於鹵化烴之溶劑,例如二氯甲烷、1,2-二氯乙烷、氯仿及四氯化碳及諸如此類;基於醚之溶劑,例如二乙醚、四氫呋喃(THF)、1,4-二噁烷、二甲氧基乙烷及諸如此類;酯溶劑,例如乙酸甲酯、乙酸乙酯及諸如此類;乙腈;基於醯胺之溶劑,例如N,N-二甲基甲醯胺(DMF)、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮及諸如此類;基於亞碸之溶劑,例如二甲亞碸(DMSO)、環丁碸(sulforane)及諸如此類;H2 O;乙酸;較佳地DMSO、DMF、甲苯及THF。可單獨使用該等溶劑中之任一者或在必要時可使用其兩種或更多種類型之組合。 每1 mol化合物(2),所用溶劑之量通常係1公升至20公升、較佳地1公升至10公升。 反應通常係在-10℃至溶劑之沸點之溫度下進行。端視於反應之完成,反應時間通常係在0.25小時至24小時或更長範圍內。 此步驟中所使用之化合物(2)可根據已知方法來產生(例如,WO2007/045989、Synlett (15), 2223-2227 (2011)及Molecular Diversity 18(2), 307-322 (2014)中所闡述之方法)。 此步驟中所使用之化合物(3)可根據已知方法來產生(例如,WO2006/110804、WO2015/003991、WO2015/11194及WO2015/162271中所闡述之方法)。 藉由方案1中所示之方法獲得之由式(1)表示之化合物容易地自反應混合物分離出且可藉由使用典型分離方式及純化方式來純化,例如過濾、溶劑萃取、蒸餾、重結晶、管柱層析等。 儘管本發明化合物所使用之形式可係本發明化合物本身,但通常藉由將本發明化合物與固體載劑、液體載劑、氣體載劑、表面活性劑及其他者混合來製備本發明化合物,且若必要,則添加黏著劑、分散劑及穩定劑以調配成可潤濕性粉末、水可分散性顆粒、可流動劑、顆粒、乾燥之可流動劑、可乳化濃縮物、水溶液、油溶液、發煙劑、氣溶膠、微膠囊及其他者。在該等調配物中,本發明化合物之含量通常在0.1重量%至99重量%、較佳地0.2重量%至90重量%範圍內。 固體載劑之實例包括呈細粉或微粒形式之黏土(例如,高嶺土(kaolin)、矽藻土、合成水合二氧化矽、文挾黏土(Fubasami clay)、膨潤土及酸性黏土)、滑石或其他無機礦物質(例如,絹雲母、石英粉末、硫粉末、活性木炭、碳酸鈣及水合二氧化矽),且液體載劑之實例包括水、醇(例如,甲醇及乙醇)、酮(例如,丙酮及甲基乙基酮)、芳香族烴(例如,苯、甲苯、二甲苯、乙基苯及甲基萘)、脂肪族烴(例如,正己烷、環己烷及煤油)、酯(例如,乙酸乙酯及乙酸丁酯)、腈(例如,乙腈及異丁腈)、醚(例如,二噁烷及二異丙基醚)、醯胺(例如,DMF及二甲基乙醯胺)、鹵化烴(例如,二氯乙烷、三氯乙烯及四氯化碳)及其他者。 表面活性劑之實例包括烷基硫酸鹽、烷基磺酸鹽、烷基芳基磺酸鹽、烷基芳基醚及其聚氧乙烯化化合物、聚乙二醇醚、多元醇酯及糖醇衍生物。 用於調配之其他助劑之實例包括黏著劑、分散劑及穩定劑,具體而言酪蛋白、明膠、多醣(例如,澱粉、阿拉伯膠、纖維素衍生物及海藻酸)、木質素衍生物、膨潤土、糖、水溶性合成聚合物(例如,聚乙烯醇、聚乙烯吡咯啶酮及聚丙烯酸)、PAP (酸性磷酸異丙基酯)、BHT (2,6-二-第三丁基-4-甲基苯酚)、BHA (2-第三丁基-4-甲氧基苯酚及3-第三丁基-4-甲氧基苯酚之化合物)、植物油、礦物油、脂肪酸或其脂肪酸酯及其他者。 用於施用本發明化合物之方法並無具體限制,只要施用形式係本發明化合物可實質上施用之形式即可,且包括(例如)對植物之施用,例如葉面施用;對用於栽培植物之區域之施用,例如淹沒處理;及對土壤之施用,例如種子消毒。 施用劑量端視於天氣狀況、劑型、施用時期、施用方法、欲施用面積、目標病害及目標作物等有所變化,但係在每1,000 m2 欲施用面積之通常1 g至500 g且較佳2 g至200 g範圍內。可乳化濃縮物、可潤濕性粉末或懸浮濃縮物等通常係藉由將其用水稀釋來施用。在此情形中,本發明化合物在稀釋後之濃度係在通常0.0005重量%至2重量%且較佳0.005重量%至1重量%範圍內。粉劑調配物或顆粒調配物等通常係以不經稀釋之其自身形式施用。在對種子之施用中,本發明化合物之量係在每1 kg種子通常0.001 g至100 g且較佳0.01 g至50 g範圍內。 在本文中,害蟲棲息地之實例包括稻田、田地、茶園、果園、非農業用地、房屋、育苗盤、育苗箱、育苗土壤及育苗床。 此外,在另一實施例中,舉例而言,可將本發明化合物投與至下文所提及之脊椎動物之內部(體內)或外部(體表)以全身性或非全身性地消滅寄生於脊椎動物中之生物或寄生蟲。內用藥劑之方法實例包括經口投與、經肛門投與、移植、經由皮下、肌內或靜脈內注射投與。外用藥劑之方法實例包括經皮投與。此外,本發明化合物可由家畜動物攝入以便消滅動物排泄物中存在之衛生昆蟲。 當將本發明化合物施用至諸如寄生害蟲之家畜動物及寵物之動物時,劑量端視於投與方法等而有所變化,但通常期望投與本發明化合物以使得活性成分(本發明化合物或其鹽)之劑量係在每1 kg動物體重通常0.1 mg至2,000 mg且較佳0.5 mg至1,000 mg範圍內。 本發明化合物可用作用於防治諸如田地、稻田、草坪、果園之農業用地中之植物病害之藥劑。本發明之化合物可防治農業用地或用於栽培以下「植物」之其他用地中所發生之病害。 作物:玉米、稻穀、小麥、大麥、黑麥、燕麥、高粱、棉花、大豆、花生、蕎麥、甜菜、油菜籽、向日葵、甘蔗、煙草及其他者;蔬菜:茄科(solanaceous)蔬菜(例如,茄子、番茄、甜椒、胡椒及馬鈴薯)、葫蘆科(cucurbitaceous)蔬菜(例如,黃瓜、南瓜、筍瓜、西瓜及甜瓜)、十字花科(cruciferous)蔬菜(例如,日本蘿蔔、白蘿蔔、辣根、球莖甘藍、大白菜、包心菜、雪裡紅、青花菜、花椰菜)、紫菀科(asteraceous)蔬菜(例如,牛蒡、茼蒿、朝鮮薊及萵苣)、百合科(liliaceous)蔬菜(例如,小洋蔥、洋蔥、大蒜及蘆筍)、牙籤草科(ammiaceous)蔬菜(例如,胡蘿蔔、香芹、芹菜及防風草)、藜科(chenopodiaceous)蔬菜(例如,菠菜及火焰菜(Swiss chard))、唇形科(lamiaceous)蔬菜(例如,紫蘇(Perilla frutescens)、薄荷及羅勒)、草莓、蕃薯、日本薯蕷(Dioscorea japonica)、芋及其他者;花:觀葉植物:果實:仁果類(例如,蘋果、梨、日本梨、木瓜(Chinese quince)及榅桲)、核果類(例如,桃子、李子、油桃、梅(Prunus mume)、櫻桃果、杏及乾果李)、柑橘類水果(例如,蜜柑(Citrus unshiu)、橙子、檸檬、萊姆橙(lime)及葡萄柚)、堅果(例如,栗子、胡桃、榛子、杏仁、開心果、腰果及澳洲胡桃(macadamia nut))、漿果類(例如,藍莓、蔓越莓、黑莓及樹莓)、葡萄、柿子(kaki persimmon)、橄欖、日本李、香蕉、咖啡、棗椰子、椰子及其他者;果樹以外之樹木:茶樹、桑樹、開花植物、行道樹(例如,光蠟樹(ash)、樺樹、山茱萸、桉樹、銀杏樹(Ginkgo biloba)、紫丁香、楓樹、櫟樹(Quercus)、白楊、美洲紫荊樹(Judas tree)、楓香樹(Liquidambar formosana)、懸鈴木、櫸樹、日本金鐘柏(Japanese arborvitae)、冷杉木、鐵杉、杜松、松(Pinus)、雲杉(Picea)及紫衫(Taxus cuspidata));及其他者。 上文所提及之「植物」包括經遺傳修飾之作物。 本發明化合物對其具有防治效能之害蟲包括植物病原體(例如絲狀真菌),以及有害節肢動物(例如有害昆蟲及有害蟎類)及線形動物(例如線蟲),且具體而言包括以下實例,但不限於其。 水稻病害:稻瘟病(稻瘟病菌(Magnaporthe grisea))、褐斑病(宮部旋孢腔菌(Cochliobolus miyabeanus))、紋枯病(立枯絲核菌(Rhizoctonia solani))、惡苗病(藤倉赤黴(Gibberella fujikuroi))及露菌病(大孢指疫黴(Sclerophthora macrospora)); 小麥病害:白粉病(白粉病菌(Erysiphe graminis))、鐮孢菌疫病(禾穀鐮孢菌(Fusarium graminearum)、燕麥鐮孢菌(F. avenaceum)、黃色鐮孢菌(F. culmorum)、紅色雪腐病菌(Microdochium nivale))、銹病(條形柄鏽菌(Puccinia striiformis)、禾柄鏽菌(P. graminis)、隱匿柄鏽菌(P. recondita))、雪腐病(紅色雪腐病菌(Micronectriella nivale))、雪腐小粒菌核病(typhulasnow blight)(核糊菌屬(Typhula sp.))、散黑穗病(小麥散黑粉菌(Ustilago tritici))、腥黑穗病(小麥網腥黑粉菌(Tilletia caries)、小麥矮腥黑粉菌(T. controversa))、眼斑病(小麥基腐病菌(Pseudocercosporella herpotrichoides))、葉斑枯病(小麥殼針孢菌(Septoria tritici))、穎枯病(穎枯殼多孢菌(Stagonospora nodorum))、褐斑病(偃麥草核腔菌(Pyrenophora tritici-repentis))、絲核菌苗立枯病(rhizoctonia seedling blight)(立枯絲核菌(Rhizoctonia solani))及全蝕病(禾頂囊殼菌(Gaeumannomyces graminis)); 大麥病害:白粉病(白粉病菌)、鐮孢菌疫病(禾穀鐮孢菌、燕麥鐮孢菌、黃色鐮孢菌、紅色雪腐病菌)、銹病(條形柄鏽菌、禾柄鏽菌、大麥白粉菌(P. hordei))、散黑穗病(麥散黑粉菌(Ustilago nuda))、雲紋病(黑麥喙孢菌(Rhynchosporium secalis))、網斑病(圓核腔菌(Pyrenophora teres))、斑點疱(禾旋孢腔菌(Cochliobolus sativus))、葉條紋病(麥類核腔菌(Pyrenophora graminea))、柱隔孢菌病(Ramularia disease)(膠質鵝斑柱隔孢菌(Ramularia collo-cygni))及絲核菌苗立枯病(立枯絲核菌); 玉米病害:銹病(玉米普通型鏽菌(Puccinia sorghi))、南方型銹病(多堆柄鏽菌(Puccinia polysora))、北方葉枯病(northern leaf blight)(玉米毛球腔菌(Setosphaeria turcica))、南方葉枯病(異旋孢腔菌(Cochliobolus heterostrophus))、炭疽病(禾生炭疽刺盤孢菌(Colletotrichum graminicola))、灰色葉斑病(玉蜀黍尾孢菌(Cercospora zeae-maydis))、眼斑病(玉蜀黍球梗孢菌(Kabatiella zeae))及暗球腔菌葉斑病(phaeosphaeria leaf spot)(玉米暗球腔菌(Phaeosphaeria maydis)); 棉花病害:炭疽病(棉花炭疽刺盤孢菌(Colletotrichum gossypii))、灰黴(Ramularia areola)、鏈格孢菌葉斑病(alternaria leaf spot)(大孢鏈格孢菌(Alternaria macrospora)、棉鏈格孢菌(A. gossypii)); 咖啡病害:銹病(咖啡駝孢鏽菌(Hemileia vastatrix)); 油菜籽病害:菌核病(核盤菌(Sclerotinia sclerotiorum))、黑斑病(芸薹鏈格孢菌(Alternaria brassicae))及黑腳病(黑脛莖點黴(Phoma lingam)); 柑橘病害:黑變病(柑橘間座殼菌(Diaporthe citri))、瘡痂病(柑橘痂囊腔菌(Elsinoe fawcettii))及果腐病(指狀青黴(Penicillium digitatum)、白邊青黴(P. italicum)); 蘋果病害:花枯病(蘋果鏈核盤菌(Monilinia mali))、潰瘍病(蘋果黑腐皮殼菌(Valsa ceratosperma))、白粉病(白叉絲單囊殼菌(Podosphaera leucotricha))、鏈格孢菌葉斑病(蘋果病變型鏈格孢菌(Alternaria alternata apple pathotype))、瘡痂病(蘋果黑星菌(Venturia inaequalis))及苦腐病(急尖炭疽刺盤孢菌(Colletotrichum acutatum)); 梨病害:瘡痂病(日本梨黑星菌(Venturia nashicola)、梨黑星菌(V. pirina))、黑斑病(日本梨病變型鏈格孢)及銹病(梨膠鏽菌(Gymnosporangium haraeanum)); 桃病害:褐腐病(桃褐腐菌(Monilinia fructicola))、瘡痂病(嗜果枝孢菌(Cladosporium carpophilum))及褐紋病(Phomopsis rot)(擬莖點黴屬(Phomopsis sp.)); 葡萄病害:炭疽病(痂囊腔菌(Elsinoe ampelina))、晚腐病(圍小叢殼菌(Glomerella cingulata))、白粉病(葡萄鉤絲殼菌(Uncinula necator))、銹病(葡萄層鏽菌(Phakopsora ampelopsidis))、黑腐病(葡萄球座菌(Guignardia bidwellii))及露菌病(葡萄生單軸黴(Plasmopara viticola)); 日本柿之病害:炭疽病(柿盤長孢菌(Gloeosporium kaki))及葉斑病(柿尾孢菌(Cercospora kaki)、柿葉球腔菌(Mycosphaerella nawae)); 葫蘆科之病害:炭疽病(葫蘆刺盤孢菌(Colletotrichum lagenarium))、白粉病(白粉菌(Sphaerotheca fuliginea))、蔓枯病(小雙胞腔菌(Didymella bryoniae))、靶斑病(多主棒孢菌(Corynespora cassiicola))、鐮孢菌萎蔫病(尖孢鐮刀菌(Fusarium oxysporum))、露菌病(黃瓜假霜黴菌(Pseudoperonospora cubensis))、疫黴腐病(phytophthora rot)(疫黴屬(Phytophthora sp.))及猝倒病(腐黴屬(Pythium sp.)); 番茄病害:早疫病(索蘭氏鏈格孢菌(Alternaria solani))、葉黴病(黃枝孢黴(Cladosporium fulvum))、葉黴病(煤灰假尾孢菌(Pseudocercospora fuligena))及晚疫病(致病疫黴(Phytophthora infestans)); 茄子病害:褐斑病(褐紋擬莖點黴(Phomopsis vexans))及白粉病(二孢白粉菌(Erysiphe cichoracearum)); 十字花科蔬菜之病害:鏈格孢菌葉斑病(蘿蔔鏈格孢菌(Alternaria japonica))、白斑病(芸苔小尾孢菌(Cercosporella brassicae))、根腫病(寄生根腫菌(Plasmodiophora parasitica))、露菌病(寄生霜黴(Peronospora parasitica)); 大蔥病害:銹病(蔥柄鏽菌(Puccinia allii)); 大豆病害:紫斑病(大豆紫斑病菌(Cercospora kikuchii))、癡圓抱屬疫癡病(sphaceloma scad)(大豆痂囊腔菌(Elsinoe glycines))、黑點病(pod and stem blight)(萊豆間座殼大豆變種(Diaporthe phaseolorum var. sojae))、銹病(豆薯層鏽菌(phakopsora pachyrhizi))、靶斑病(多主棒孢菌)、炭疽病(大豆炭疽刺盤孢菌(Colletotrichum glycines)、毛豆炭疽刺盤孢菌(C. truncatum))、氣生絲核菌(Rhizoctonia aerial)疫病(立枯絲核菌)、殼針孢屬(septoria)褐斑病(大豆殼針孢菌(Septoria glycines))及蛙眼葉斑病(大豆尾孢菌(Cercospora sojina)); 菜豆病害:炭疽病(菜豆炭疽刺盤孢菌(Colletotrichum lindemuthianum)); 花生病害:早期葉斑病(球座尾孢菌(Cercospora personata))、晚期葉斑病(花生尾孢菌(Cercospora arachidicola))及白絹病(southern blight)(齊整小核菌(Sclerotium rolfsii)); 豌豆病害:白粉病(豌豆白粉菌(Erysiphe pisi)); 馬鈴薯病害:早疫病(索蘭氏鏈格孢菌)、晚疫病(致病疫黴)及黃萎病(verticillium wilt)(黑白輪枝菌(verticillium albo-atrum)、大麗輪枝菌(V. dahliae)、變黑輪枝菌(V. nigrescens)); 草莓病害:白粉病(律草單囊殼菌(Sphaerotheca humuli)); 茶樹病害:網疱疫病(網狀外擔菌(Exobasidium reticulatum))、白瘡痂病(痂囊腔菌(Elsinoe leucospila))、灰疫病(擬盤多毛孢屬(Pestalotiopsis sp.))及炭疽病(茶炭疽刺盤孢菌(Colletotrichum theae-sinensis)); 煙草病害:褐斑病(長柄鏈格孢菌(Alternaria longipes))、白粉病(二孢白粉菌)、炭疽病(煙草炭疽刺盤孢菌(Colletotrichum tabacum))、露菌病(煙草霜黴菌(Peronospora tabacina))及黑脛病(煙草疫黴(Phytophthora nicotianae)); 糖甜菜病害:尾孢菌屬(cercospora)葉斑病(甜菜生尾孢菌(Cercospora beticola))、葉枯病(瓜亡革菌(Thanatephorus cucumeris))、根腐病(瓜亡革菌)及絲囊黴屬(aphanomyces)根腐病(螺殼狀絲囊黴(Aphanomyces cochlioides)); 薔薇病害:黑斑病(薔薇雙殼菌(Diplocarpon rosae))及白粉病(薔薇單囊殼菌(Sphaerotheca pannosa)); 菊花之病害:葉枯病(野菊殼針孢(Septoria chrysanthemi-indici))及白銹病(掘柄鏽菌(Puccinia horiana)); 洋蔥病害:葡萄孢屬(botrytis)葉枯病(灰葡萄孢菌(Botrytis cinerea)、蔥細絲葡萄孢菌(B. byssoidea)、蔥鱗葡萄孢菌(B. squamosa))、灰黴頸腐病(蔥腐葡萄孢菌(Botrytis allii))及小菌核腐敗病(蔥鱗葡萄孢菌); 各種作物病害:灰黴病(灰葡萄孢菌)及菌核病(核盤菌); 日本蘿蔔之病害:鏈格孢菌葉斑病(芸薹生鏈格孢菌(Alternaria brassicicola)); 草坪草病害:幣斑病(dollar spot)(同果核盤菌(Sclerotinia homoeocarpa))、褐斑病及巨斑病(立枯絲核菌);及 香蕉病害:辛加托卡病(Sigatoka disease)(斐濟球腔菌(Mycosphaerella fijiensis)、香蕉褐條斑球腔菌(Mycosphaerella musicola))。 半翅目(Hemiptera):飛虱科(Delphacidae)(例如,灰飛虱(Laodelphax striatellus)、褐飛虱(Nilaparvata lugens)或白背飛虱(Sogatella furcifera));角頂葉蟬亞科(Deltocephalinae)(例如,偽黑尾葉蟬(Nephotettix cincticeps)或二點黑尾葉蟬(Nephotettix virescens));蚜科(Aphididae)(例如,棉蚜(Aphis gossypii)、桃蚜(Myzus persicae)、菜蚜(Brevicoryne brassicae)、馬鈴薯長管蚜(Macrosiphum euphorbiae)、馬鈴薯蚜(Aulacorthum solani)、稻麥蚜(Rhopalosiphum padi)、橘蚜(Toxoptera citricidus));蝽科(Pentatomidae)(例如,稻綠蝽(Nezara antennata)、點蜂緣蝽(Riptortus clavatus)、中稻緣蝽(Leptocorisa chinensis)、尖角二星蝽(Eysarcoris parvus)、茶翅蝽(Halyomorpha mista)或美國牧草盲蝽(Lygus lineolaris));粉虱科(Aleyrodidae)(例如,溫室粉虱(Trialeurodes vaporariorum)或銀葉粉虱(Bemisia argentifolii));蚧總科(Coccoidea)(例如,橘紅腎圓盾介殼蟲(Aonidiella aurantii)、梨圓介殼蟲(Comstockaspis perniciosa)、橘矢尖蚧(Unaspis citri)、紅蠟介殼蟲(Ceroplastes rubens)或吹綿介殼蟲(Icerya purchasi));綱蝽科(Tingidae);木虱科(Psyllidae);臭蟲(溫帶臭蟲(Cimex lectularius))及其他者。 鱗翅目(Lepidoptera):螟蛾科(Pyralidae)(例如,二化螟(Chilo suppressalis)、三化螟(Tryporyza incertulas)、瘤野螟(Cnaphalocrocis medinalis)、棉大捲葉野螟(Notarcha derogata)、印度穀斑螟(Plodia interpunctella)、亞洲玉米螟(Ostrinia furnacalis)、菜心螟(Hellula undalis)、蘭草螟蛾(Pediasia teterrellus))、夜蛾科(Noctuidae)(例如,斜紋夜盜蛾(Spodoptera litura)、甜菜葉蛾(Spodoptera exigua)、東方黏蟲(Pseudaletia separata)、甘藍夜蛾(Mamestra brassicae)、小地老虎(Agrotis ipsilon)、黑點銀紋夜蛾(Plusia nigrisigna)、粉夜蛾屬(Trichoplusia spp.)、實夜蛾屬(Heliothis spp.)或鈴夜蛾屬(Helicoverpa spp.));粉蝶科(Pieridae)(例如,紋白蝶(Pieris rapae))、捲葉蛾科(Tortricidae)(例如,茶小捲葉蛾屬(Adoxophyes spp.)、桃折心蟲(Grapholita molesta)、蘋果蠹蛾(Cydia pomonella)、大豆食心蟲(Leguminivora glycinivorella)、日豆小捲葉蛾(Matsumuraeses azukivora)、棉褐帶捲葉蛾(Adoxophyes orana fasciata)、茶小捲葉蛾屬、茶捲葉蛾(Homona magnanima)、杏黃捲葉蛾(Archips fuscocupreanus)、蘋果蠹蛾);細蛾科(Gracillariidae)(例如,茶細蛾(Caloptilia theivora)、金紋細蛾(Phyllonorycter ringoniella));果蛀蛾科(Carposinidae)(例如,桃蛀果蛾(Carposina niponensis));潛蛾科(Lyonetiidae)(例如,潛蛾屬(Lyonetia spp.));毒蛾科(Lymantriidae)(例如,毒蛾屬(Lymantria spp.)或黃毒蛾屬(Euproctis spp.));巢蛾科(Yponomeutidae)(例如,小菜蛾(Plutella xylostella));麥蛾科(Gelechiidae)(例如,紅鈴蟲(Pectinophora gossypiella)或馬鈴薯蠹蛾(Phthorimaea operculella));燈蛾科(Arctiidae)(例如,美國白蛾(Hyphantria cunea));穀蛾科(Tineidae)(例如,衣蛾(Tinea translucens)或袋衣蛾(Tineola bisselliella));及其他者; 纓翅目(Thysanoptera):纓翅目(例如,西方花薊馬(Frankliniella occidentalis)、南黃薊馬(Thrips palmi)、小黃薊馬(Scirtothrips dorsalis)、蔥薊馬(Thrips tabaci)、台灣花薊馬(Frankliniella intonsa)、煙草花薊馬(Frankliniella fusca)); 雙翅目(Diptera):家蠅(Musca domestica)、淡色庫蚊(Culex pipiens pallens)、三角虻(Tabanus trigonus)、蔥種蠅(Hylemya antiqua)、玉米種蠅(Hylemya platura)、中華瘧蚊(Anopheles sinensis)、稲葉潛蠅(Agromyza oryzae)、大麥水蠅(Hydrellia griseola)、稻黃潛蠅(Chlorops oryzae)、瓜實蠅(Dacus cucurbitae)、地中海果實蠅(Ceratitis capitata)、非洲菊斑潛蠅(Liriomyza trifolii)及其他者; 鞘翅目(Coleoptera):茄二十八星瓢蟲(Epilachna vigintioctopunctata)、黃守瓜(Aulacophora femoralis)、黃條葉蚤(Phyllotreta striolata)、稻負泥蟲(Oulema oryzae)、稻象鼻蟲(Echinocnemus squameus)、水稻水象鼻蟲(Lissorhoptrus oryzophilus)、墨西哥棉蛉象鼻蟲(Anthonomus grandis)、綠豆象(Callosobruchus chinensis)、寄生穀象鼻蟲(Sphenophorus venatus)、日本金龜子(Popillia japonica)、古銅異麗金龜(Anomala cuprea)、根葉甲屬(Diabrotica spp.)、科羅拉多金花蟲(Leptinotarsa decemlineata)、叩甲屬(Agriotes spp.)、鋸角毛竊蠹(Lasioderma serricorne)、姬圓鰹節蟲(Anthrenus verbasci)、擬榖盜(Tribolium castaneum)、褐粉蠹(Lyctus brunneus)、馬拉白星天牛(Anoplophora malasiaca)、縱坑切梢小蠹(Tomicus piniperda)及其他者; 直翅目(Orthoptera):飛蝗(Locusta migratoria)、非洲螻蛄(Gryllotalpa africana)、小翅稻蝗(Oxya yezoensis)、日本稻蝗(Oxya japonica)及其他者; 膜翅目(Hymenoptera):菜葉蜂(Athalia rosae)、切葉蟻屬(Acromyrmex spp.)、美國火蟻屬(Solenopsis spp.)及其他者; 線蟲類:葉芽線蟲(Aphelenchoides besseyi)、草黴芽線蟲(Nothotylenchus acris)、大豆胞囊線蟲(Heterodera glycines)、根瘤線蟲(Meloidogyne incognita)、根腐線蟲(Pratylenchus)、假根節線蟲(Nacobbus aberrans)及其他者; 蜚蠊目(Blattariae):德國姬蠊(Blattella germanica)、黑褐家蠊(Periplaneta fuliginosa)、美洲蜚蠊(Periplaneta americana)、棕色家蠊(Periplaneta brunnea)、東方蜚蠊(Blatta orientalis)及其他者; 蟎蜱目(Acarina):葉蟎科(Tetranychidae)(例如,二點葉蟎(Tetranychus urticae)、柑橘葉蟎(Panonychus citri)或小爪蟎屬(Oligonychus spp.));節蜱科(Eriophyidae)(例如,橘刺皮節蜱(Aculops pelekassi));細蟎科(Tarsonemidae)(例如,多食細蟎(Polyphagotarsonemus latus));細須蟎科(Tenuipalpidae);杜克葉蟎科(Tuckerellidae);粉蟎科(Acaridae)(例如,腐食酪蟎(Tyrophagus putrescentiae));塵蟎科(Pyroglyphidae)(例如,美洲室塵蟎(Dermatophagoides farinae)或歐洲室塵蟎(Dermatophagoides pteronyssinus));肉食蟎科(Cheyletidae)(例如,普通肉食蟎(Cheyletus eruditus)、馬六甲肉食蟎(Cheyletus malaccensis)或莫氏肉食蟎(Cheyletus moorei));皮刺蟎科(Dermanyssidae);及其他者。 包含本發明化合物或其鹽之調配物亦可用於與治療家畜疾病或畜牧業有關之領域中,且例如可消滅寄生於脊椎動物(例如人類、牛、綿羊、豬、家禽、狗、貓及魚)之內部及/或外部上之生物或寄生蟲,以維護公共衛生。 害蟲之實例包括硬蜱屬(Ixodes spp.) (例如,肩突硬蜱(Ixodes scapularis))、牛蜱屬(Boophilus spp.) (例如,微小牛蜱(Boophilus microplus))、花蜱屬(Amblyomma spp.)、長鬚壁蝨屬(Hyalomma spp.)、扇頭壁蝨屬(Rhipicephalus spp.) (例如,血色扇頭壁蝨(Rhipicephalus sanguineus))、血蜱屬(Haemaphysalis spp.) (例如,長角血蜱(Haemaphysalis longicornis))、矩頭蜱屬(dermacentor spp.)、鈍緣蜱屬(Ornithodoros spp.) (例如,非洲鈍緣蜱(Ornithodoros moubata))、雞蟎(Dermanyssus gallinae)、林禽刺蟎(Ornithonyssus sylviarum)、疥蟎屬(Sarcoptes spp.) (例如,人疥蟎(Sarcoptes scabiei))、痂恙蟲屬(Psoroptes spp.)、食皮疥蟲屬(Chorioptes spp.)、毛囊蟲屬(Demodex spp.)、真恙蟎屬(Eutrombicula spp.)、裸舌甲屬(Ades spp.)(例如,白線斑蚊(Aedes albopictus))、瘧蚊屬(Anopheles spp.)、家蚊屬(Culex spp.)、庫蠓屬(Culicoides spp.)、家蠅屬(Musca spp.)、牛蠅屬(Hypoderma spp.)、馬蠅屬(Gasterophilus spp.)、黑角蠅屬(Haematobia spp.)、牛虻屬(Tabanus spp.)、蚋屬(Simulium spp.)、錐鼻蟲屬(Triatoma spp.)、毛虱目(Phthiraptera)(例如,齧虱屬(Damalinia spp.))、長齶虱屬(Linognathus spp.)、獸虱屬(Haematopinus spp.)、櫛頭蚤屬(Ctenocephalides spp.) (例如,貓櫛頭蚤(Ctenocephalides felis))、鼠蚤屬(Xenopsylla spp.)、小黃單家蟻(monomorium pharaonis)及線蟲、金線蟲(例如,巴西鼠鉤蟲(Nippostrongylus brasiliensis)、艾氏毛線蟲(Trichostrongylus axei)、蛇形毛樣細圓蟲(Trichostrongylus colubriformis))、旋毛蟲屬(Trichinella spp.) (例如,旋毛蟲(Trichinella spiralis))、撚轉胃蟲(Haemonchus contortus)、細頸屬(Nematodirus spp.) (例如,巴特斯細頸線蟲(Nematodirus battus))、環頸奧斯他胃蟲(Ostertagia circumcincta)、庫柏毛樣線蟲屬(Cooperia spp.)、鼠包膜條蟲(Hymenolepis nana)及其他害蟲。 本發明之二噻𠷬(1)係作為(例如)殺真菌劑之活性成分使用。 本發明之二噻𠷬(1)可藉由製成諸如油、乳液、可潤濕性粉末、可流動製劑、顆粒、粉末、氣溶膠、薰蒸劑或諸如此類之期望形式來使用。在此情形中,本發明之二噻𠷬(1)之含量不受限制且可根據各種條件自寬範圍適當地選擇,該等條件係例如製劑形式、欲治療之病害種類、植物種類、病害之嚴重程度、施用部位、施用時間、施用方法、組合使用之化學品(殺蟲劑、殺線蟲劑、殺蟎劑、殺真菌劑、除草劑、植物生長控制劑、增效劑、土壤改良劑等)、肥料之量及種類等等。基於殺真菌製劑之總量,該含量通常係約0.01重量%至約95重量%。 含有本發明之二噻𠷬(1)作為活性成分之殺真菌製劑可根據已知製程來製備。舉例而言,本發明之二噻𠷬(1)可與諸如固體載劑、液體載劑、氣態載劑或諸如此類之載劑混合。 視情況,可添加表面活性劑及其他佐劑用於製備。 可用之載劑可係通常用於此領域中之已知載劑中之任一者。 可用固體載劑之實例係黏土(高嶺土黏土、矽藻土、合成水合二氧化矽、膨潤土、文挾黏土、酸性黏土及諸如此類)、滑石、陶瓷、其他無機礦物、矽鈰石、石英、硫、活性碳、碳酸鈣、水合二氧化矽等之細粉或顆粒。 可用液體載劑係(例如)水、醇(例如甲醇、乙醇等)、酮(例如丙酮、甲基乙基酮等)、芳香族烴(例如苯、甲苯、二甲苯、乙基苯、甲基萘等)、脂肪族烴(例如己烷、環己烷、煤油、輕質油等)、酯(例如乙酸乙酯、乙酸丁酯等)、腈(例如乙腈、異丁腈等)、醚(例如二異丙基醚、二噁烷等)、醯胺(例如N,N-二甲基甲醯胺、N,N-二甲基乙醯胺等)、鹵化烴(例如二氯甲烷、三氯乙烷、四氯化碳等)、二甲亞碸、大豆油、棉花籽油、植物油等等。 可用氣態載劑(推進劑)之實例係丁烷氣、LPG (液化石油氣)、二甲醚、二氧化碳等。 可用表面活性劑之實例係烷基酯硫酸鹽、烷基磺酸鹽、烷基芳基磺酸鹽、烷基芳基醚、其聚氧乙烯化產物、聚乙二醇醚、多元醇酯、糖醇化合物等。 用於製備之可用佐劑之實例係固定劑,例如酪蛋白、明膠、多醣(澱粉粉末、阿拉伯膠、纖維素化合物、海藻酸等)、木質素化合物、膨潤土、醣類、合成水溶性聚合物(聚乙烯醇、聚乙烯吡咯啶酮、聚丙烯酸等)及諸如此類;穩定劑,例如PAP (酸性磷酸異丙基酯)、BBH (2,6-二-第三丁基-4-甲基苯酚)、BHA (2-第三丁基-4-甲氧基苯酚及3-第三丁基-4-甲氧基苯酚之混合物)、植物油、礦物油、脂肪酸、其酯及諸如此類。 由此獲得之本發明之殺真菌製劑可原樣使用或經水稀釋使用。該製劑可藉由與以下中之任一者混合來製備:殺蟲劑、殺線蟲劑、殺蟎劑、殺真菌劑、除草劑、植物生長控制劑、增效劑、土壤改良劑等。本發明之製劑可與其他製劑同時施用。 當本發明之製劑用作用於農業及園藝中之殺真菌劑時,本發明之製劑之量不受限制且可根據各種條件自寬範圍適當地選擇,該等條件係例如活性成分之濃度、製劑形式、欲治療之病害種類、植物種類、病害或蟎蟲之嚴重程度、施用時間、施用方法、組合使用之化學品(殺蟲劑、殺線蟲劑、殺蟎劑、殺真菌劑、除草劑、植物生長控制劑、增效劑、土壤改良劑等)、肥料之量及種類等等。該量通常係每100 m2 面積約0.001 g至約100 g。當使用經水稀釋之乳液、可潤濕性粉末、可流動製劑或諸如此類時,殺真菌或殺蟎製劑之濃度係約0.1 ppm至約1000 ppm、較佳約1 ppm至500 ppm。顆粒、粒子或諸如此類不經稀釋而如此施用。 本發明之化合物之特徵在於具有優良殺真菌活性及廣譜活性。該化合物可用於防治歸因於致病性真菌及抗性致病性真菌之植物病害。此等致病性真菌之實例包括引起以下病害或對治療以下病害之殺真菌劑具有抗性之彼等真菌:稻瘟病、水稻紋枯病、番茄灰黴病及諸如此類、蘋果白粉病、蘋果斑點落葉病(alternaria blotch)、柿白粉病、葡萄白粉病、大麥白粉病、小麥白粉病、黃瓜白粉病、黃瓜灰黴病、番茄晚疫病、馬鈴薯晚疫病及諸如此類。 實例 本發明將參考製備實例、調配實例及測試實例更詳細地闡述。 本發明參考以下參考實例、製造實例、調配實例及測試實例更詳細地闡述。然而,本發明並不限於該等實例。另外,可在不背離本發明之範圍之範圍內做出改變。 參考實例12- -1-(2- 氯苯基 ) 乙酮之製備 在0℃下向1-(2-氯苯基)乙酮(10.00 g, 64.51 mmol)於二乙醚(35 ml)中之經冷卻溶液緩慢添加溴(3.32 mL, 64.51 mmol)。然後將所得反應混合物在0℃下攪拌3小時。在減壓下將所有揮發物蒸餾之後,藉由硫代硫酸鈉水溶液淬滅殘餘物且用二乙醚(3 × 20 ml)萃取。將合併之有機層用蒸餾水、之後鹽水溶液洗滌、經硫酸鈉乾燥、過濾且在減壓下濃縮,得到14.90 g呈淺棕色液體之粗產物。然後其不經進一步純化即用於下一步驟中。1 H NMR (CDCl3 , 400 MHz) δ: 7.57-7.55 (m, 1H), 7.48-7.44 (m, 2H), 7.38-7.36 (m, 1H), 4.52 (s, 2H)。 參考實例22- -1-(2- 氯苯基 ) 乙醇之製備 在0℃下向2-溴-1-(2-氯苯基)乙酮(10.00 g, 42.91 mmol)於甲醇(40 ml)中之經冷卻溶液逐份添加硼氫化鈉(1.63 g, 42.91 mmol)。然後將所得反應混合物在室溫下攪拌1小時。在減壓下將所有揮發物蒸餾之後,藉由蒸餾水(70 ml)淬滅殘餘物且用乙酸乙酯(3 × 20 ml)萃取。將合併之有機層用蒸餾水、之後鹽水溶液洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到9.90 g呈無色液體之粗產物。然後其不經進一步純化即用於下一步驟中。1 H NMR (CDCl3 , 400 MHz) δ: 7.64-7.62 (m, 1H), 7.37-7.33 (m, 1H), 7.28-7.27 (m, 1H), 7.24-7.22 (m, 1H), 5.33-5.30 (m, 1H), 3.81-3.78 (m, 1H), 3.47-3.42 (m, 1H), 2.71-2.70 (m, 1H)。 參考實例3甲磺酸 2- -1-(2- 氯苯基 ) 乙基酯之製備 在0℃下向2-溴-1-(2-氯苯基)乙醇(9.90 g, 41.94 mmol)於四氫呋喃(35 ml)中之經冷卻溶液緩慢添加三乙胺(6.35 g, 62.92 mmol),之後添加甲磺醯氯(4.82 g, 41.94 mmol)。然後將所得反應混合物在0℃下攪拌2小時。在減壓下將所有揮發物蒸餾之後,藉由蒸餾水(70 ml)淬滅殘餘物且用乙酸乙酯(4 × 20 ml)萃取。將合併之有機層用蒸餾水、之後鹽水溶液洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到12.40 g呈白色固體之粗產物。然後其不經進一步純化即用於下一步驟中。1 H NMR (CDCl3 , 400 MHz) δ: 7.59-7.54 (m, 1H), 7.42-7.35 (m, 2H), 7.24-7.22 (m, 1H), 6.14-6.11 (m, 1H), 3.78-3.73 (m, 1H), 3.66-3.63 (m, 1H), 3.08 (m, 3H)。 製造實例12-(4-(2- 氯苯基 )-1,3- 二噻 𠷬 -2- 亞基 )-2-( 吡啶 -3- ) 乙腈 (1c-3H 1c-3L) 在氮氣氛下在0℃下向氫氧化鉀(0.22 g, 3.97 mmol)於二甲亞碸(3 ml)中之經攪拌溶液緩慢添加2-(吡啶-3-基)乙腈(0.19 g, 1.59 mmol)於二甲亞碸(1 ml)中之溶液,之後添加二硫化碳(0.303 g, 3.97 mmol)於二甲亞碸(1 ml)中之溶液。然後將所得反應混合物在室溫下攪拌20分鐘。在室溫下向此混合物緩慢添加甲磺酸2-溴-1-(2-氯苯基)乙基酯(0.50 g, 1.59 mmol)於二甲亞碸(1 ml)中之溶液。然後將反應混合物進一步在室溫下攪拌3小時。將反應混合物用冰冷卻之蒸餾水(10 ml)稀釋且用乙酸乙酯(3 × 10 ml)萃取。將合併之有機層用蒸餾水洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到粗產物。藉由管柱層析在矽膠上用乙酸乙酯及正己烷之混合物作為溶析液來純化由此獲得之粗產物,分別獲得0.07 g及0.11 g呈淺黃色固體之標題化合物之兩種區域異構物1c-3H及1c-3L。使用正己烷及乙酸乙酯之溶劑系統,標題化合物之該兩種區域異構物可在TLC上分離,且Rf值較高之一者指定為1c-3H,而TLC上Rf值較低之另一者指定為1c-3L。 1c-3H:1 H NMR (CDCl3, 400 MHz) δ: 8.83 (s, 1H), 8.54 (d, J = 4.0 Hz, 1H), 7.85-7.82 (m, 1H), 7.65-7.62 (m, 1H), 7.44-7.40 (m, 1H), 7.35-7.28 (m, 3H), 5.75-5.72 (m, 1H), 3.94-3.89 (m, 1H), 3.74-3.69 (m, 1H)。 1c-3L:1 H NMR (CDCl3, 400 MHz) δ: 8.84 (s, 1H), 8.54 (d, J = 4.8 Hz, 1H), 7.83-7.83 (m, 1H), 7.71-7.68 (m, 1H), 7.46-7.43 (m, 1H), 7.37-7.30 (m, 3H), 5.73-5.68 (m, 1H), 3.96-3.89 (m, 1H), 3.74-3.69 (m, 1H)。 製造實例2(E&Z)-2-(4-(2- 氯苯基 )-1,3- 二噻 𠷬 -2- 亞基 )-2-(6- 氯吡啶 -3- ) 乙腈 (1c-42) 在氮氣氛下在0℃下向氫氧化鉀(0.13 g, 2.38 mmol)於二甲亞碸(3 ml)中之經攪拌溶液緩慢添加2-(6-氯吡啶-3-基)乙腈(0.15 g, 0.95 mmol)於二甲亞碸(1 ml)中之溶液,之後添加二硫化碳(0.18 g, 2.38 mmol)於二甲亞碸(1 ml)中之溶液。然後將所得反應混合物在室溫下攪拌20分鐘。在室溫下向此混合物緩慢添加甲磺酸2-溴-1-(2-氯苯基)乙基酯(0.30 g, 0.95 mmol)於二甲亞碸(1 ml)中之溶液。然後將反應混合物進一步在室溫下攪拌3小時。將反應混合物用冰冷卻之蒸餾水(10 ml)稀釋且用乙酸乙酯(3 × 10 ml)萃取。將合併之有機層用蒸餾水洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到粗產物。藉由管柱層析在矽膠上用乙酸乙酯及正己烷之混合物作為溶析液來純化由此獲得之粗產物,獲得0.08 g呈棕色黏性油狀物之為兩種區域異構物之混合物之標題化合物。1 H NMR (CDCl3, 400 MHz) δ: 8.62-8.59 (m, 1H), 7.83-7.79 (m, 1H), 7.64-7.50 (m, 1H), 7.45-7.29 (m, 4H), 5.76-5.69 (m, 1H), 3.99-3.90 (m, 1H), 3.79-3.70 (m, 1H)。 本發明之代表性化合物例示於下表1至5中,但本發明並不限於該等化合物。 除製造實例1及2中所獲得之化合物以外,表1至5中所示之化合物係藉由與製造實例1及2中所闡述之方法或說明書中所闡述之方法類似之方法來產生。 表1至5中之縮寫係如下所示。 F:氟,Cl:氯,Br:溴,Me:甲基,t-Bu:第三丁基,CF3 :三氟甲基,Ph:苯基,NO2 :硝基,CN:氰基,OMe:甲氧基,CF3 O:三氟甲氧基,NH2 :胺基。 表1:屬一般結構(1a)之所合成化合物之細節*: *此處H及L分別係指使用正己烷及乙酸乙酯之溶劑系統,在TLC上較高及較低Rf值之化合物之兩種區域異構物。 表2:屬一般結構(1b)之所合成化合物之細節*: *此處H及L分別係指使用正己烷及乙酸乙酯之溶劑系統,在TLC上較高及較低Rf值之化合物之兩種區域異構物。 表3:屬一般結構(1c)之所合成化合物之細節*: *此處H及L分別係指使用正己烷及乙酸乙酯之溶劑系統,在TLC上較高及較低Rf值之化合物之兩種區域異構物。 表4:屬一般結構(1d)之所合成化合物之細節*: *此處H及L分別係指使用正己烷及乙酸乙酯之溶劑系統,在TLC上較高及較低Rf值之化合物之兩種區域異構物。 表5:屬一般結構(1e)之所合成化合物之細節*: *此處H及L分別係指使用正己烷及乙酸乙酯之溶劑系統,在TLC上較高及較低Rf值之化合物之兩種區域異構物。 由式(1)表示之所合成化合物之1 H NMR數據示於表6至表10中。 表6 表7 表8 表9 表10 下文給出調配實例,其中份係指重量份。 調配實例1 (可乳化濃縮物) 將10份本發明之每一化合物溶解於45份Solvesso® 150及35份N-甲基吡咯啶酮中。向其添加10份乳化劑(商標名:Sorpol® 3005X,由Toho Kagaku Co., Ltd.製造)。將該等成分在攪拌下混合,藉此產生10%之可乳化濃縮物。 調配實例2 (可潤濕性粉末) 將20份本發明之每一化合物添加至2份月桂基硫酸鈉、4份木質素磺酸鈉、20份含水合成氧化矽之細粉及54份黏土之混合物。將該等成分在果汁機攪拌下混合,藉此產生20%之可潤濕性粉末。 調配實例3 (顆粒) 將5份本發明之每一化合物與2份十二烷基苯磺酸鈉、10份膨潤土及83份黏土混合,之後充分攪動。添加適宜量之水,且將混合物進一步攪拌。將混合物藉由粒化器製粒且風乾,產生5%顆粒。 調配實例4 (粉劑) 將1份本發明之每一化合物溶解於適宜量之丙酮中。向該溶液添加5份含水合成氧化矽之細粉、0.3份酸性磷酸異丙基酯(PAP)及93.7份黏土,之後藉由果汁機混合並攪拌。藉由蒸發自其去除丙酮,產生1%之粉末調配物。 調配實例5 (可流動製劑) 將20份本發明之每一化合物與20份含有3份聚氧乙烯三苯乙烯基苯基醚磷酸和三乙醇胺及0.2份Rhodorsil® 426R (由RhodiaChimie製造)之水混合。藉由碾磨機(商標名:DYNO-Mill,且由Willy A. Bachofen AG製造)使用濕法將該混合物粉碎,且與60份含有8份丙二醇及0.32份黃原膠之水進一步混合,藉此產生20%於水中之懸浮液。 下文給出測試實例以展示本發明之化合物可用作殺真菌劑之活性成分。測試實例 1 ( 對灰葡萄孢菌之殺真菌測試 ) 至少在三葉期時將本發明化合物之溶液(500 ppm及200 ppm)噴灑於新鮮健康之黃瓜植株上。將經處理植株之子葉切下,並將其葉子放在塑膠托盤上之濕薄型紙上。使用微量吸量管將50 µl孢子懸浮液(1 × 106 cfu孢子/ml)滴在葉子中部上。且然後將一小塊圓片形脫脂棉放在孢子滴上,且再將50 µl孢子懸浮液滴在該圓片上。將葉子保持在室溫(20℃)下。 量測接種五天後真菌之徑向生長,並將化合物之活性顯示為根據以下方程式計算之預防值。預防值(%) = {1-(經處理上之徑向生長) / (對照上之徑向生長)} × 100。 在500 ppm之處理濃度下展現50%或更大預防值之化合物係如下: 化合物編號:1c-1、1c-2H、1c-2L、1c-3、1c-3H、1c-3L、1c-4H、1c-4L、1c-5L、1c-6L、1c-8、1c-8H、1c-8L、1c-9、1c-9H、1c-9L、1c-10H、1c-10L、1c-11H、1c-11L、1c-13H、1c-13L、1c-14H、1c-15H、1c-16、1c-16H、1c-19、1c-20、1c-23、1c-23H、1c-23L、1c-24、1c-24H、1c-25H、1c-25L、1c-26、1c-26H、1c-26L、1c-27H、1c-28L、1c-29H、1c-29L、1c-30H、1c-32H、1c-32L、1c-33、1c-34H、1c-34L、1c-35、1c-35H、1c-35L、1d-1H、1d-6H、1d-6L、1d-13、1d-17、1d-17H、1d-17L、1e-3、1e-7。 在200 ppm之處理濃度下展現50%或更大預防值之化合物係如下: 化合物編號:1c-2H、1c-2L、1c-3、1c-3H、1c-3L、1c-4H、1c-4L、1c-5L、1c-6L、1c-8、1c-8H、1c-8L、1c-9、1c-9H、1c-9L、1c-10H、1c-10L、1c-11H、1c-13H、1c-13L、1c-14H、1c-15H、1c-16、1c-16H、1c-19、1c-20、1c-23、1c-23H、1c-23L、1c-24H、1c-25H、1c-25L、1c-26、1c-26H、1c-26L、1c-27H、1c-29H、1c-29L、1c-32H、1c-32L、1c-33、1c-34H、1c-34L、1c-35、1c-35H。測試實例 2 ( 對黃瓜白粉菌之殺真菌測試 ) 將本發明化合物之溶液(500 ppm)噴灑於新鮮健康之2週齡黃瓜植株上。將該等植株風乾且接種新製備之孢子懸浮液(1 × 106 cfu孢子/ml)。然後將經接種之植株置於溫室(25℃,60%濕度及16L8D)中。 量測接種12天後之病害面積率,並將化合物之活性顯示為根據以下方程式計算之預防值。預防值(%) = {1-(經處理上之病害面積率) / (對照上之病害面積率)} × 100。 展現50%或更大之預防值之化合物係如下: 化合物編號:1c-1、1c-1H、1c-1L、1c-2H、1c-2L、1c-3、1c-3H、1c-3L、1c-4H、1c-4L、1c-5H、1c-5L、1c-6、1c-6H、1c-6L、1c-7H、1c-7L、1c-8、1c-8H、1c-8L、1c-9、1c-9H、1c-9L、1c-10H、1c-10L、1c-11H、1c-11L、1c-13H、1c-13L、1c-14H、1c-15H、1c-15L、1c-16、1c-16H、1c-16L、1c-17H、1c-18L、1c-19H、1c-19L、1c-20、1c-21H、1c-21L、1c-22H、1c-23、1c-23H、1c-23L、1c-25H、1c-25L、1c-26、1c-26H、1c-26L、1c-27H、1c-27L、1c-28H、1c-28L、1c-29H、1c-29L、1c-30H、1c-30L、1c-31H、1c-31L、1c-32H、1c-32L、1c-33、1c-34H、1c-34L、1c-35、1c-35H、1c-35L、1c-36、1c-37、1c-37、1c-40H、1c-40L、1c-41H、1c-41L、1d-1、1d-1H、1d-1L、1d-12、1d-13、1d-13L。測試實例 3 ( 對致病疫黴之殺真菌測試 ) 至少在三葉期時將本發明化合物之溶液(500 ppm)噴灑於新鮮健康之番茄植株上。將該等植株風乾且接種新製備之孢子囊懸浮液(1 × 106 cfu遊走孢子/ml)。然後將經接種之植株置於露室(dew chamber)(20℃及100%濕度)中。接種後一天,將植株轉移至恒溫室(20℃,80%濕度及16L8D)。 量測接種5天後之病害面積率,並將化合物之活性顯示為根據以下方程式計算之預防值。預防值(%) = {1-(經處理上之病害面積率) / (對照上之病害面積率)} × 100。 展現50%或更大之預防值之化合物係如下: 化合物編號:1c-1、1C-16、1c-16H、1c-16L、1c-19H。測試實例 4 ( 對稻瘟病菌 (Pyricularia grisea) 之殺真菌測試 ) 將本發明化合物之溶液(500 ppm)噴灑於新鮮健康之2週齡小米植株上。將該等植株風乾且接種新製備之孢子懸浮液(1 × 106 cfu孢子/ml)。然後將經接種之植株置於露室(25℃及100%濕度)中。接種後一天,將植株轉移至恒溫室(25℃,80%濕度及16L8D)。 量測接種5-7天後之病害面積率,並將化合物之活性顯示為根據以下方程式計算之預防值。預防值(%) = {1-(經處理上之病害面積率) / (對照上之病害面積率)} × 100。 展現50%或更大之預防值之化合物係如下: 化合物編號:1c-1、1c-1L、1c-2H、1c-2L、1c-3、1c-3H、1c-3L、1c-4H、1c-4L、1c-5H、1c-5L、1c-6、1c-6H、1c-6L、1c-8、1c-8H、1c-8L、1c-9、1c-9H、1c-9L、1c-10H、1c-10L、1c-11H、1c-11L、1c-12、1c-12H、1c-13、1c-13H、1c-13L、1c-14H、1c-15H、1c-15L、1c-16、1c-16H、1c-16L、1c-17H、1c-18L、1c-19、1c-19L、1c-20、1c-21H、1c-21L、1c-23、1c-23H、1c-23L、1c-24、1c-24H、1c-25H、1c-25L、1c-26、1c-26H、1c-26L、1c-27H、1c-30L、1c-32H、1c-32L、1c-34H、1c-34L、1c-35、1c-35H、1c-35L、1c-37、1c-37L、1c-38H、1c-38L、1c-44、1b-5L、1d-1H、1d-1L、1d-6L、1d-7、1d-7H、1d-7L、1d-8、1d-11、1d-11H、1d-11L、1d-12L、1d-15、1d-16、1d-16H、1d-16L、1d-17、1d-17H、1e-6。 (注意) 如上文所闡述,本發明係藉由本發明之較佳實施例來說明。然而,應理解,本發明之範圍應僅由申請專利範圍來解釋。應理解,本文中所引用之專利、專利申請案及文獻係以引用的方式併入本文中,如同其內容明確地闡述於本文中一般。本申請案主張於2017年3月15日向印度專利局(Indian Patent Office)(印度智慧財產(Intellectual Property India))提出申請之印度專利申請案第201711008910號之優先權,其全部內容係以引用的方式併入本文中。 工業適用性 本發明之二噻𠷬化合物具有針對植物病害之防治效應且可用作植物防治劑之活性成分。Hereinafter, the present invention will be explained in more detail with reference to examples, but the technical scope of the present invention is not limited to the examples. Throughout the specification, the singular expression is to be understood as encompassing the concept of the plural. Therefore, the singular articles (such as "a", "the", "the" In addition, terms used herein are to be understood as being used in the meaning commonly used in the art, unless explicitly stated otherwise. Therefore, unless otherwise defined, all terms and scientific and technical terms used herein have the same meaning as the terms commonly understood by those skilled in the art. In the event of a conflict, the present specification, including definitions, will control.Dithiazide 𠷬 Compound or salt thereof or N- Oxide The present invention provides a dithiazide compound represented by the formula (1) or a salt thereof or an N-oxide thereof for use in agriculture and horticulture.Where R1 , R2 , R3 , Y1 , Y2 And the Q system is as defined above. The presence of one or more possible asymmetric carbon atoms in the compound of formula (1) means that the compound may optionally exist in an isomeric form, i.e., a mirror image or a non-image form. The presence of one or more possible double bonds in the compound of formula (1) means that the compound can exist in a variety of non-imagewise isomeric forms. Therefore, the structure:Means two forms, namely Z form and E form:and. Atropisomers may also be present due to limited rotation about a single bond. Formula (1) is intended to include all such possible isomeric forms and mixtures thereof. The invention includes all such possible isomeric forms of the compounds of formula (1) and mixtures thereof. Likewise, formula (1) is intended to include all possible tautomers. The invention includes all possible tautomeric forms of the compounds of formula (1). Next, the terms in this specification are explained below. In the present specification, the number of substituents of the group defined by "optionally substituted" or "substituted" is not specifically limited and is one or plural. In addition, unless otherwise indicated, the description for each group applies to a substituent on one or the other of the other groups of the group. "C1-6 "Alkyl" means a straight or branched saturated hydrocarbon group having from 1 to 6 carbon atoms. "C2-6 "Alkenyl" means a straight or branched unsaturated hydrocarbon group having 2 to 6 carbon atoms and having 1 to 3 double bonds. "C2-6 "Alkynyl" means a straight or branched unsaturated hydrocarbon group having 2 to 6 carbon atoms and containing 1 triple bond. "C3-8 "Cycloalkyl" means a cyclic alkyl group having from 3 to 8 carbon atoms and includes such cyclic alkyl groups having a partially bridged structure. "C1-6 Alkoxy group (C1-6 "alkoxy"" means "C1-6 Alkoxy group (C1-6 "alkoxy group)", and "C1-6 The definition of the "alkyl group" and the "C" described above1-6 The alkyl group is the same. "Aryl" means a monocyclic or polycyclic aromatic hydrocarbon. "Heterocyclic" means a saturated, unsaturated or aromatic heterocyclic group having at least one of nitrogen, oxygen, phosphorus and/or sulfur atoms in the ring and which may be bonded at any substitutable position. "Heteroaryl" means an aromatic heterocyclic group having at least one of nitrogen, oxygen and/or sulfur atoms in the ring and which may be bonded at any substitutable position, wherein the heteroaryl ring member atom In addition to carbon atoms, 1, 2, 3 or 4 heteroatoms selected from N, O and S are also included. Specific examples of each group as used in the present specification are shown below. Examples of halogens include, but are not particularly limited to, fluorine, chlorine, bromine, iodine, and the like. C1-6 Examples of alkyl groups include, but are not specifically limited to, C1-6 Linear or branched alkyl such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, t-butyl, n-pentyl, n-hexyl and the like . C1-6 Examples of haloalkyl groups include, but are not particularly limited to, C substituted with from 1 to 9, preferably from 1 to 5, halogen atoms.1-6 Linear or branched alkyl such as fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, 2,2-difluoroethyl, trifluoromethyl, 2,2,2 Trifluoroethyl, pentafluoroethyl, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, heptafluoroisobutyl and the like. C1-6 Examples of alkoxy groups include, but are not specifically limited to, C1-6 Linear or branched alkoxy group, such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, second butoxy, tert-butoxy And so on. C1-6 Examples of haloalkoxy include, but are not particularly limited to, C substituted with from 1 to 9, preferably from 1 to 5, halogen atoms.1-6 Linear or branched alkoxy groups such as fluoromethoxy, chloromethoxy, bromomethoxy, iodomethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-tri Fluoroethoxy, pentafluoroethoxy, 3,3,3-trifluoropropoxy, 4,4,4-trifluorobutoxy, heptafluoroisobutoxy and the like. C1-6 Alkoxy C1-6 Examples of alkyl groups include, but are not specifically limited to, C1-6 Linear or branched alkyl via C1-6 A linear or branched alkoxy substituted alkoxyalkyl group, such as methoxymethyl, ethoxymethyl, n-propoxymethyl, isopropoxymethyl, n-butoxymethyl , isobutoxymethyl, second butoxymethyl, tert-butoxymethyl, methoxyethyl, ethoxyethyl, methoxy-n-propyl, methoxy-n-butyl Base and the like. C1-6 Haloalkoxy C1-6 Examples of the alkyl group include, but are not particularly limited to, a linear or branched alkoxyalkyl group substituted with 1 to 9, preferably 1 to 5 halogen atoms, such as a fluoromethoxymethyl group, Chloromethoxymethyl, bromomethoxymethyl, iodomethoxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, 2,2,2-trifluoroethoxymethyl And so on. C3-8 Examples of cycloalkyl groups include, but are not particularly limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and the like. C3-8 Cycloalkyl C1-6 Examples of alkyl groups include, but are not particularly limited to, cyclopropylmethyl, cyclobutylethyl, cyclopentylmethyl, cyclohexylmethyl, and the like. C1-6 Examples of alkylcarbonyl groups include, but are not specifically limited to, C1-6 Linear or branched alkylcarbonyl group, such as methylcarbonyl (ethinyl), ethylcarbonyl (propyl), n-propylcarbonyl (butyl), isopropylcarbonyl (isobutyl), n-butylcarbonyl (pentyl), isobutylcarbonyl (isoamyl), t-butylcarbonyl, tert-butylcarbonyl, and the like. C1-6 Examples of haloalkylcarbonyl include, but are not particularly limited to, C substituted with from 1 to 9, and preferably from 1 to 5, halogen atoms.1-6 Linear or branched alkylcarbonyl such as fluoromethylcarbonyl, chloromethylcarbonyl, bromomethylcarbonyl, iodomethylcarbonyl, dichloromethylcarbonyl, trichloromethylcarbonyl, difluoromethylcarbonyl, tri Fluoromethylcarbonyl, chlorodifluoromethylcarbonyl, bromodifluoromethylcarbonyl, dichlorofluoromethylcarbonyl, 2,2,2-trichloroethylcarbonyl, 2,2,2-trifluoroethylcarbonyl, Pentafluoroethylcarbonyl and the like. C1-6 Examples of alkoxycarbonyl groups include, but are not specifically limited to, C1-6 Linear or branched alkoxycarbonyl group, such as methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, second butoxy Alkylcarbonyl, a third butoxycarbonyl group, and the like. C1-6 Examples of haloalkoxycarbonyl include, but are not particularly limited to, C substituted with from 1 to 9, preferably from 1 to 5, halogen atoms.1-6 a linear or branched alkoxycarbonyl group such as fluoromethoxycarbonyl, chloromethoxycarbonyl, bromomethoxycarbonyl, iodomethoxycarbonyl, dichloromethoxycarbonyl, trichloromethoxycarbonyl, Difluoromethoxycarbonyl, trifluoromethoxycarbonyl, 2,2,2-trifluoroethoxymethyl, pentafluoroethoxycarbonyl, 3,3,3-trifluoropropoxycarbonyl, 4, 4,4-Trifluorobutoxycarbonyl, heptafluoroisopropoxycarbonyl and the like. C3-8 Examples of cycloalkylcarbonyl groups include, but are not particularly limited to, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, and the like. C3-8 Examples of the cycloalkoxycarbonyl group include, but are not particularly limited to, a cyclopropyloxycarbonyl group, a cyclobutyloxycarbonyl group, a cyclopentyloxycarbonyl group, a cyclohexyloxycarbonyl group, and the like. Cyano C1-6 Examples of alkyl groups include, but are not specifically limited to, C substituted by cyano1-6 Linear or branched alkyl such as cyanomethyl, cyanoethyl, cyano-n-propyl, cyano-isopropyl, cyano-n-butyl, cyano-isobutyl, cyano - a second butyl group, a cyano-t-butyl group, a cyano-n-hexyl group, and the like. Cyano C1-6 Examples of alkoxy groups include C substituted by a cyano group1-6 Linear or branched alkoxy group, such as cyanomethoxy, cyanoethoxy, cyano-n-propoxy, cyano-isopropoxy, cyano-n-butoxy, cyano- Isobutoxy, cyano-second butoxy, cyano-t-butoxy, cyano-hexyloxy and the like. C2-6 Examples of alkenyl groups include, but are not particularly limited to, vinyl, allyl, 2-butenyl, 3-butenyl, 1-methylallyl, and the like. C2-6 Examples of haloalkenyl groups include, but are not particularly limited to, 2,2-dichlorovinyl, 2,2-dibromovinyl, 2,2-difluorovinyl, 3,3-difluoro-2- Allyl, 4,4-difluoro-3-butenyl, 4,4,4-trifluoro-2-butenyl and the like. C2-6 Examples of alkynyl groups include, but are not particularly limited to, ethynyl, 2-propynyl (propargyl), 1-methyl-2-propynyl, 1-butynyl, 2-butynyl, 3 - butynyl and the like. C2-6 Examples of haloalkynyl groups include, but are not particularly limited to, fluoroethynyl, bromoethynyl, chloroethynyl, iodoethynyl, 3,3,3-trifluoro-1-propynyl, and the like. Cyano C2-6 Examples of alkenyl groups include, but are not particularly limited to, 2-cyanovinyl, 2,2-dicyanovinyl, 3-cyano-2-allyl, 3,3-dicyano-2- Allyl, 4-cyano-3-butenyl, 4,4-dicyano-3-butenyl, 4,4,4-tricyano-2-butenyl and the like. Cyano C2-6 Examples of alkynyl groups include, but are not particularly limited to, cyanoethynyl, 3-cyano-1-propynyl, and the like. C1-6 Examples of alkylsulfonyl groups include, but are not specifically limited to, C1-6 Linear or branched alkylsulfonyl, such as methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonate Anthracenyl, t-butylsulfonyl, tert-butylsulfonyl and the like. C1-6 Examples of haloalkylsulfonyl groups include, but are not particularly limited to, C substituted with 1 to 9, preferably 1 to 5, halogen atoms.1-6 Linear or branched alkyl sulfinylene, such as fluoromethylsulfonyl, chloromethylsulfonyl, bromomethylsulfonyl, iodomethylsulfonyl, dichloromethylsulfonyl, Trichloromethylsulfonyl, difluoromethylsulfonyl, trifluoromethylsulfonyl, chlorodifluoromethylsulfonyl, bromodifluoromethylsulfonyl, dichlorofluoromethylsulfonyl 2,2,2-trichloroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, pentafluoroethylsulfonyl and the like. C1-6 Examples of alkylsulfinyl groups include, but are not specifically limited to, C1-6 Linear or branched alkyl sulfinylene, such as methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, isopropylsulfinyl, n-butylsulfin Base, isobutylsulfinyl, second butylsulfinyl, tert-butylsulfinyl, and the like. C1-6 Examples of haloalkylsulfinyl groups include, but are not particularly limited to, C substituted with 1 to 9 and preferably 1 to 5 halogen atoms.1-6 Linear or branched alkyl sulfinylene, such as fluoromethylsulfinyl, chloromethylsulfinyl, bromomethylsulfinyl, iodomethylsulfinyl, dichloromethyl Sulfosyl, trichloromethylsulfinyl, difluoromethylsulfinyl, trifluoromethylsulfinyl, chlorodifluoromethylsulfinyl, bromodifluoromethylsulfin Base, dichlorofluoromethylsulfinyl, 2,2,2-trichloroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, pentafluoroethylsulfinyl And so on. C1-6 Examples of alkylthio groups include, but are not specifically limited to, C1-6 Linear or branched alkylthio, such as methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, second butylthio , a third butyl thio group, and the like. C1-6 Examples of haloalkylthio groups include, but are not particularly limited to, C substituted with 1 to 9 and preferably 1 to 5 halogen atoms.1-6 Linear or branched alkylthio group, such as fluoromethylthio, chloromethylthio, bromomethylthio, iodomethylthio, dichloromethylthio, trichloromethylthio, difluoromethylthio, three Fluoromethylthio, chlorodifluoromethylthio, bromodifluoromethylthio, dichlorofluoromethylthio, 2,2,2-trichloroethylthio, 2,2,2-trifluoroethylsulfide Base, pentafluoroethylthio group and the like. C3-8 Examples of cycloalkylsulfonyl groups include, but are not particularly limited to, cyclopropylsulfonyl, cyclobutylsulfonyl, cyclopentylsulfonyl, cyclohexylsulfonyl, and the like. C3-8 Examples of cycloalkylsulfinyl groups include, but are not particularly limited to, cyclopropylsulfinylene, cyclobutylsulfinyl, cyclopentylsulfinyl, cyclohexylsulfinyl, and the like. C3-8 Examples of cycloalkylthio groups include, but are not particularly limited to, cyclopropylthio, cyclobutylthio, cyclopentylthio, cyclohexylthio, and the like. C3-8 Cycloalkyl C1-6 Examples of alkylsulfonyl groups include, but are not particularly limited to, cyclopropylmethylsulfonyl, 2-cyclopropylethylsulfonyl, 3-cyclopropylpropylsulfonyl, cyclohexylmethyl Sulfonyl and the like. C3-8 Cycloalkyl C1-6 Examples of alkylsulfinyl groups include, but are not particularly limited to, cyclopropylmethylsulfinyl, 2-cyclopropylethylsulfinyl, 3-cyclopropylpropylsulfinyl, Cyclohexylmethylsulfinyl and the like. C3-8 Cycloalkyl C1-6 Examples of alkylthio groups include, but are not particularly limited to, cyclopropylmethylthio, 2-cyclopropylethylthio, 3-cyclopropylpropylthio, cyclohexylmethylthio, and the like. C1-6 Alkoxy C1-6 Examples of alkylthio groups include, but are not specifically limited to, C1-6 Linear or branched alkylthio group via C1-6 a linear or branched alkoxy-substituted alkoxyalkylthio group, such as methoxymethylthio, ethoxymethylthio, n-propoxymethylthio, isopropoxymethylthio, N-butoxymethylthio group, second butoxymethylthio group, tert-butoxymethylthio group, 2-methoxyethylthio group and the like. C2-6 Examples of alkenyloxy groups include, but are not particularly limited to, vinyloxy, 1-propenyloxy, isopropenyloxy, allyloxy, 2-butenyloxy, 3-butenyl Oxyl, 1-methylallyloxy and the like. C2-6 Examples of haloalkenyloxy include, but are not particularly limited to, 2,2-dichlorovinyloxy, 2,2-dibromovinyloxy, 2,2-difluorovinyloxy, 3, 3-difluoro-2-allyloxy, 4,4-difluoro-3-butenyloxy, 4,4,4-trifluoro-2-butenyloxy and the like. C2-6 Examples of alkynyloxy include, but are not particularly limited to, ethynyloxy, 2-propynyloxy, 1-methyl-2-propynyloxy, 1,1-dimethyl-2- Propynyloxy, 1-butynyloxy, 2-butynyloxy, 3-butynyloxy and the like. C2-6 Examples of haloalkynyloxy include, but are not particularly limited to, fluoroethynyloxy, bromoethynyloxy, chloroethynyloxy, iodoethynyloxy, 3,3,3-trifluoro-1 - propynyloxy and the like. C1-6 Examples of alkylsulfonyloxy include, but are not particularly limited to, C1-6 Linear or branched alkylsulfonyl, for example, methylsulfonyloxy, ethylsulfonyloxy, n-propylsulfonyloxy, isopropylsulfonyloxy, n-butyl Sulfohydryloxy, isobutylsulfonyloxy, t-butylsulfonyloxy, tert-butylsulfonyloxy and the like. C1-6 Examples of alkylsulfinyloxy include, but are not particularly limited to, C1-6 Linear or branched alkyl sulfinyloxy, such as methylsulfinyloxy, ethylsulfinyloxy, n-propylsulfinyloxy, isopropylsulfin Alkoxy, n-butylsulfinyloxy, isobutylsulfinyloxy, t-butylsulfinyloxy, tert-butylsulfinyloxy and the like. Examples of substituted or unsubstituted amine groups include, but are not particularly limited to, amine groups, monoalkylamino groups, dialkylamino groups, monodecylamino groups, and the like. Examples of alkyl groups include the C mentioned above1-6 Alkyl and the like. Examples of sulfhydryl groups include the C mentioned above1-6 Alkylcarbonyl, C1-6 Haloalkylcarbonyl, C1-6 Alkoxycarbonyl, C1-6 Haloalkoxycarbonyl, arylcarbonyl, aryloxycarbonyl and the like. Examples of aryl groups include, but are not particularly limited to, phenyl, 1-naphthyl, 2-naphthyl, and the like. Aryl C1-6 Examples of alkyl groups include, but are not particularly limited to, benzyl, phenylethyl, phenyl-n-propyl, and the like. The aryl C1-6 The alkyl group can be further substituted at both the alkyl group and the aryl group. Examples of aryloxy groups include, but are not particularly limited to, phenoxy, 1-naphthyloxy, 2-naphthyloxy, and the like. Aryl C1-6 Examples of alkoxy groups include, but are not particularly limited to, benzyloxy, phenylethoxy, phenyl-n-propoxy, phenyl-n-butoxy, 1-naphthylmethoxy, 2- Naphthylmethoxy and the like. Examples of heteroaryloxy groups include, but are not particularly limited to, pyridyloxy, pyrimidinyloxy, pyrazolyloxy, and the like. Examples of the arylsulfonyl group include, but are not particularly limited to, a phenylsulfonyl group, a 1-naphthylsulfonyl group, a 2-naphthylsulfonyl group, and the like. Examples of the arylsulfinyl group include, but are not particularly limited to, a phenylsulfinyl group, a 1-naphthylsulfinyl group, a 2-naphthylsulfinyl group, and the like. Examples of arylthio groups include, but are not particularly limited to, phenylthio, 1-naphthylthio, 2-naphthylthio, and the like. Examples of the arylsulfonyloxy group include, but are not particularly limited to, a phenylsulfonyloxy group, a 1-naphthylsulfonyloxy group, a 2-naphthylsulfonyloxy group, and the like. Examples of the arylsulfinyloxy group include, but are not particularly limited to, phenylsulfinyloxy, 1-naphthylsulfinyloxy, 2-naphthylsulfinyloxy, and the like . Aryl C1-6 Examples of alkylthio groups include, but are not particularly limited to, benzylthio, phenylethylthio, phenyl-n-propylthio, phenyl-n-butylthio, 1-naphthylmethylthio , 2-naphthylmethylthio and the like. Examples of arylcarbonyl groups include, but are not particularly limited to, phenylcarbonyl, 1-naphthylcarbonyl, 2-naphthylcarbonyl, and the like. Examples of the aryloxycarbonyl group include, but are not particularly limited to, a phenyloxycarbonyl group, a 1-naphthyloxycarbonyl group, a 2-naphthyloxycarbonyl group, and the like. Examples of heteroaryl groups include, but are not particularly limited to, thienyl, furanyl, pyrrolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyrazolyl, imidazolyl, oxadiazolyl, Thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, decyl, isodecyl, oxazolyl, quinazoline Polinyl, oxazolyl, benzoxazolyl, benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzimidazolyl, quinolyl, isoquinolinyl, pyridoindole , porphyrinyl, pyridazinyl, quinoxalinyl, fluorenyl, phenothiazine furyl, benzofuranyl, decyl, benzothienyl and the like. All aryl and heteroaryl groups mentioned above may be further substituted as appropriate. Examples of the number of substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10, and more preferably 1 to 5). Examples of heterocyclic groups include, but are not particularly limited to, thienyl, furyl, tetrahydrofuranyl, dioxolanyl, dioxoalkyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, oxazolyl, isomerism Azyl, oxazolinyl, oxazolidinyl, isoxazolyl, thiazolyl, isothiazolyl, thiazolinyl, thiazolidinyl, isothiazolinyl, pyrazolyl, pyrazolyl, imidazolyl , imidazolinyl, imidazolidinyl, oxadiazolyl, oxadiazolyl, thiadiazolyl, triazolyl, triazolinyl, triazolyl, tetrazolyl, tetrazolinyl, pyridine , dihydropyridyl, tetrahydropyridyl, hexahydropyridyl, oxazinyl, dihydrooxazinyl, morpholinyl, thiazinyl, dihydrothiazinyl, thiamorpholinyl, pyridazinyl , dihydropyridazinyl, tetrahydropyridazinyl, hexahydroazinyl, oxadiazinyl, dihydrooxadiazinyl, tetrahydrooxadiazinyl, thiadiazolyl, thiadiazinyl, dihydrogen Thiadiazinyl, tetrahydrothiazinyl, pyrimidinyl, dihydropyrimidinyl, tetrahydropyrimidinyl, hexahydropyrimidinyl, pyrazinyl, dihydropyrazinyl, tetrahydropyrazinyl, hexahydropyrazine Base, triazinyl, Hydrotriazinyl, tetrahydrotriazinyl, hexahydrotriazinyl, tetrazinyl, dihydrotetrazinyl, fluorenyl, porphyrin, isodecyl, oxazolyl, quinazolinyl, Dihydroquinazolinyl, tetrahydroquinazolinyl, oxazolyl, benzoxazolyl, benzoxazolinyl, benzisoxazolyl, benzisoxazolinyl, benzothiazolyl Benzoisothiazolyl, benzisothiazolinyl, benzimidazolyl, oxazoline, quinolyl, dihydroquinolinyl, tetrahydroquinolyl, isoquinolinyl, dihydroisoquinoline , tetrahydroisoquinolyl, pyridoindoleyl, dihydrobenzoxazinyl, porphyrinyl, dihydroporphyrinyl, tetrahydroporphyrinyl, pyridazinyl, dihydropyridazinyl, tetra Hydropyridazinyl, quinoxalinyl, dihydroquinoxalinyl, tetrahydroquinoxalinyl, fluorenyl, dihydrobenzotriazinyl, dihydrobenzotetrazinyl, phenothiazineylfuranyl, Benzofuranyl, decyl, benzothienyl and the like. The heterocyclic groups include those substituted at the substitutable position with a pendant oxy or thioketo group. All of the heterocycles mentioned above may be further substituted as appropriate. Examples of the number of substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10 and more preferably 1 to 5). Examples of "substituted" or "substituent" include, but are not particularly limited to, halogen, nitro, cyano, hydroxy, methionyl, C1-6 Alkyl, C1-6 Haloalkyl, C1-6 Alkoxy, C1-6 Haloalkoxy, C1-6 Alkoxy C1-6 Alkyl, C1-6 Haloalkoxy C1-6 Alkyl, C3-8 Cycloalkyl, C3-8 Cycloalkyl C1-6 Alkyl, C1-6 Alkylcarbonyl, C1-6 Haloalkylcarbonyl, C1-6 Alkoxycarbonyl, C1-6 Haloalkoxycarbonyl, arylcarbonyl, aryloxycarbonyl, C1-6 Cyanoalkyl, C1-6 Cyanoalkoxy, C2-6 Alkenyl, C2-6 Haloalkenyl, C2-6 Alkynyl, C2-6 Haloalkynyl, C1-6 Alkylsulfonyl, C1-6 Haloalkylsulfonyl, C1-6 Alkylsulfinyl, C1-6 Haloalkylsulfinyl, C1-6 Alkylthio, C1-6 Haloalkylthio, C3-8 Cycloalkylsulfonyl, C3-8 Cycloalkylsulfinyl, C3-8 Cycloalkylthio, C3-8 Cycloalkyl C1-6 Alkylsulfonyl, C3-8 Cycloalkyl C1-6 Alkylsulfinyl, C3-8 Cycloalkyl C1-6 Alkylthio, C1-6 Alkoxy C1-6 Alkylsulfonyl, C1-6 Alkoxy C1-6 Alkylsulfinyl, C1-6 Alkoxy C1-6 Alkylthio, C2-6 Alkenyloxy, C2-6 Haloalkenyloxy, C2-6 Alkynyloxy, C2-6 Haloalkynyloxy, C1-6 Alkylsulfonyloxy, C1-6 Haloalkylsulfonyloxy, C1-6 Alkylsulfinyloxy, C1-6 Haloalkylsulfinyloxy, OCN, SCN, SF5 Substituted or unsubstituted amine, aryl, aryl C1-6 Alkyl, aryloxy, aryl C1-6 Alkoxy, arylsulfonyl, arylsulfinyl, arylthio, aryl C1-6 Alkylsulfonyl, aryl C1-6 Alkylsulfinyl, aryl C1-6 Alkylthio, heterocyclic, heterocyclic C1-6 Alkyl, heterocyclic oxy and the like. The salt of the compound represented by the formula (1) may be any type of salt as long as it is an agriculturally acceptable salt. Examples of such salts include inorganic acid salts such as hydrochlorides, sulfates, nitrates and the like; organic acid salts such as acetates, methanesulfonates and the like; alkali metal salts such as sodium salts, potassium salts and the like Alkaline earth metal salts such as magnesium salts, calcium salts and the like; quaternary ammonium salts such as dimethylammonium, triethylammonium and the like; and the like. In the present invention, the N-oxide is a compound which constitutes an oxidation of an atom of a ring in the heterocyclic group. The heterocyclic group which may constitute the N-oxide may be, for example, a fused ring containing a pyridine ring, a fused ring containing a pyrazine ring, a fused ring containing a pyridazine ring or a fused ring containing a pyrimidine ring. In the compound (1) of the present invention, preferred compounds are those in which R1 Hydrogen, halogen or C1-6 a compound of an alkyl group, and more preferably a compound (1) wherein R1 A compound that is hydrogen or methyl. In the compound (1) of the present invention, preferred compounds are those in which R2 Hydrogen, halogen or C1-6 a compound of an alkyl group, and more preferably a compound (1) wherein R2 A compound that is hydrogen. In the compound (1) of the present invention, preferred compounds are those in which R3 Hydrogen, halogen or C1-6 a compound of an alkyl group, and more preferably a compound (1) wherein R3 A compound that is hydrogen. In the compound (1) of the present invention, a preferred compound is Y1 a compound substituted with an aryl group or an optionally substituted pyridyl group, and more preferably a compound (1) wherein Y1 a substituted phenyl group, optionally substituted 3-pyridyl group or optionally substituted 4-pyridyl compound, and particularly preferably compound (1) wherein Y1 A 3-pyridyl compound which is optionally substituted. In the compound (1) of the present invention, a preferred compound is Y2 a compound substituted with an aryl group or an optionally substituted pyridyl group, and more preferably a compound (1) wherein Y2 A compound of a phenyl group which is optionally substituted. Among the compounds (1) of the present invention, preferred compounds are those in which a Q-based cyano group. In the compound (1) of the present invention, preferred compounds are those in which R4 , R5 , R6 , R7 And R8 Same or different and each is hydrogen, halogen, C1-6 Alkyl, C1-6 Haloalkyl, C1-6 Alkoxy or C1-6 a halogenated alkoxy compound, and more preferably a compound (1) wherein R4 , R5 , R6 , R7 And R8 Compounds which are the same or different and each are hydrogen, fluorine, chlorine, bromine, tert-butyl, trifluoromethyl, methoxy or trifluoromethoxy. In the compound (1) of the present invention, preferred compounds are those in which R9 , R10 , R11 , R12 , R13 , R14 , R15 , R16 , R17 , R18 , R19 And R20 Compounds which are the same or different and each are hydrogen or halogen, and more preferably compound (1) is R9 , R10 , R11 , R12 , R13 , R14 , R15 , R16 , R17 , R18 , R19 And R20 A compound of hydrogen or chlorine. In the compound (1) of the present invention, preferred compounds are those in which Rtwenty one , Rtwenty two , Rtwenty three , Rtwenty four And R25 Identical or different and each is hydrogen, halogen, nitro, cyano, optionally substituted amine, C1-6 Alkyl, C1-6 Haloalkyl, C1-6 Alkoxy, C1-6 a halogenated alkoxy group or a compound of an optionally substituted aryl group, and more preferably a compound (1) wherein Rtwenty one , Rtwenty two , Rtwenty three , Rtwenty four And R25 Compounds which are the same or different and each are hydrogen, fluorine, chlorine, bromine, nitro, cyano, amine, methyl, trifluoromethyl, methoxy, trifluoromethoxy or phenyl. In the compound (1) of the present invention, preferred compounds are those in which R26 , R27 , R28 , R29 , R30 , R31 , R32 , R33 , R34 , R35 , R36 And R37 Compounds which are the same or different and each are hydrogen or halogen, and more preferably compound (1) is R26 , R27 , R28 , R29 , R30 , R31 , R32 , R33 , R34 , R35 , R36 And R37 A compound that is hydrogen. Among these compounds, a more preferred compound of the present invention is a compound or a salt thereof or an N-oxide thereof:1 Hydrogen, halogen or C1-6 Alkyl; R2 Hydrogen, halogen or C1-6 Alkyl; R3 Hydrogen, halogen or C1-6 Alkyl; Y1 a substituted aryl or optionally substituted pyridyl group;2 An optionally substituted aryl or optionally substituted pyridyl group; Q is a cyano group. More preferably, the compound of the present invention is a compound or a salt thereof or an N-oxide thereof:1 Hydrogen or methyl; R2 Hydrogen; R3 Hydrogen; Y1 a substituted phenyl group, optionally substituted 3-pyridyl group or optionally substituted 4-pyridyl group;2 a phenyl group which is optionally substituted; a Q-based cyano group. Particularly preferred compounds of the invention are those wherein the compound or a salt thereof or an N-oxide thereof:1 Hydrogen or methyl; R2 Hydrogen; R3 Hydrogen; Y1 3-pyridyl group substituted as appropriate; Y2 a phenyl group which is optionally substituted; a Q-based cyano group. The present invention also provides a process for producing a dithiazide represented by the formula (1) or a salt thereof or an N-oxide thereof:, where R1 , R2 , R3 , Y1 , Y2 And the Q system is as defined above. The dithiazide compound represented by the formula (1) of the present invention can be easily produced according to the following Reaction Scheme 1, but is not limited to the methods. The dithiazide compound represented by the formula (1) can be produced by reacting the compound (2) with the compound (3) and carbon disulfide in the presence of a base and a solvent as mentioned in Reaction Scheme 1. Reaction scheme 1Where R1 , R2 , R3 , Y1 , Y2 And the Q system is as defined above. Meanwhile, A and B are the same or different and each represents a suitable de-bonding group such as chlorine, bromine and iodine; substituted or unsubstituted C1-6 An alkyl sulfonate group; and a substituted or unsubstituted aryl sulfonate group. The amount of the compound (3) to be used is usually 0.5 mol to 5 mol, preferably 1 mol to 2 mol, per 1 mol of the compound (2). The amount of carbon disulfide used is usually 2 mol to 10 mol, preferably 1 mol to 2 mol, per 1 mol of the compound (2). This reaction is carried out in the presence of a suitable base. As the base, a conventional base can be widely used, and examples of the base include: an alkali metal carbonate such as sodium carbonate, potassium carbonate, cesium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate, and the like; an alkali metal hydroxide such as Sodium hydroxide, potassium hydroxide and the like; alkali metal hydrides such as sodium hydride and potassium hydride and the like; alkali metal hydrides such as sodium hydride and potassium hydride and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, Potassium tert-butoxide and the like; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylaminopyridine And hexahydropyridine and the like, preferably sodium hydroxide, potassium hydroxide, sodium hydride, potassium hydride, sodium methoxide, sodium ethoxide and potassium butoxide. Any one of these bases or a combination of two or more of these types is used. In the case of using an organic base, it can be used in a large excess to be used as a solvent. The amount of the base to be used is usually 2 mol to 5 mol, preferably 2 mol to 3 mol, per 1 mol of the compound (2). The reactions mentioned above are carried out in a suitable solvent or in the absence of any solvent. When the above-mentioned reaction is carried out in a solvent, there is no limitation on the solvent as long as the solvent is inactive with respect to the reaction mentioned above. Examples of such a solvent include: a solvent based on a fatty acid or an alicyclic hydrocarbon such as n-hexane, cyclohexane, n-heptane, and the like; a solvent based on an aromatic hydrocarbon such as benzene, chlorobenzene, toluene, xylene, and the like a solvent based on a halogenated hydrocarbon such as dichloromethane, 1,2-dichloroethane, chloroform, carbon tetrachloride, and the like; an ether-based solvent such as diethyl ether, tetrahydrofuran (THF), 1,4-dioxin Alkanes, dimethoxyethanes and the like; ester solvents such as methyl acetate, ethyl acetate and the like; acetonitrile; guanamine-based solvents such as N,N-dimethylformamide (DMF), N, N-dimethylacetamide, N-methyl-2-pyrrolidone, and the like; a solvent based on hydrazine, such as dimethyl hydrazine (DMSO), sulforane, and the like;2 O; acetic acid; preferably DMSO, DMF, toluene and THF. Any of these solvents may be used alone or a combination of two or more types thereof may be used as necessary. The amount of the solvent used is usually from 1 liter to 20 liters, preferably from 1 liter to 10 liters per 1 mol of the compound (2). The reaction is usually carried out at a temperature of from -10 ° C to the boiling point of the solvent. The reaction time is usually in the range of 0.25 hours to 24 hours or longer depending on the completion of the reaction. The compound (2) used in this step can be produced according to a known method (for example, WO2007/045989, Synlett (15), 2223-2227 (2011), and Molecular Diversity 18(2), 307-322 (2014). The method described). The compound (3) used in this step can be produced according to a known method (for example, the methods described in WO2006/110804, WO2015/003991, WO2015/11194, and WO2015/162271). The compound represented by the formula (1) obtained by the method shown in Scheme 1 is easily isolated from the reaction mixture and can be purified by using a typical separation method and purification method such as filtration, solvent extraction, distillation, recrystallization. , column chromatography, etc. Although the compound of the present invention may be used in the form of the compound of the present invention, the compound of the present invention is usually prepared by mixing the compound of the present invention with a solid carrier, a liquid carrier, a gas carrier, a surfactant, and others, and If necessary, add an adhesive, a dispersing agent and a stabilizer to prepare a wettable powder, water-dispersible granules, a flowable agent, granules, a dry flowable agent, an emulsifiable concentrate, an aqueous solution, an oil solution, Smoke agents, aerosols, microcapsules and others. The content of the compound of the invention in these formulations is generally in the range of from 0.1% by weight to 99% by weight, preferably from 0.2% by weight to 90% by weight. Examples of solid carriers include clays in the form of fine powders or particulates (for example, kaolin, diatomaceous earth, synthetic hydrated cerium oxide, fubasami clay, bentonite and acid clay), talc or other inorganic minerals. Substances (eg, sericite, quartz powder, sulfur powder, activated charcoal, calcium carbonate, and hydrated ceria), and examples of liquid carriers include water, alcohols (eg, methanol and ethanol), ketones (eg, acetone and methyl) Ethyl ketone), aromatic hydrocarbons (eg, benzene, toluene, xylene, ethylbenzene, and methylnaphthalene), aliphatic hydrocarbons (eg, n-hexane, cyclohexane, and kerosene), esters (eg, ethyl acetate) Ester and butyl acetate), nitriles (for example, acetonitrile and isobutyronitrile), ethers (for example, dioxane and diisopropyl ether), decylamine (for example, DMF and dimethylacetamide), halogenated hydrocarbons (eg, dichloroethane, trichloroethylene, and carbon tetrachloride) and others. Examples of the surfactant include alkyl sulfates, alkyl sulfonates, alkyl aryl sulfonates, alkyl aryl ethers and polyoxyethylated compounds thereof, polyethylene glycol ethers, polyol esters, and sugar alcohols. derivative. Examples of other auxiliaries for formulation include adhesives, dispersants and stabilizers, in particular casein, gelatin, polysaccharides (for example, starch, gum arabic, cellulose derivatives and alginic acid), lignin derivatives, Bentonite, sugar, water-soluble synthetic polymers (for example, polyvinyl alcohol, polyvinylpyrrolidone and polyacrylic acid), PAP (isopropyl isopropyl phosphate), BHT (2,6-di-t-butyl-4) -methylphenol), BHA (a compound of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol), vegetable oil, mineral oil, fatty acid or its fatty acid ester And others. The method for administering the compound of the present invention is not particularly limited as long as the administration form is a form in which the compound of the present invention can be substantially applied, and includes, for example, application to plants, such as foliar application; for cultivation of plants Application of the area, such as submergence treatment; and application to the soil, such as seed disinfection. The dosage will vary depending on the weather conditions, dosage form, period of administration, method of application, area to be applied, target disease and target crop, etc., but at every 1,000 m.2 The area to be applied is usually in the range of 1 g to 500 g and preferably 2 g to 200 g. Emulsifying concentrates, wettable powders or suspension concentrates and the like are usually applied by diluting them with water. In this case, the concentration of the compound of the present invention after dilution is in the range of usually 0.0005 wt% to 2 wt% and preferably 0.005 wt% to 1 wt%. Powder formulations or granule formulations and the like are usually applied in their own form without dilution. In the application to the seed, the amount of the compound of the present invention is usually in the range of 0.001 g to 100 g and preferably 0.01 g to 50 g per 1 kg of seed. In this context, examples of pest habitats include rice fields, fields, tea gardens, orchards, non-agricultural land, houses, seedling trays, nursery boxes, nursery soils, and nursery beds. Further, in another embodiment, for example, the compound of the present invention can be administered to the inside (in vivo) or the outside (body surface) of the vertebrate mentioned below to eliminate parasitism systemically or non-systemically. A creature or parasite in a vertebrate. Examples of methods of internal administration include oral administration, transanal administration, transplantation, administration via subcutaneous, intramuscular or intravenous injection. Examples of methods of topical agents include transdermal administration. Furthermore, the compounds of the invention may be ingested by livestock animals in order to eliminate the presence of hygienic insects in animal waste. When the compound of the present invention is applied to animals such as livestock animals and pets of parasitic pests, the dosage is varied depending on the administration method, etc., but it is generally desired to administer the compound of the present invention such that the active ingredient (the compound of the present invention or The dose of the salt is usually in the range of 0.1 mg to 2,000 mg and preferably 0.5 mg to 1,000 mg per 1 kg of animal body weight. The compound of the present invention can be used as an agent for controlling plant diseases in agricultural land such as fields, rice fields, lawns, orchards. The compound of the present invention can prevent diseases occurring in agricultural land or other sites for cultivating the following "plants". Crops: corn, rice, wheat, barley, rye, oats, sorghum, cotton, soybeans, peanuts, buckwheat, sugar beets, rapeseed, sunflower, sugar cane, tobacco and others; vegetables: solanaceous vegetables (eg, Eggplant, tomato, sweet pepper, pepper and potato), cucurbitaceous vegetables (eg cucumber, pumpkin, winter squash, watermelon and melon), cruciferous vegetables (eg, Japanese radish, white radish, spicy) Roots, bulbs, Chinese cabbage, cabbage, snow red, broccoli, broccoli), asteraceous vegetables (eg, burdock, sage, artichoke and lettuce), liliaceous vegetables (eg, small onions) , onions, garlic and asparagus), ammiaceous vegetables (eg carrots, parsley, celery and parsnips), chenopodiaceous vegetables (eg spinach and saucy (Swiss chard)), lip shape Laciaceous vegetables (eg Perilla frutescens, mint and basil), strawberries, sweet potatoes, Dioscorea japonica, alfalfa and others; flowers: foliage plants: fruits Pome fruit (eg, apple, pear, Japanese pear, Chinese quince and medlar), stone fruit (eg, peach, plum, nectarine, plum (Prunus mume), cherry fruit, apricot and dried fruit plum), Citrus fruits (eg, Citrus unshiu, oranges, lemons, limes, and grapefruits), nuts (eg, chestnuts, walnuts, hazelnuts, almonds, pistachios, cashews, and macadamia nuts) , berries (eg, blueberries, cranberries, blackberries, and raspberries), grapes, kaki persimmon, olives, Japanese plums, bananas, coffee, date palms, coconuts, and others; trees other than fruit trees: tea trees, Mulberry, flowering plants, street trees (for example, ash, birch, hawthorn, eucalyptus, ginkgo biloba, lilac, maple, eucalyptus (Quercus), poplar, bauhinia (Judas tree) ), Liquidambar formosana, Platanus, Eucalyptus, Japanese arborvitae, fir, hemlock, juniper, Pinus, Picea, and Taxus cuspidata; And others. The "plant" mentioned above includes genetically modified crops. The pests to which the compounds of the present invention have control properties include plant pathogens (e.g., filamentous fungi), as well as harmful arthropods (e.g., harmful insects and harmful mites) and linear animals (e.g., nematodes), and specifically include the following examples, but Not limited to it. Rice diseases: rice blast (Magnaporthe grisea), brown spot (Cochliobolus miyabeanus), sheath blight (Rhizoctonia solani), mite disease (Fujikang) Gibberella fujikuroi and sclerotium (Sclerophthora macrospora); wheat disease: powdery mildew (Erysiphe graminis), Fusarium bacterium (Fusarium graminearum) ), F. avenaceum, F. culmorum, Microdochium nivale, rust (Puccinia striiformis, Pleurotus ostreatus) . graminis), P. recondita, snow rot (Micronectriella nivale), typhulasnow blight (Typhula sp.) , smut (Ustilago tritici), smut (Tilletia caries, T. controversa), eye spot disease ( Wheat rot (Pseudocercosporella herpotrichoides), leaf spot blight (Septoria tritici), Blight (Stagonospora nodorum), brown spot (Pyrenophora tritici-repentis), rhizoctonia seedling blight (Rhizobacter serrata) (Rhizoctonia solani)) and total eclipse (Gaeumannomyces graminis); barley disease: powdery mildew (white powdery mildew), Fusarium blight (Fusarium graminearum, Fusarium oxysporum, Fusarium oxysporum Bacteria, red snow rot), rust (Puccinia striiformis, Pleurotus ostreatus, P. hordei), smut (Ustilago nuda), moiré (Rhynchosporium secalis), net spot disease (Pyrenophora teres), spotted blisters (Cochliobolus sativus), leaf streak disease (M. genus) Pyrenophora graminea)), Ramularia disease (Ramularia collo-cygni) and Rhizoctonia solani (Rhizobium ssp.); Corn disease: rust ( Puccinia sorghi), southern rust (Puccinia polysora), northern leaf blight (jade) Setosphaeria turcica, Southern leaf blight (Cochliobolus heterostrophus), anthracnose (Colletotrichum graminicola), gray leaf spot (C. cerevisiae) (Cercospora zeae-maydis)), eye spot disease (Kabatiella zeae) and phaeosphaeria leaf spot (Phaeosphaeria maydis); cotton disease: Anthracnose (Colletotrichum gossypii), Ramularia areola, Alternaria leaf spot (Alternaria macrospora, Alternaria californica) A. gossypii); coffee disease: rust (Hemileia vastatrix); rapeseed disease: sclerotinia (Sclerotinia sclerotiorum), black spot (Alternaria Alternaria brassicae) and black foot disease (Phoma lingam); citrus diseases: melanosis (Diaporthe citri), scab (Elsinoe) Fawcettii)) and fruit rot (Penicillium digitatum, white Penicillium (P. italicum); Apple disease: flower blight (Monilinia mali), ulcer disease (Valsa ceratosperma), powdery mildew (white cross silk single shell) (Podosphaera leucotricha), Alternaria leaf spot (Alternaria alternata apple pathotype), scab (Venturia inaequalis) and bitter rot (quick anthrax) Colletotrichum acutatum; Pear disease: scab disease (Venturia nashicola, V. pirina), black spot (Japanese pear-shaped Alternaria) and Rust (Gymnosporangium haraeanum); Peach disease: brown rot (Monilinia fructicola), scab (Cladosporium carpophilum) and Phomopsis rot (Phomopsis rot) Phomopsis sp.; grape disease: anthracnose (Elsinoe ampelina), late rot (Glomerella cingulata), powdery mildew (grape stalk) Uncinula necator), rust (Phakopsora ampelopsidis), black rot (grape squash) (Guignardia bidwellii)) and Phytophthora (Plasmopara viticola); Japanese persimmon disease: anthracnose (Gloeosporium kaki) and leaf spot (Cercospora) Kaki), Mycosphaerella nawae); disease of Cucurbitaceae: anthracnose (Colletotrichum lagenarium), powdery mildew (Sphaerotheca fuliginea), blight (small double Didymella bryoniae), target spot disease (Corynespora cassiicola), Fusarium oxysporum, Fucobacterium (Pseudoperonospora) Cubensis)), phytophthora rot (Phytophthora sp.) and rickety (Pythium sp.); tomato disease: early blight (Alternaria solani) (Alternaria solani)), leaf mold (Cladosporium fulvum), leaf mold (Pseudocercospora fuligena) and late blight (Phytophthora infestans); eggplant Diseases: brown spot (Phomopsis vexans) and powdery mildew (Eryia sphaeroides) Siphe cichoracearum)); diseases of cruciferous vegetables: Alternaria leaf spot (Alternaria japonica), leukoplakia (Cercosporella brassicae), clubroot disease (parasitic Plasmodiophora parasitica, Peruvian porcini (Peronospora parasitica); Scallion disease: rust (Puccinia allii); Soybean disease: Purple spot (Cercospora kikuchii) ), sphaceloma scad (Elsinoe glycines), pod and stem blight (Diaporthe phaseolorum var. sojae) , rust (phakopsora pachyrhizi), target spot disease (Pseudomonas sphaeroides), anthracnose (Glyphs of Colletotrichum glycines, C. truncatum) Rhizoctonia aerial disease (Rhizobacter serrata), septoria brown spot (Septoria glycines) and frog eye leaf spot (soybean Cercospora sojina); Bean disease: anthracnose (Colletotrichum lindemuthianum)); Peanut disease: early leaf spot (Cercospora personata), advanced leaf spot (Cercospora arachidicola) and southern blight (small blight) Sclerotium rolfsii); pea disease: powdery mildew (Erysiphe pisi); potato disease: early blight (Alternaria solani), late blight (Phytophthora infestans) and verticillium (verticillium wilt) (verticillium albo-atrum, V. dahliae, V. nigrescens); strawberry disease: powdery mildew Sphaerotheca humuli); Tea tree disease: Reticulum disease (Exobasidium reticulatum), white acne (Elsinoe leucospila), Phytophthora (Pestalotiopsis sp.) .)) and anthracnose (Colletotrichum theae-sinensis); tobacco diseases: brown spot (Alternaria longipes), powdery mildew (white powder), anthracnose (Tobacco anthrax (Colletotrichum tabacum), dew disease (tobacco cream) Mold (Peronospora tabacina) and black plague (Phytophthora nicotianae); Sugar beet disease: cercospora leaf spot (Cercospora beticola), leaf blight ( Thanatephorus cucumeris, root rot (Gua dynasty) and aphanomyces root rot (Aphanomyces cochlioides); rose disease: black spot ( Diplocarpon rosae and powdery mildew (Sphaerotheca pannosa); disease of chrysanthemum: leaf blight (Septoria chrysanthemi-indici) and white rust (handle rust) Puccinia horiana); Onion disease: Botrytis leaf blight (Botrytis cinerea, B. byssoidea, B. squamosa) )), gray mold neck rot (Botrytis allii) and small sclerotia sp. (Bacillus sphaeroides); various crop diseases: gray mold (Botrytis cinerea) and sclerotinia (Sclerotium); Japanese radish disease: Alternaria brassicola (Alternaria brassicicola) Turfgrass disease: dollar spot (Sclerotinia homoeocarpa), brown spot and giant spot disease (Rhizobium); and banana disease: Sigatoka disease (Mycosphaerella fijiensis, Mycosphaerella musicola). Hemiptera: Delphacidae (for example, Laodelphax striatellus, Nilaparvata lugens or Sogatella furcifera); Deltocephalinae (eg, Nephotettix cincticeps or Nephotettix virescens); Aphididae (eg, Aphis gossypii, Myzus persicae, Rapeseed) (Brevicoryne brassicae), Macrosiphum euphorbiae, Aulacorthum solani, Rhopalosiphum padi, Toxoptera citricidus, Pentatomidae (eg, rice green carp (Nezara) Antennata), Riptortus clavatus, Leptocorisa chinensis, Eysarcoris parvus, Halyomorpha mista or Lygus lineolaris; (Aleyrodidae) (for example, Trialeurodes vaporariorum or Bemisia argentifolii); Coccoidea (for example, Aonidiella aurantii, Pear round scale insect (Comstock) Aspis perniciosa), Unaspis citri, Ceroplastes rubens or Icerya purchasi; Tingidae; Psyllidae; bed bug (temperate bed bug) (Cimex lectularius)) and others. Lepidoptera: Pyralidae (eg, Chilo suppressalis, Tryporyza incertulas, Cnaphalocrocis medinalis, Notarcha derogata, Plodia interpunctella, Ostrinia furnacalis, Hellula undalis, Pediasia teterrellus, Noctuidae (eg, Spodoptera litura) ), Spodoptera exigua, Pseudaletia separata, Mamestra brassicae, Agrotis ipsilon, Plusia nigrisigna, Spodoptera frugiperda Trichoplusia spp.), Heliothis spp. or Helicoverpa spp.; Pieridae (eg, Pieris rapae), Tortricidae (eg, tea) Adoxophyes spp., Grapholita molesta, Cydia pomonella, Leguminivora glycinivorella, Matsumuraeses azukivora, Cotton brown leaf moth (Ad Oxophyes orana fasciata), Homona magnanima, Archips fuscocupreanus, and codling moth; (Gracillariidae) (eg, Caloptilia theivora, golden moth) Phyllonorycter ringoniella)); Carposinidae (for example, Carposina niponensis); Lyonetiidae (for example, Lyonetia spp.); Lymantriidae ( For example, Lymantria spp. or Euproctis spp.; Yponomeutidae (eg, Plutella xylostella); Gelechiidae (eg, red bollworm) Pectinophora gossypiella) or Phthorimaea operculella; Arctiidae (eg, Hyphantria cunea); Tineidae (eg, Tinea translucens or Coat Moth) (Tineola bisselliella); and others; Thysanoptera: Thysanoptera (for example, Frankliniella occidentalis, Thrips palmi, Scirtothrips dorsalis, Green onion horse Thrips tabaci), Frankliniella intonsa, Frankliniella fusca; Diptera: Musca domestica, Culex pipiens pallens, Tabanus Trigonus), Hylemya antiqua, Hylemya platura, Anopheles sinensis, Agromyza oryzae, Hydrellia griseola, Chlorops oryzae ), Dacus cucurbitae, Ceratitis capitata, Liriomyza trifolii and others; Coleoptera: Epilachna vigintioctopunctata, yellow Aulacophora femoralis, Phyllotreta striolata, Oulema oryzae, Echinocnemus squameus, Lisorhoptrus oryzophilus, Mexican cotton aphid weevil (Anthonomus grandis), mung bean (Callosobruchus chinensis), parasitic worm (Sphenophorus venatus), Japanese chafer (Popillia japonica), bronze terracotta (Anomala cuprea) ), Diabrotica spp., Leptinotarsa decemlineata, Agriotes spp., Lasioderma serricorne, Anthrenus verbasci, Tribolium castaneum, Lyctus brunneus, Anoplophora malasiaca, Tomicus piniperda and others; Orthoptera: Locusta migratoria ), Gryllotalpa africana, Oxya yezoensis, Oxya japonica and others; Hymenoptera: Athalia rosae, Acromyrmex Spp.), Solenopsis spp. and others; nematodes: Aphelenchoides besseyi, Nothotylenchus acris, Heterodera glycines, Meloidogyne incognita ), root rot nematode (Pratylenchus), pseudo-root-knot nematode (Nacobbus aberrans) and others; Blattariae: Blattella germanica, Periplaneta fuliginosa, beauty Periplaneta americana, Periplaneta brunnea, Blatta orientalis, and others; Acarina: Tetranychidae (eg, Tetranychus urticae) ), Panonychus citri or Oligonychus spp.; Eriophyidae (for example, Aculops pelekassi); Tarsonemidae (for example, Polyphagotarsonemus latus); Tenuipalpidae; Tuckerellidae; Acaridae (eg, Tyrophagus putrescentiae); Dynamite family (Pyroglyphidae) (eg, Dermatophagoides farinae or Dermatophagoides pteronyssinus); Cheyletidae (eg, Cheyletus eruditus, Cheyletus malaccensis, or Mohs) Cheyletus moorei); Dermanyssidae; and others. Formulations comprising a compound of the invention or a salt thereof can also be used in the field of treating livestock disease or animal husbandry, and for example can eliminate parasitic vertebrate (eg human, cow, sheep, pig, poultry, dog, cat and fish) Biological or parasites on the inside and / or outside to maintain public health. Examples of pests include Ixodes spp. (e.g., Ixodes scapularis), Boophilus spp. (e.g., Boophilus microplus), Amaranthus (Amblyomma) Spp.), Hyalomama spp., Rhipicephalus spp. (eg, Rhipicephalus sanguineus), Haemaphysalis spp. (eg, long-horned blood) Ha (Haemaphysalis longicornis), dermacentor spp., Ornithodoros spp. (eg, Ornithodoros moubata), chicken larvae (Dermanyssus gallinae), forest locust hedgehog (Ornithonyssus sylviarum), Sarcotes spp. (eg, Sarcoptes scabiei), Psoroptes spp., Chorioptes spp., Trichomonas ( Demodex spp.), Eutrobicula spp., Ades spp. (eg Aedes albopictus), Anopheles spp., Culex Spp.), Culicoides spp., Musca spp., Hypoderma spp., Ghost (Gaster) (ophilus spp.), Haematobia spp., Tabanus spp., Simulium spp., Triatoma spp., Phthiraptera (eg, biting) Damalinia spp., Linognathus spp., Haematopinus spp., Ctenocephalides spp. (eg, Ctenocephalides felis), Xenopsylla spp., monomorium pharaonis, and nematodes, golden worms (eg, Nippostrongylus brasiliensis, Trichostrongylus axei, snake-like worms) (Trichostrongylus colubriformis)), Trichinella spp. (eg, Trichinella spiralis), Haemonchus contortus, Nematodirus spp. (eg, Nematodes) (Nematodirus battus)), Ostertagia circumcincta, Cooperia spp., Hymenolepis nana and other pests. The dithiazide (1) of the present invention is used as an active ingredient of, for example, a fungicide. The dithiazide (1) of the present invention can be used by making a desired form such as an oil, an emulsion, a wettable powder, a flowable formulation, a granule, a powder, an aerosol, a fumigant or the like. In this case, the content of the dithiazide (1) of the present invention is not limited and may be appropriately selected depending on various conditions, such as the form of the preparation, the type of the disease to be treated, the type of the plant, and the disease. Severity, application site, application time, application method, combined use of chemicals (insecticides, nematicides, acaricides, fungicides, herbicides, plant growth control agents, synergists, soil amendments, etc.) ), the amount and type of fertilizer, etc. The amount is usually from about 0.01% by weight to about 95% by weight based on the total amount of the fungicidal preparation. The fungicidal preparation containing the dithiazide (1) of the present invention as an active ingredient can be produced according to a known process. For example, the dithiazide (1) of the present invention can be mixed with a carrier such as a solid carrier, a liquid carrier, a gaseous carrier or the like. Surfactants and other adjuvants may be added for preparation, as appropriate. Useful carriers can be any of the known carriers commonly used in the art. Examples of solid carriers that can be used are clay (kaolin clay, diatomaceous earth, synthetic hydrated ceria, bentonite, clam clay, acid clay, and the like), talc, ceramics, other inorganic minerals, vermiculite, quartz, sulfur, active Fine powder or granules of carbon, calcium carbonate, hydrated cerium oxide, and the like. Usable liquid carriers are, for example, water, alcohols (eg methanol, ethanol, etc.), ketones (eg acetone, methyl ethyl ketone, etc.), aromatic hydrocarbons (eg benzene, toluene, xylene, ethylbenzene, methyl) Naphthalene, etc.), aliphatic hydrocarbons (such as hexane, cyclohexane, kerosene, light oil, etc.), esters (such as ethyl acetate, butyl acetate, etc.), nitriles (such as acetonitrile, isobutyronitrile, etc.), ethers ( For example, diisopropyl ether, dioxane, etc.), guanamine (such as N,N-dimethylformamide, N,N-dimethylacetamide, etc.), halogenated hydrocarbons (such as dichloromethane, three Ethyl chloride, carbon tetrachloride, etc.), dimethyl hydrazine, soybean oil, cottonseed oil, vegetable oil, and the like. Examples of useful gaseous carriers (propellants) are butane gas, LPG (liquefied petroleum gas), dimethyl ether, carbon dioxide, and the like. Examples of useful surfactants are alkyl ester sulfates, alkyl sulfonates, alkyl aryl sulfonates, alkyl aryl ethers, polyoxyethylated products thereof, polyethylene glycol ethers, polyol esters, Sugar alcohol compounds and the like. Examples of adjuvants useful for the preparation are fixatives, such as casein, gelatin, polysaccharides (starch powder, gum arabic, cellulosic compounds, alginic acid, etc.), lignin compounds, bentonite, sugars, synthetic water soluble polymers. (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acid, etc.) and the like; stabilizers such as PAP (acidic isopropyl phosphate), BBH (2,6-di-tert-butyl-4-methylphenol) ), BHA (a mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol), vegetable oil, mineral oil, fatty acid, ester thereof, and the like. The fungicidal preparation of the present invention thus obtained can be used as it is or diluted with water. The preparation can be prepared by mixing with any of the following: insecticides, nematicides, acaricides, fungicides, herbicides, plant growth control agents, synergists, soil amendments, and the like. The formulations of the invention can be administered simultaneously with other formulations. When the preparation of the present invention is used as a fungicide for use in agriculture and horticulture, the amount of the preparation of the present invention is not limited and may be appropriately selected according to various conditions, such as the concentration of the active ingredient, the preparation. Form, type of disease to be treated, plant type, severity of disease or aphid, application time, application method, combined use of chemicals (insecticides, nematicides, acaricides, fungicides, herbicides, plants) Growth control agents, synergists, soil amendments, etc.), amount and type of fertilizer, and the like. This amount is usually every 100 m2 The area is from about 0.001 g to about 100 g. When a water-diluted emulsion, a wettable powder, a flowable formulation or the like is used, the concentration of the fungicidal or acaricidal formulation is from about 0.1 ppm to about 1000 ppm, preferably from about 1 ppm to 500 ppm. Granules, particles or the like are applied as such without dilution. The compounds of the invention are characterized by excellent fungicidal activity and broad spectrum activity. The compound is useful for controlling plant diseases attributed to pathogenic fungi and resistant pathogenic fungi. Examples of such pathogenic fungi include those which cause the following diseases or are resistant to fungicides for the treatment of the following diseases: rice blast, rice sheath blight, tomato gray mold and the like, apple powdery mildew, apple spots Alternaria blotch, persimmon powdery mildew, grape powdery mildew, barley powdery mildew, wheat powdery mildew, cucumber powdery mildew, cucumber gray mold, tomato late blight, potato late blight and the like. EXAMPLES The invention will be explained in more detail with reference to preparation examples, formulation examples and test examples. The invention is explained in more detail with reference to the following reference examples, manufacturing examples, formulation examples, and test examples. However, the invention is not limited to the examples. In addition, changes may be made without departing from the scope of the invention. Reference example 12- bromine -1-(2- Chlorophenyl ) Preparation of ethyl ketone To a cooled solution of 1-(2-chlorophenyl)ethanone (10.00 g, 64.51 mmol) in diethyl ether (35 ml), EtOAc (3. The resulting reaction mixture was then stirred at 0 ° C for 3 hours. After distilling all the volatiles under reduced pressure, the~~~~~~~~~~~ The combined organic layers were washed with EtOAc EtOAc (EtOAc)EtOAc. It was then used in the next step without further purification.1 H NMR (CDCl3 , 400 MHz) δ: 7.57-7.55 (m, 1H), 7.48-7.44 (m, 2H), 7.38-7.36 (m, 1H), 4.52 (s, 2H). Reference example 22- bromine -1-(2- Chlorophenyl ) Preparation of ethanol Add sodium borohydride (1.63 g, 42.91 mmol) to a solution of 2-bromo-1-(2-chlorophenyl)ethanone (10.00 g, 42.91 mmol) in methanol (40 ml) ). The resulting reaction mixture was then stirred at room temperature for 1 hour. After distilling all the volatiles under reduced pressure, the~~~~~~~~~~~~~ The combined organic layers were washed with EtOAc EtOAc (EtOAc)EtOAc. It was then used in the next step without further purification.1 H NMR (CDCl3 , 400 MHz) δ: 7.64-7.62 (m, 1H), 7.37-7.33 (m, 1H), 7.28-7.27 (m, 1H), 7.24-7.22 (m, 1H), 5.33-5.30 (m, 1H) , 3.81-3.78 (m, 1H), 3.47-3.42 (m, 1H), 2.71-2.70 (m, 1H). Reference example 3Methanesulfonic acid 2- bromine -1-(2- Chlorophenyl ) Preparation of ethyl ester Triethylamine (6.35 g, 62.92 mmol) was slowly added to a cooled solution of 2-bromo-1-(2-chlorophenyl)ethanol (9.90 g, 41.94 mmol) in THF (35 ml). Methanesulfonium chloride (4.82 g, 41.94 mmol) was then added. The resulting reaction mixture was then stirred at 0 °C for 2 hours. After distilling all the volatiles under reduced pressure, the~~~~~~~~~~~~ The combined organic layers were washed with EtOAc EtOAc m. It was then used in the next step without further purification.1 H NMR (CDCl3 , 400 MHz) δ: 7.59-7.54 (m, 1H), 7.42-7.35 (m, 2H), 7.24-7.22 (m, 1H), 6.14-6.11 (m, 1H), 3.78-3.73 (m, 1H) , 3.66-3.63 (m, 1H), 3.08 (m, 3H). Manufacturing example 12-(4-(2- Chlorophenyl )-1,3- Dithiazide 𠷬 -2- Subunit )-2-( Pyridine -3- base ) Acetonitrile (1c-3H and 1c-3L) 2-(Pyridin-3-yl)acetonitrile (0.19 g, 1.59) was slowly added to a stirred solution of potassium hydroxide (0.22 g, 3.97 mmol) in dimethyl hydrazine (3 ml). A solution of dimethyl sulfoxide (1 ml) followed by a solution of carbon disulfide (0.303 g, 3.97 mmol) in dimethyl hydrazine (1 ml). The resulting reaction mixture was then stirred at room temperature for 20 minutes. A solution of 2-bromo-1-(2-chlorophenyl)ethyl methanesulfonate (0.50 g, 1.59 mmol) in dimethyl hydrazine (1 ml) was slowly added to this mixture at room temperature. The reaction mixture was then further stirred at room temperature for 3 hours. The reaction mixture was diluted with ice-cooled distilled water (10 mL) andEtOAc. The combined organic layers were washed with brine, dried over sodium sulfate The crude product thus obtained was purified by column chromatography on a silica gel using a mixture of ethyl acetate and n-hexane as a solvent to obtain a mixture of 0.07 g and 0.11 g of the title compound as a pale yellow solid. Structures 1c-3H and 1c-3L. Using a solvent system of n-hexane and ethyl acetate, the two regioisomers of the title compound can be separated on TLC, and one of the higher Rf values is designated as 1c-3H, while the lower Rf value on TLC is lower. One is designated as 1c-3L. 1c-3H:1 H NMR (CDCl3, 400 MHz) δ: 8.83 (s, 1H), 8.54 (d, J = 4.0 Hz, 1H), 7.85-7.82 (m, 1H), 7.65-7.62 (m, 1H), 7.44-7.40 (m, 1H) , 7.35-7.28 (m, 3H), 5.75-5.72 (m, 1H), 3.94-3.89 (m, 1H), 3.74-3.69 (m, 1H). 1c-3L:1 H NMR (CDCl3, 400 MHz) δ: 8.84 (s, 1H), 8.54 (d, J = 4.8 Hz, 1H), 7.83-7.83 (m, 1H), 7.71-7.68 (m, 1H), 7.46-7.43 (m, 1H) , 7.37-7.30 (m, 3H), 5.73-5.68 (m, 1H), 3.96-3.89 (m, 1H), 3.74-3.69 (m, 1H). Manufacturing example 2(E&Z)-2-(4-(2- Chlorophenyl )-1,3- Dithiazide 𠷬 -2- Subunit )-2-(6- Chloropyridine -3- base ) Acetonitrile (1c-42) 2-(6-chloropyridin-3-yl)acetonitrile (0.15) was slowly added to a stirred solution of potassium hydroxide (0.13 g, 2.38 mmol) in dimethyl hydrazine (3 ml) at 0 ° C under a nitrogen atmosphere. g, 0.95 mmol) in dimethyl hydrazine (1 ml), followed by a solution of carbon disulfide (0.18 g, 2.38 mmol) in dimethyl hydrazine (1 ml). The resulting reaction mixture was then stirred at room temperature for 20 minutes. A solution of 2-bromo-1-(2-chlorophenyl)ethyl methanesulfonate (0.30 g, 0.95 mmol) in dimethyl hydrazine (1 ml) was slowly added to this mixture at room temperature. The reaction mixture was then further stirred at room temperature for 3 hours. The reaction mixture was diluted with ice-cooled distilled water (10 mL) andEtOAc. The combined organic layers were washed with brine, dried over sodium sulfate The crude product thus obtained was purified by column chromatography on a silica gel using a mixture of ethyl acetate and n-hexane as a solvent, to obtain 0.08 g of a brown viscous oil as two regioisomers. The title compound of the mixture.1 H NMR (CDCl3, 400 MHz) δ: 8.62-8.59 (m, 1H), 7.83-7.79 (m, 1H), 7.64-7.50 (m, 1H), 7.45-7.29 (m, 4H), 5.76-5.69 (m, 1H), 3.99-3.90 (m, 1H), 3.79-3.70 (m, 1H). Representative compounds of the invention are illustrated in the following Tables 1 to 5, but the invention is not limited to such compounds. Except for the compounds obtained in the production of Examples 1 and 2, the compounds shown in Tables 1 to 5 were produced by a method similar to that described in the methods or the descriptions set forth in Production Examples 1 and 2. The abbreviations in Tables 1 to 5 are as follows. F: fluorine, Cl: chlorine, Br: bromine, Me: methyl, t-Bu: tert-butyl, CF3 :trifluoromethyl, Ph: phenyl, NO2 : nitro, CN: cyano, OMe: methoxy, CF3 O: trifluoromethoxy, NH2 : Amine. Table 1: Details of the synthesized compounds belonging to the general structure (1a)*: *H and L herein refer to two regioisomers of a compound having a higher and lower Rf value on TLC, using a solvent system of n-hexane and ethyl acetate, respectively. Table 2: Details of the synthesized compounds belonging to the general structure (1b)*: *H and L herein refer to two regioisomers of a compound having a higher and lower Rf value on TLC, using a solvent system of n-hexane and ethyl acetate, respectively. Table 3: Details of the synthesized compounds belonging to the general structure (1c)*: *H and L herein refer to two regioisomers of a compound having a higher and lower Rf value on TLC, using a solvent system of n-hexane and ethyl acetate, respectively. Table 4: Details of the synthesized compounds belonging to the general structure (1d)*: *H and L herein refer to two regioisomers of a compound having a higher and lower Rf value on TLC, using a solvent system of n-hexane and ethyl acetate, respectively. Table 5: Details of the synthesized compounds belonging to the general structure (1e)*: *H and L herein refer to two regioisomers of a compound having a higher and lower Rf value on TLC, using a solvent system of n-hexane and ethyl acetate, respectively. a compound synthesized by the formula (1)1 H NMR data are shown in Tables 6 to 10. Table 6 Table 7 Table 8 Table 9 Table 10 Examples of the formulation are given below, wherein the parts are parts by weight. Formulation Example 1 (Emulsible Concentrate) 10 parts of each compound of the present invention were dissolved in 45 parts of Solvesso® 150 and 35 parts of N-methylpyrrolidone. Add 10 parts of emulsifier to it (trade name: Sorpol® 3005X, manufactured by Toho Kagaku Co., Ltd.). The ingredients are mixed with agitation to produce a 10% emulsifiable concentrate. Formulation Example 2 (Wettability Powder) 20 parts of each compound of the present invention were added to 2 parts of sodium lauryl sulfate, 4 parts of sodium lignosulfonate, 20 parts of fine powder of aqueous synthetic cerium oxide, and 54 parts of clay. mixture. The ingredients were mixed under agitation by a juicer to produce a 20% wettable powder. Formulation Example 3 (Particles) Five parts of each compound of the present invention were mixed with 2 parts of sodium dodecylbenzenesulfonate, 10 parts of bentonite and 83 parts of clay, followed by thorough agitation. A suitable amount of water is added and the mixture is further stirred. The mixture was granulated by a granulator and air dried to yield 5% granules. Formulation Example 4 (Powder) One part of each compound of the present invention was dissolved in a suitable amount of acetone. To the solution were added 5 parts of a fine powder of aqueous synthetic cerium oxide, 0.3 part of acidic isopropyl phosphate (PAP) and 93.7 parts of clay, followed by mixing and stirring by a juicer. Acetone was removed from it by evaporation to yield a 1% powder formulation. Formulation Example 5 (Flowable Formulation) 20 parts of each compound of the present invention and 20 parts containing 3 parts of polyoxyethylene tristyrylphenyl ether phosphate and triethanolamine and 0.2 part of Rhodorsil® Mix 426R (made by RhodiaChimie). The mixture was pulverized by a wet method (trade name: DYNO-Mill, manufactured by Willy A. Bachofen AG) and further mixed with 60 parts of water containing 8 parts of propylene glycol and 0.32 parts of xanthan gum. This produces a 20% suspension in water. Test examples are given below to demonstrate that the compounds of the invention are useful as active ingredients in fungicides.Test case 1 ( Fungicidal test against Botrytis cinerea ) A solution of the compound of the invention (500 ppm and 200 ppm) was sprayed onto fresh, healthy cucumber plants at least during the three-leaf stage. The cotyledons of the treated plants were cut and the leaves were placed on a wet tissue paper on a plastic tray. 50 μl spore suspension (1 × 10) using a micropipette6 Cfu spores/ml) dripped on the middle of the leaves. Then, a small piece of disc-shaped cotton wool was placed on the spore drop, and 50 μl of the spore suspension was again dropped on the wafer. The leaves were kept at room temperature (20 ° C). The radial growth of the fungus was measured five days after inoculation, and the activity of the compound was shown as a preventive value calculated according to the following equation. Prevention value (%) = {1 - (radial growth on treatment) / (radial growth on control)} × 100. Compounds exhibiting a 50% or greater prophylactic value at a treatment concentration of 500 ppm are as follows: Compound No.: 1c-1, 1c-2H, 1c-2L, 1c-3, 1c-3H, 1c-3L, 1c-4H , 1c-4L, 1c-5L, 1c-6L, 1c-8, 1c-8H, 1c-8L, 1c-9, 1c-9H, 1c-9L, 1c-10H, 1c-10L, 1c-11H, 1c -11L, 1c-13H, 1c-13L, 1c-14H, 1c-15H, 1c-16, 1c-16H, 1c-19, 1c-20, 1c-23, 1c-23H, 1c-23L, 1c-24 , 1c-24H, 1c-25H, 1c-25L, 1c-26, 1c-26H, 1c-26L, 1c-27H, 1c-28L, 1c-29H, 1c-29L, 1c-30H, 1c-32H, 1c -32L, 1c-33, 1c-34H, 1c-34L, 1c-35, 1c-35H, 1c-35L, 1d-1H, 1d-6H, 1d-6L, 1d-13, 1d-17, 1d-17H , 1d-17L, 1e-3, 1e-7. Compounds exhibiting a 50% or greater prophylactic value at a treatment concentration of 200 ppm are as follows: Compound No.: 1c-2H, 1c-2L, 1c-3, 1c-3H, 1c-3L, 1c-4H, 1c-4L , 1c-5L, 1c-6L, 1c-8, 1c-8H, 1c-8L, 1c-9, 1c-9H, 1c-9L, 1c-10H, 1c-10L, 1c-11H, 1c-13H, 1c -13L, 1c-14H, 1c-15H, 1c-16, 1c-16H, 1c-19, 1c-20, 1c-23, 1c-23H, 1c-23L, 1c-24H, 1c-25H, 1c-25L , 1c-26, 1c-26H, 1c-26L, 1c-27H, 1c-29H, 1c-29L, 1c-32H, 1c-32L, 1c-33, 1c-34H, 1c-34L, 1c-35, 1c -35H.Test case 2 ( Fungicidal test on cucumber powdery mildew ) A solution of the compound of the invention (500 ppm) was sprayed onto fresh, healthy 2 week old cucumber plants. The plants are air-dried and inoculated with a freshly prepared spore suspension (1 × 10)6 Cfu spores / ml). The inoculated plants were then placed in a greenhouse (25 ° C, 60% humidity and 16 L 8D). The disease area ratio after 12 days of inoculation was measured, and the activity of the compound was shown as a preventive value calculated according to the following equation. Prevention value (%) = {1 - (processed disease area rate) / (control disease area rate)} × 100. Compounds exhibiting a prophylactic value of 50% or greater are as follows: Compound No.: 1c-1, 1c-1H, 1c-1L, 1c-2H, 1c-2L, 1c-3, 1c-3H, 1c-3L, 1c -4H, 1c-4L, 1c-5H, 1c-5L, 1c-6, 1c-6H, 1c-6L, 1c-7H, 1c-7L, 1c-8, 1c-8H, 1c-8L, 1c-9 , 1c-9H, 1c-9L, 1c-10H, 1c-10L, 1c-11H, 1c-11L, 1c-13H, 1c-13L, 1c-14H, 1c-15H, 1c-15L, 1c-16, 1c -16H, 1c-16L, 1c-17H, 1c-18L, 1c-19H, 1c-19L, 1c-20, 1c-21H, 1c-21L, 1c-22H, 1c-23, 1c-23H, 1c-23L , 1c-25H, 1c-25L, 1c-26, 1c-26H, 1c-26L, 1c-27H, 1c-27L, 1c-28H, 1c-28L, 1c-29H, 1c-29L, 1c-30H, 1c -30L, 1c-31H, 1c-31L, 1c-32H, 1c-32L, 1c-33, 1c-34H, 1c-34L, 1c-35, 1c-35H, 1c-35L, 1c-36, 1c-37 , 1c-37, 1c-40H, 1c-40L, 1c-41H, 1c-41L, 1d-1, 1d-1H, 1d-1L, 1d-12, 1d-13, 1d-13L.Test case 3 ( Fungicidal test for Phytophthora infestans ) A solution of the compound of the invention (500 ppm) was sprayed onto fresh, healthy tomato plants at least during the three-leaf stage. The plants are air-dried and inoculated with a freshly prepared sporangia suspension (1 × 10)6 Cfu travels spores / ml). The inoculated plants were then placed in a dew chamber (20 ° C and 100% humidity). One day after inoculation, the plants were transferred to a thermostatic chamber (20 ° C, 80% humidity and 16 L8D). The disease area ratio after 5 days of inoculation was measured, and the activity of the compound was shown as a preventive value calculated according to the following equation. Prevention value (%) = {1 - (processed disease area rate) / (control disease area rate)} × 100. Compounds exhibiting a prophylactic value of 50% or greater are as follows: Compound Nos.: 1c-1, 1C-16, 1c-16H, 1c-16L, 1c-19H.Test case 4 ( Magnaporthe oryzae (Pyricularia grisea) Fungicidal test ) A solution of the compound of the invention (500 ppm) was sprayed onto fresh, healthy 2 week old millet plants. The plants are air-dried and inoculated with a freshly prepared spore suspension (1 × 10)6 Cfu spores / ml). The inoculated plants were then placed in an open room (25 ° C and 100% humidity). One day after inoculation, the plants were transferred to a thermostatic chamber (25 ° C, 80% humidity and 16 L8D). The disease area ratio after 5-7 days of inoculation was measured, and the activity of the compound was shown as a preventive value calculated according to the following equation. Prevention value (%) = {1 - (processed disease area rate) / (control disease area rate)} × 100. Compounds exhibiting a preventive value of 50% or greater are as follows: Compound No.: 1c-1, 1c-1L, 1c-2H, 1c-2L, 1c-3, 1c-3H, 1c-3L, 1c-4H, 1c -4L, 1c-5H, 1c-5L, 1c-6, 1c-6H, 1c-6L, 1c-8, 1c-8H, 1c-8L, 1c-9, 1c-9H, 1c-9L, 1c-10H , 1c-10L, 1c-11H, 1c-11L, 1c-12, 1c-12H, 1c-13, 1c-13H, 1c-13L, 1c-14H, 1c-15H, 1c-15L, 1c-16, 1c -16H, 1c-16L, 1c-17H, 1c-18L, 1c-19, 1c-19L, 1c-20, 1c-21H, 1c-21L, 1c-23, 1c-23H, 1c-23L, 1c-24 , 1c-24H, 1c-25H, 1c-25L, 1c-26, 1c-26H, 1c-26L, 1c-27H, 1c-30L, 1c-32H, 1c-32L, 1c-34H, 1c-34L, 1c -35, 1c-35H, 1c-35L, 1c-37, 1c-37L, 1c-38H, 1c-38L, 1c-44, 1b-5L, 1d-1H, 1d-1L, 1d-6L, 1d-7 , 1d-7H, 1d-7L, 1d-8, 1d-11, 1d-11H, 1d-11L, 1d-12L, 1d-15, 1d-16, 1d-16H, 1d-16L, 1d-17, 1d -17H, 1e-6. (Note) As described above, the present invention is illustrated by the preferred embodiments of the present invention. However, it should be understood that the scope of the invention should be construed only by the scope of the claims. It is to be understood that the patents, patent applications, and documents cited herein are hereby incorporated by reference in their entirety in their entirety in their entirety herein The present application claims priority to Indian Patent Application No. 201711008910, filed on March 15, 2017, to the Indian Patent Office (Intellectual Property India), the entire contents of which are incorporated by reference. The manner is incorporated herein. Industrial Applicability The dithiazide compound of the present invention has an antibacterial effect against plant diseases and can be used as an active ingredient of a plant control agent.

Claims (14)

一種由式(1)表示之二噻𠷬化合物:, 或其鹽或其N-氧化物, 其中R1 、R2 及R3 相同或不同,且各自表示氫、鹵素、C1-6 烷基、C1-6 鹵代烷基、C1-6 烷氧基、C1-6 鹵代烷氧基、C1-6 烷氧基C1-6 烷基、C1-6 鹵代烷氧基C1-6 烷基、C2-6 烯基、C2-6 鹵代烯基、C2-6 炔基、C2-6 鹵代炔基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、視情況經取代之芳基、視情況經取代之雜芳基或視情況經取代之雜環基,R1 、R2 及R3 基團中之兩者一起可經由或不經由至少一個雜原子形成環,表示為R1 、R2 及R3 之該等基團可視情況經進一步取代;Y1 表示視情況經取代之芳基、視情況經取代之吡啶基、視情況經取代之吡嗪基、視情況經取代之嘧啶基或視情況經取代之嗒嗪基;Y2 表示視情況經取代之芳基或視情況經取代之雜芳基;Q表示氫、硝基、氰基、C1-6 烷基、C1-6 鹵代烷基、C3-8 環烷基、C3-8 環烷基C1-6 烷基、C1-6 烷基羰基、C1-6 鹵代烷基羰基、C3-8 環烷基羰基、C1-6 烷氧基羰基、C1-6 鹵代烷氧基羰基、C3-8 環烷氧基羰基、C1-6 烷硫基、C1-6 鹵代烷基硫基、C3-8 環烷基硫基、C3-8 環烷基C1-6 烷硫基、C1-6 烷氧基C1-6 烷硫基、C1-6 烷基磺醯基、C1-6 烷基亞磺醯基、C1-6 鹵代烷基磺醯基、C1-6 鹵代烷基亞磺醯基、C3-8 環烷基磺醯基、C3-8 環烷基亞磺醯基、C3-8 環烷基C1-6 烷基磺醯基、C3-8 環烷基C1-6 烷基亞磺醯基、視情況經取代之芳硫基、視情況經取代之芳基C1-6 烷硫基、視情況經取代之芳基磺醯基、視情況經取代之芳基亞磺醯基、視情況經取代之芳基、視情況經取代之雜芳基或視情況經取代之雜環基。A dithiazide compound represented by formula (1): Or a salt thereof or an N-oxide thereof, wherein R 1 , R 2 and R 3 are the same or different and each represents hydrogen, halogen, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkane Oxy, C 1-6 haloalkoxy, C 1-6 alkoxy C 1-6 alkyl, C 1-6 haloalkoxy C 1-6 alkyl, C 2-6 alkenyl, C 2-6 Haloalkenyl, C 2-6 alkynyl, C 2-6 haloalkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-6 alkyl, optionally substituted aryl And optionally substituted heteroaryl or optionally substituted heterocyclic group, the two of the R 1 , R 2 and R 3 groups together may form a ring via or without at least one hetero atom, denoted as R 1 The groups of R 2 and R 3 may be further substituted as appropriate; Y 1 represents an optionally substituted aryl group, optionally substituted pyridyl group, optionally substituted pyrazinyl group, optionally substituted Pyrimidinyl or optionally substituted pyridazinyl; Y 2 represents optionally substituted aryl or optionally substituted heteroaryl; Q represents hydrogen, nitro, cyano, C 1-6 alkyl, C 1-6 haloalkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 halogenated Alkylcarbonyl, C 3-8 cycloalkylcarbonyl, C 1-6 alkoxycarbonyl, C 1-6 haloalkoxycarbonyl, C 3-8 cycloalkoxycarbonyl, C 1-6 alkylthio, C 1-6 haloalkylthio, C 3-8 cycloalkylthio, C 3-8 cycloalkyl C 1-6 alkylthio, C 1-6 alkoxy C 1-6 alkylthio, C 1 -6 alkylsulfonyl, C 1-6 alkylsulfinylene, C 1-6 haloalkylsulfonyl, C 1-6 haloalkylsulfinyl, C 3-8 cycloalkylsulfonyl , C 3-8 cycloalkylsulfinyl, C 3-8 cycloalkyl C 1-6 alkylsulfonyl, C 3-8 cycloalkyl C 1-6 alkylsulfinylene, optionally Substituted arylthio, optionally substituted aryl C 1-6 alkylthio, optionally substituted arylsulfonyl, optionally substituted arylsulfinyl, optionally substituted An aryl group, optionally substituted heteroaryl or optionally substituted heterocyclic group. 如請求項1之二噻𠷬化合物或其鹽或其N-氧化物,其中R1 、R2 及R3 相同或不同,且各自表示氫、鹵素或C1-6 烷基。The thiazide compound according to claim 1 or a salt thereof or an N-oxide thereof, wherein R 1 , R 2 and R 3 are the same or different and each represents hydrogen, halogen or C 1-6 alkyl. 如請求項1或2之二噻𠷬化合物或其鹽或其N-氧化物,其中R1 、R2 及R3 相同或不同,且各自表示氫或C1-6 烷基。The thiazide compound according to claim 1 or 2, wherein R 1 , R 2 and R 3 are the same or different and each represents hydrogen or a C 1-6 alkyl group, or a salt thereof or an N-oxide thereof. 如請求項1至3中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 係視情況經取代之芳基或視情況經取代之吡啶基。The dithiaxanthene compound of any one of claims 1 to 3, or a salt thereof, or an N-oxide thereof, wherein Y 1 is optionally substituted aryl or optionally substituted pyridyl. 如請求項1至4中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 係視情況經取代之吡啶基。The dithiaxanthene compound of any one of claims 1 to 4, or a salt thereof, or an N-oxide thereof, wherein Y 1 is optionally substituted pyridyl. 如請求項1至5中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 表示:, 其中*係與母體化合物之連接點。The dithiazide compound according to any one of claims 1 to 5, or a salt thereof or an N-oxide thereof, wherein Y 1 represents: , where * is the point of attachment to the parent compound. 如請求項1至5中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 表示:, 其中*係與母體化合物之連接點。The dithiazide compound according to any one of claims 1 to 5, or a salt thereof or an N-oxide thereof, wherein Y 1 represents: , where * is the point of attachment to the parent compound. 如請求項1至5中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Y1 表示:, 其中*係與母體化合物之連接點。The dithiazide compound according to any one of claims 1 to 5, or a salt thereof or an N-oxide thereof, wherein Y 1 represents: , where * is the point of attachment to the parent compound. 如請求項1至8中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係視情況經取代之芳基。The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of claims 1 to 8, wherein Y 2 is an optionally substituted aryl group. 如請求項1至8中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係視情況經取代之雜芳基。The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of claims 1 to 8, wherein Y 2 is optionally substituted heteroaryl. 如請求項1至8及10中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Y2 係選自由以下組成之群:;且 *係與該母體化合物之連接點。The dithiaxanthene compound or a salt thereof or an N-oxide thereof according to any one of claims 1 to 8 and 10, wherein the Y 2 is selected from the group consisting of: , and And * is the point of attachment to the parent compound. 如請求項1至11中任一項之二噻𠷬化合物或其鹽或其N-氧化物,其中Q係氰基。The dithiaxanthene compound of any one of claims 1 to 11 or a salt thereof or an N-oxide thereof, wherein the Q is a cyano group. 一種植物病害防治劑,其含有如請求項1至12中任一項之二噻𠷬化合物或其鹽或其N-氧化物。A plant disease controlling agent comprising the dithiazide compound according to any one of claims 1 to 12, or a salt thereof or an N-oxide thereof. 一種殺真菌劑,其含有如請求項1至12中任一項之二噻𠷬化合物或其鹽或其N-氧化物。A fungicide comprising the dithiazide compound according to any one of claims 1 to 12, or a salt thereof or an N-oxide thereof.
TW107108616A 2017-03-15 2018-03-14 Novel dithiolane compound or a salt or an n-oxide and use thereof TW201837025A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201711008910 2017-03-15
IN201711008910 2017-03-15

Publications (1)

Publication Number Publication Date
TW201837025A true TW201837025A (en) 2018-10-16

Family

ID=62002170

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107108616A TW201837025A (en) 2017-03-15 2018-03-14 Novel dithiolane compound or a salt or an n-oxide and use thereof

Country Status (3)

Country Link
AR (1) AR111179A1 (en)
TW (1) TW201837025A (en)
WO (1) WO2018167677A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061716A (en) * 1990-09-13 1991-10-29 Uniroyal Chemical Company, Inc. Fungicidal 3,3-bisthioalkyl-2-pyridylacrylic acid compounds
US7897638B2 (en) 2005-04-12 2011-03-01 Philadelphia Health & Education Corporation Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules
WO2007045989A1 (en) 2005-10-20 2007-04-26 Pfizer Limited Pyridyl derivatives useful as h3 ligands
WO2015003991A1 (en) 2013-07-12 2015-01-15 Syngenta Participations Ag Novel microbiocides
WO2015011194A1 (en) 2013-07-26 2015-01-29 Syngenta Participations Ag Novel microbiocides
WO2015162269A1 (en) 2014-04-25 2015-10-29 Syngenta Participations Ag Microbiocidal imidazole derivatives
WO2015162268A1 (en) 2014-04-25 2015-10-29 Syngenta Participations Ag Microbiocidal imidazole derivatives
WO2015162271A1 (en) 2014-04-25 2015-10-29 Syngenta Participations Ag Microbiocidal imidazole derivatives

Also Published As

Publication number Publication date
WO2018167677A1 (en) 2018-09-20
AR111179A1 (en) 2019-06-12

Similar Documents

Publication Publication Date Title
TWI609008B (en) Tetrazolinone compounds and its use
CN104271571B (en) Terazololine-one compound and application thereof
EP3029035B1 (en) Tetrazolinone compound, and use thereof
CN105636957B (en) Terazololine-one compound and application thereof
CN105593217B (en) Terazololine-one compound and application thereof
KR20150070113A (en) Tetrazolinone compounds and their use as pesticides
BR112015026644B1 (en) TETRAZOLINONE COMPOUND AND USE OF THE SAME
US9788547B2 (en) Aromatic compound and uses thereof
EP3130584B1 (en) Aromatic compound and uses thereof
CN105636955B (en) Terazololine-one compound and application thereof
AU2017293178A1 (en) Heterocyclic compound and harmful arthropod controlling agent containing same
BR112016012482B1 (en) aromatic compound, its use, agent and method of pest control
US10070646B2 (en) Tetrazolinone compound and application thereof
EP3124484B1 (en) Tetrazolinone compound and application thereof
US9822095B2 (en) Tetrazolinone compound and application thereof
TW201837025A (en) Novel dithiolane compound or a salt or an n-oxide and use thereof
TW201831457A (en) Novel fungicidal carbamate compounds